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Abstract 
Most biochemical reactions in nature are catalyzed by enzymes. These biocatalysts 
accelerate reaction rates by lowering the activation energy and can carry out different 
competing and incompatible reactions at the same time. The active site of the enzyme binds 
to the substrate, catalyzes the reaction and releases the reactions products. The small 
biocatalysts are distinguished by extraordinary properties and characteristics such as high 
selectivity, accuracy, and exceptional high catalytic activities. These features make 
enzymes interesting for various applications in pharma and food industry, agriculture or 
waste management. However, production of natural enzymes on a large scale remains 
challenging. Therefore, research aims for artificial methods to mimic the properties and 
catalytic activities of enzymes. 
This thesis focusses on new approaches for the imitation of natural, single enzymes and 
their cooperation in enzymatic clusters. Natural, soluble enzymes frequently have a 
hydrophobic core and a hydrophilic shell ensuring their solubility and functionality in 
complex environments. Inspired by nature, the general principle of core-shell structures is 
used within this work. A new biopolymer conjugate with attached catalytic moieties is 
developed to mimic enzymatic functionality. Similar to nature’s polypeptide chains, the 
natural polysaccharide dextran is used as carrier material that allows bioorthogonal 
attachment of hydrophilic polymers as shielding corona as well as artificial cleavage sites. 
Such artificial moieties are e.g. supramolecular catalysts which can mimic enzyme-like 
active sites. Macrocyclic polyamines are known to be highly selective in cleaving 
adenosine triphosphate (ATP) to its diphosphate (ADP). Cyclic polyamines with functional 
groups are designed to allow an attachment to the dextran-based backbone. The 
ATPase-like enzymatic system demonstrates catalytic activity in in vitro assays and high 
biocompatibility. The potential application and performance of the artificial ATPase in 
complex cellular environment still needs to be evaluated. 
In addition, the cooperation of enzymes in molecular machines is mimicked. Molecular 
machines are multifunctional enzymatic clusters in which enzymes work together to 
perform complex and demanding transformations. In this thesis, a new access to such 
multifunctional enzymatic cascade reactions is presented using artificial methods. A 
catalytically active hexapeptide is conjugated to the surface of cytochrome c (Cyt c). The 
combination of the esterase-like activity of the histidine-containing peptide with the 
peroxidase activity of Cyt c results in a biomaterial that performs catalytic cascade 
reactions within one entity. Additionally, it is possible to transfer the designed approach 
to other proteins. Further experiments will focus on modifications with several functional 
entities to implement more complex cascade reactions. 
Both developed systems represent promising approaches for the mimicking of enzymes 
and enzymatic clusters by artificial methods. Further studies will focus on their application 
possibilities in vitro and enhanced multifunctionality. 
   
IX 
Zusammenfassung 
In der Natur katalysieren Enzyme die meisten biochemischen Reaktionen. Diese 
Biokatalysatoren beschleunigen Reaktionen, indem sie deren Aktivierungsenergie herab-
setzen. Enzyme führen viele konkurrierende Reaktionen durch. In ihrem aktiven Zentrum 
wird das Substrat gebunden, die Reaktion katalysiert und die Reaktionsprodukte werden 
freigesetzt. Enzyme zeichnen sich durch außergewöhnliche Eigenschaften wie eine hohe 
Selektivität, Präzision und hohe katalytische Aktivität aus. Jene Merkmale machen sie für 
Anwendungen in der Pharma- und Lebensmittelindustrie sowie in der Land- und 
Abfallwirtschaft besonders interessant. Da die Herstellung von natürlichen Enzymen in 
großen Mengen allerdings schwierig ist, stellt die Entwicklung künstlicher Methoden zur 
Nachahmung von enzymatischen Eigenschaften ein sehr interessantes Forschungsfeld dar. 
In dieser Arbeit werden neue Herangehensweisen für die Imitation von einzelnen 
Enzymen und ihrem Zusammenspiel in enzymatischen Clustern beschrieben. Lösliche 
Enzyme besitzen in der Natur häufig einen eher hydrophoben Kern und eine hydrophile 
Hülle, die ihre Löslichkeit und Funktionalität gewährleisten. Dieses generelle Prinzip wird 
in dieser Arbeit verwendet, um ein neuartiges Biopolymerkonjugat mit katalytisch aktiven 
Komponenten zu entwickeln. Als Trägermaterial wird das natürliche Polysaccharid 
Dextran verwendet, das durch Modifizierung die gleichzeitige Anbringung einer abschirm-
enden Korona und von künstlichen, aktiven Zentren ermöglicht. Solche Zentren sind z.B. 
supramolekulare Strukturen wie macrocyclische Polyamine. Diese Verbindungen, können 
Adenosintriphosphate (ATP) in Adenosindiphosphate (ADP) spalten. Eine synthetische 
Modifizierung der Polyamine ermöglicht ihre Anbindung an das Dextran Rückgrat. Das 
ATPase ähnliche enzymatische System zeigt katalytische Aktivität und eine hohe 
Biokompatibilität in in vitro Experimenten. Zukünftig können weitere Untersuchungen zur 
Anwendung der künstlichen ATPase in zellulärer Umgebung durchgeführt werden. 
Zusätzlich wird die Interaktion von Enzymen in molekularen Maschinen nachgeahmt. 
Molekulare Maschinen sind Zusammenschlüsse mehrerer Enzyme zu hochkomplexen 
funktionellen Einheiten. In dieser Arbeit wird eine neue Idee zum Nachbau solcher multi-
funktionalen Netzwerke, die Kaskadenreaktionen durchführen können, präsentiert. Ein 
Hexapeptid, das katalytisch aktive Histidine enthält, wird auf die Oberfläche von Cyto-
chrom c (Cyt c) aufgebracht. Die Kombination der Esterase ähnlichen Aktivität des Peptids 
mit der Peroxidase Aktivität von Cyt c führt zu einem Biomaterial das katalytische Kaska-
denreaktionen durchführen kann. Außerdem ist es möglich, das entwickelte System auf 
andere Proteine zu übertragen. Weitere Experimente sollen die Einführung mehrerer 
Funktionalitäten ermöglichen und komplexere Kaskadenreaktionen erlauben. 
Beide hier entwickelten Systeme stellen vielversprechende Ideen für die Nachahmung von 
Enzymen und Enzymclustern dar. Zukünftig sollen deren Anwendungsmöglichkeiten in 
vitro und eine verbesserte Multifunktionalität untersucht werden.  
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1 
1 Introduction and Basic Concepts 
1.1 Enzymes – Multifunctional Catalysts 
Structure and Organization 
Enzymes are nature’s multifunctional biological catalysts. Almost all known enzymes are, 
with few exceptions, proteins that are formed by the folding of linear peptide chains. These 
polypeptides consist of the standard 20 amino acids which differ in their side chains in 
size, charge, shape, hydrophobic or hydrophilic character or in their chemical reactivity.[1] 
The sequence of amino acids determines the primary structure of proteins and enzymes, 
respectively.[2] The folding of the main chain to the tertiary structure is a very complex 
process and devoid of symmetry, however, the distribution of the side chains of amino 
acids is remarkable. Soluble enzymes that are not attached to cellular components such as 
membranes have an interior that consists of mainly hydrophobic residues such as leucine, 
valine or phenylalanine whereas the surface features more hydrophilic residues such as 
glutamate, lysine and arginine (Figure 1a). This distribution is driven by thermodynamic 
forces to cluster the hydrophobic groups in the core of the enzyme to ensure greater 
stability of the structure which is mainly associated with noncovalent, hydrophobic 
intermolecular forces.[3-4] The described architecture protects the catalytically active sites 
of the enzymes and guarantees their full functionality in complex and demanding 
biosystems. 
Catalytic Activity and Mechanisms 
Enzymes are distinguished by an enormous catalytic activity located in their active sites. 
In comparison to the whole enzyme, the active site represents only a small part of the total 
volume of the enzyme’s structure but provides arrangement of the catalytically active 
amino acid residues. The active center generates a specific, selective environment such as 
clefts, crevices or cavities which bind the substrate noncovalently and facilitate the 
catalysis (Figure 1a). The 20 standard amino acids are often not sufficient for carrying out 
complex chemical reactions at the active site of the enzyme.[5] Therefore lots of enzymes 
need small molecules, called cofactors, for their catalytic activity. Non-proteinogenic 
chemical compounds like pyridoxal phosphate, ubiquinone or ascorbic acid assist during 
catalysis. Cofactors are divided into two groups: metals (inorganic ions) and small organic 
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compounds, called coenzymes. The latter are often derivatives of vitamins that can be 
either bound tightly or loosely to the enzyme. If they are bound tightly or even covalently, 
the coenzyme is called a prosthetic group and cannot dissociate from the enzyme.[6] 
 
Figure 1: (a) Cross section of enzymes. Nature’s multifunctional catalysts provide in their active sides a 
distinct, often hydrophobic local environment with clefts or cavities for interaction with their substrates. 
Reprinted with permission from Blasiak et al.[7] and Brown et al.[8] (b) Comparison of catalyzed and 
uncatalyzed chemical reaction in energy diagram: enzymes accelerate reactions by lowering the activation 
energy and facilitate the formation of the transition state.  
Enzymes are inevitable for all biochemical transformations since without their presence 
most reactions cannot occur. They accelerate reactions by factors of as much as a million 
or more.[1] The setup of enzymes enables their high selectivity and accuracy towards 
chemical reactions. This property is ensured by their capacity to specifically bind lots of 
different molecules. Enzymes use all available kinds of intermolecular forces such as 
hydrogen bonding, dipole or van-der-Waals forces[9] to bring their reaction partners in an 
optimal orientation for the cleavage or setup of new chemical bonds. Often the catalyzed 
reactions occur via transition states, which are the highest energy species in reaction 
pathways. At the same time enzymes facilitate the formation of such transition states and 
reduce the activation energy of reactions (Figure 1b).[10] The bonding of substrate to 
enzyme enables a catalyzed reaction pathway whose transition state has a lower activation 
energy than for the comparable reaction without an enzyme. 
Enzymes have fundamentally five catalytical mechanisms to form and stabilize a transition 
state. Mostly they use one or multiple of the following approaches: The first strategy uses 
bonding energy. Hereby bonding of the transition state to the enzyme is stronger than 
bonding to substrates or reaction products. The second mechanism is covalent catalysis. 
At this, amino acid residues, mostly nucleophilic ones like lysines, or enzymatic cofactors 
like pyridoxal phosphate form covalent bonds to the substrate and generate a transient 
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intermediate product. The histidine decarboxylase is an example of such a covalent 
catalysis by forming histamine from histidine using covalent catalysis.[11] A further 
strategy is general acid-base catalysis. Amino acid residues like histidines act as acids or 
bases while donating or accepting protons. The acetylcholinesterase (AChE) is an enzyme 
that uses acid-base catalysis to cleave acetylcholine and some other neurotransmitters.[12] 
Metal ion catalysis represents the fourth catalytical strategy. In metal complexes or as 
redox partners, positive metal ions (Zn2+, Fe2+/3+, Cu+/2+) support the catalysis while 
stabilizing negative charges or activating water molecules. Carboxypeptidase A, an 
exopeptidase, uses Zn2+ in its active center for the hydrolysis of peptide bonds.[13] The last 
strategy is catalysis by approximation. By binding two or more substrates in the right 
orientation and conformation, their spatial position allows for a significantly increased 
reaction rate. The NMP-Kinases (nucleoside-monophosphate kinase) bring two 
nucleotides in close proximity to facilitate the transfer of one phosphate group to the 
other.[14] 
Classification of Enzymes 
Often enzymes have general names that provide no information about the type of their 
catalyzed reactions. The name is basically formed by attaching the suffix -ase to the 
substrate they bind and transform. 
Table 1: The six main classes of enzymes according to their catalyzed type of reaction with general and 
specific examples.[1] 
enzyme class type of reaction examples 
oxidoreductases 
oxidation-reduction, transfer of oxygen and/or 
hydrogen atoms or electrons 
alcohol dehydrogenase, 
cytochrome c oxidase 
transferases 
transfer of functional groups 
like acetyl, methyl or phosphate groups 
transaminases, 
hexokinase 
hydrolases hydrolysis by using water 
esterases, 
pepsin 
lyases 
non-hydrolytic removal of groups of atoms to 
form double bonds 
aldolase, 
fumarase 
isomerases 
rearrangement of groups or atoms within a 
molecule (intramolecular group transfer) 
retinol isomerase 
tartrate epimerase 
ligases 
joining of two molecules by forming a new bond 
and mostly ATP cleavage 
synthetases 
urea carboxylase 
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In 1964, enzymes were divided into six numbered main classes by the International Union 
of Biochemistry[15] according to the reaction they catalyze. Table 1 displays the six major 
enzyme classes. These groups are further divided into subgroups so that a four-digit 
number can identify all known enzymes, e.g., the tripeptide aminopeptidase has the 
number EC 3.4.11.4 where 3 stands for a hydrolase, 4 peptidase, 11 aminopeptidase and 4 
for the specific tripeptide aminopeptidase. 
Enzyme Kinetics 
Terms and calculations that are used in physical chemistry to describe chemical reaction 
kinetics are transferred to characterize the catalytic activity of enzymes. These methods 
provide not only information about the catalytic enzymatic rates but also facts about 
mechanisms of enzyme catalysis, regulation and binding processes.[16] 
 
Figure 2: (a) Formation of enzyme-substrate complex and release of product and enzyme. (b) 
Michaelis-Menten kinetics with saturation curve of an enzyme. vmax is maximal velocity which is approached 
asymptotically. The Michaelis-Menten constant KM is the substrate concentration at which vmax is reached 
by half. (c) Overview of important enzymatic parameters to describe enzyme kinetics. 
In 1913, L. Michaelis and M. Menten[17-18] proposed a simple model to describe enzyme 
kinetics. They assumed that the enzyme-catalyzed reaction occurs in two stages with a 
first formation of an enzyme-substrate complex followed by an actual catalysis step which 
releases the product (Figure 2a). In 1924, the model was further used by G. Briggs and 
J. Haldane who used steady-state assumption[19] to simplify the kinetic equations. Some 
kinetic parameters[20] will be briefly discussed in the following paragraph but explained in 
detail once applied. Generally, enzymatic velocity depends on substrate concentration as 
shown in Figure 2b. The maximum speed of a reaction vmax can be initially achieved once 
substrate concentration is high enough to generate a constant rate of product formation. 
The Michaelis-Menten constant KM describes the substrate concentration at which the 
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reaction rate is half of maximum velocity. KM displays an inverse measurement of 
substrate’s affinity and depends on enzyme and substrate as well as on temperature, pH or 
ionic strength. A small value for KM describes a very tight binding to the substrate, a high 
KM value, in contrast, a very loose binding. By means of maximal velocity vmax, the turnover 
rate kcat (catalytic rate, rate constant, turnover constant, turnover number) can be 
calculated. This number describes the number of substrate molecules which can be 
converted per second to the product at full substrate saturation. The ratio of kcat to KM is 
called catalytic efficiency (kinetic efficiency, specificity constant) and combines substrate’s 
affinity of the enzyme with speed of product formation. This parameter allows for 
comparison of different enzymes because it is defined by two independent parameters. 
Potential Application of Enzymes 
The possible utilization of enzymes in pharma[21-22], food[23-24], detergent[25] or textile[26] 
industry attracted huge attention in the last years. Beginning with zymosis which is a 
process known for over 200 years as alcoholic fermentation and which was fully clarified 
by L. Pasteur in 1857[27], enzymes are nowadays being used as highly specific biocatalysts 
which loom large in modern biotechnology.[28] They play an important role in the biogas 
and bioethanol production as well as in biosensors and biofuel cells. However, modern 
synthetic chemistry methods advanced enormously in the past years, enzymatic 
biotransformations still remain the most economic and most cost-effective techniques in 
many cases. With high turnover numbers and enormous rate accelerations, enzymes are 
outstanding biocatalysts that can be recovered and reused multiple times. In particular, in 
the synthesis of enantiomerically pure compounds, which is still a challenge for organic 
chemists, enzymes have proven superior properties. One example is the synthesis of 
statins.[29] These compounds inhibit the enzyme HMG-CoA reductase which catalyzes an 
important step in cholesterol biosynthesis. Statins lower cholesterol level and therefore the 
probability of morbidity and mortality from coronary heart disease.[30-31] Various statins, 
like atorvastatin, rosuvastatin or fluvastatin have stereospecific side chains of 
3,5-dihydroxy acids which are synthesized enantiomerically pure by lipases, nitrilases or 
aldolases. But not only isolated enzymes are in the focus of today’s research, also 
immobilized enzymes[32] or association of multiple enzyme complexes[33-34] are in the 
scope of industrial applications. For example, the second most abundant polysaccharide in 
nature xylan, a hemicellulose, consisting of mainly D-xyloses can be broken down by 
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xylanases.[35] The association of multiple xylanases to the “xylanosome” plays an 
important role in the degradation of hemicelluloses. All linked enzymes interact 
synergistically with each other and their most important application is as biobleachers in 
the paper industry as alternatives to toxic chlorine-containing chemicals. 
The central focus of today’s research lies in improvements of activity, specificity, stability, 
and multiple functionality of enzymes for various applications. To meet these 
requirements the development of techniques such as mimicking enzymatic activity or 
altering their natural catalytic properties is necessary. For mentioned reasons the 
following two main chapters will focus first on the state of the art of artificial enzyme 
mimics and specifically on artificial ATPases. Secondly, the attention will be on 
cooperation of enzymes in clusters and networks, performing cascade reactions. A short 
overview of nature’s models, as well as a literature overview on the last reported synthetic 
approaches, will be shown. 
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1.2 Artificial Enzymes 
As outlined in the previous chapter, interest in natural enzymes and their outstanding 
properties is enormous. Viable alternatives are enzyme mimics or artificial enzymes. 
However, the structural complexity of those biocatalysts is still beyond synthetic ability of 
modern chemistry. Today only small protein-like structures consisting of around fifty 
amino acids can be synthesized by solid phase peptide chemistry in a reliable way and with 
good yields.[36] Side reactions, sequence terminations and problems with maintaining 
chiral information are main problems occurring during peptide synthesis. Peptides and 
proteins of greater length need to be prepared by using complex strategies such as chemical 
ligation methods.[37] Modern biotechnology offers the opportunities for the controlled 
expression of enzymes with novel and unnatural amino acids. Thus, selective optimization 
and adaptions can be induced to existing enzymes. However, the upscaling of these 
techniques is challenging and do not allow for established, routine synthesis. Moreover, 
prediction of secondary and tertiary structures as well as the resulting properties and 
functions remains demanding. Hence, mimicking structure and catalytic function of 
enzymes with help of all tools from chemistry gained huge interest in the last years. 
Further advantages of artificial enzymes are not only their easier and more inexpensive 
preparation procedures but also possibilities to tune and control their structural properties, 
catalytic efficiencies and their adaption to various, chemical surroundings. The following 
sections will provide a state of the art of various ideas and concepts for mimicking 
enzymatic structures and catalytic activities based on non-peptide scaffolds. In the last 
years, several reviews discussed (nanomaterial-based) artificial enzymes in general.[38-40] 
The focus in the present thesis is set to the most important and latest results in the field. 
The overview will start with inorganic materials, then the spectrum will be broadened to 
bioinspired polymeric and dendritic compounds and end up with supramolecular 
structures used for enzymatic artificial catalysis. One group of supramolecular catalysts 
will be highlighted because of their extraordinary catalytic properties and their potential 
application as artificial ATPases. 
1.2.1 Inorganic Materials as Enzyme Mimics 
Nanosized enzyme mimics based on inorganic materials have several advantages. Low 
cost, excellent tolerance to extreme conditions and stability (high temperature, acidity or 
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organic solvents), a simple separation from reaction mixtures and additional features such 
as paramagnetic properties are major benefits.[38, 41] Inorganic materials are mostly used 
in the form of nanoparticles, called “nanozymes”. The term was first used in 2004 to 
describe gold nanoparticles with enzyme-like activity.[42] The gold particles were 
passivated with a monolayer of 1-sufanyloctane and functionalized by a self-assembling of 
aza-crown functionalized thiols (Figure 3a). These triazacyclononane units were then able 
to bind transition-metal ions such as Cu2+ and Zn2+. If Zn2+ is complexed within the 
aza-crown units particles showed transphosphorylation activity towards 2-hydroxypropyl 
p-nitrophenyl phosphate (HPNP), a model of RNA, releasing the spectrophotometrically 
measurable p-nitrophenol (reaction shown in Figure 3b). At that time, Zn2+-based gold 
particle catalyst represented one of the best catalysts of HPNP. About ten years later, a 
similar system was published using phenoxyguanidine moieties as end groups of the 
alkanethiols (Figure 3b).[43] In this case, the exact catalytic mechanism was clarified. The 
guanidine acts in a neutral form as a base and in its protonated form as an acid. Thus, 
bifunctional catalysis can be achieved within one catalytic system. 
 
Figure 3: (a) Gold nanoparticles functionalized with selfassembled aza-crown functionalized thiols that can 
bind Zn2+. The groups on the surface demonstrate transphosphorylation activity towards 2-hydroxypropyl 
p-nitrophenyl phosphate (HPNP), a model of RNA (structure shown in (b), top right corner). Adapted with 
permission from Manea et al.[42] (b) Further developed derivative of (a) and clarification of the exact 
mechanism of bifunctional catalysis with phenoxyguanidine moieties on the surface of gold nanoparticles 
towards HPNP. Adapted with permission from Salvio et al.[43] 
Gold particles in general have a broad field of application,[44] because not only passivated 
or covered gold particles demonstrate catalytic activity. For water-dispersed gold sol, 
catalytic activity was observed when used as “naked” gold particles.[45] Gold nanoparticles 
with a diameter of 3.6 nm were able to catalyze the redox reaction of glucose and air 
oxygen (O2) to gluconic acid and H2O2 under mild conditions - a reaction which is naturally 
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carried out by glucose oxidase (GOx). In contrast, nanoparticles of other metals such as 
Cu, Ag, Pd and Pt showed barely any GOx-like activity. 
Other metals such as iron, copper or rare earths are used as artificial enzymes either in 
combination with gold or alone. For example, a nanocomposite consisting of gold 
nanoparticles which have a glucose oxidase-like activity, and V2O5 nanowires which 
exhibit intrinsic peroxidase-like activity, was used for the detection of glucose (Figure 
4).[46] Without using natural enzymes, the system represents a complete inorganic hybrid 
material with enzymatic, catalytic properties. The cascade reaction which is carried out on 
the surface of the nanocomposite material is in detail discussed in chapter 1.3.2 (Covalent 
Linkage of Enzymes). 
 
Figure 4: Nanocomposite of gold nanoparticles and vanadium oxide nanowires. (a) Preparation of 
nanocomposite and catalyzed reaction. Redrawn from Qu et al.[46] (b) TEM images of (A) V2O5 nanowires (B) 
V2O5-PDA, (C) V2O5-PDA-AuNP nanocomposite and detailed picture (D) of Au-NPs on the surface of 
V2O5-PDA. Adapted and reprinted with permission from Qu et al.[46] 
Vanadium pentoxide nanowires were also used as artificial enzymes for mimicking natural 
vanadium haloperoxidases.[47] This enzyme prevents bacteria growth on the surface of 
certain seaweeds and is used to stop biofilm formation on ship hulls which increases 
hydrodynamic drag and causes increased fuel consumption. The antibacterial behavior can 
be explained by formation of hypobromous acid (HOBr) during catalysis. Bromide ions 
(Br-) are oxidized in presence of hydrogen peroxide (H2O2) to hypohalous acid which stops 
chemical signaling in bacteria. The nanowires have an average length of 300 nm and a 
width of 20 nm and demonstrated their antibacterial behavior even in situ. The catalytic 
activity of the V2O5 wires remained unchanged after mixing with paint formulations for 
shipping industry. 
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Another interesting system based on an inorganic material are TiO2@CeOx core-shell 
nanoparticles with an outstanding peroxidase-like catalytic activity.[48] A commercial TiO2 
powder suspension was used and covered with a layer of organometallic CeOx on the 
surface. The used technique allowed to tune thickness of the CeOx layer on the shell and 
additionally the oxidation state of Ce in either Ce3+ or Ce4+ which has an influence on 
catalytic activity. This redox reaction represents a key step in several natural redox 
enzymes and the ratio between both states is important for the efficiency of artificial 
enzyme mimics based on that redox pair. Furthermore, if compared to natural enzymes 
like horseradish peroxidase (HRP) or other artificial enzymes, the TiO2@CeOx core-shell 
nanoparticles display an exceptional performance regarding their MichaelisMenten-
constant Km and vmax, the maximal reaction rate. 
Laccase mimics are an example of copper-based nanozymes.[49] Laccases are multi 
copper-containing enzymes that are mainly found in plants, mushrooms and 
microorganisms. They carry out the coupled reaction of oxidizing phenolic substances and 
reducing oxygen. The enzyme mimic used guanosine monophosphate (GMP) to coordinate 
multiple Cu2+ ions in a metal-organic framework (MOF) similar to natural laccases. The 
system demonstrated excellent catalytic activity towards various phenol containing 
substrates such as hydroquinone, naphthol and catechol. 
Iron-based materials such as Fe3O4 particles are an additional example. However, particles 
were long-time considered chemically and biologically inert, in 2007, their intrinsic 
peroxidase-like activity was discovered.[50] The particles catalyzed the reaction of different 
typical peroxidase substrates consuming H2O2, followed typical Michaelis-Menten kinetics 
and demonstrated similar behavior to horseradish peroxidase (HRP). Iron oxide materials 
with enzyme-like activity feature additionally ferromagnetic properties and have to date 
found many applications in biomedicine and diagnostics (e.g. magnetic resonance imaging, 
MRI).[51] 
Often metal nanoparticles are coated with metal catalysts or conjugated with enzymes, in 
order to combine the separating power of the magnetic properties with the catalytic 
activity of the metal surface or the enzyme conjugate.[52] Magnetoferritin nanoparticles 
were covered with human heavy-chain ferritin as shown in Figure 5.[53] These particles 
that are 4.7 nm in diameter, were used to examine tumor tissue in an imaging technique 
without using targeting ligands or contrasting agents resulting in good differentiation of 
malign and benign histoid-specimens. Thereby the protein corona binds to a transferrin 
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receptor which is overexpressed by tumor cells in colon, human breast and liver cancer. 
The iron core exhibits its peroxidase-like activity by catalyzing the reaction of 
di-azo-aminobenzene (DAB), a typical peroxidase substrate, and H2O2 which releases a 
brown dye after the peroxidase-like reaction. 
 
Figure 5: (a) Formation of magnetoferritin nanoparticles by encapsulating iron oxide nanoparticles inside of 
a recombinant human heavy-chain ferritin (HFn) protein shell. (b) Cryo TEM image of M-HFn nanoparticles 
(left) and TEM image of HFn protein corona (right). Both figures reprinted with permission from Fan et al.[53] 
Despite the extraordinary findings and results shown in this section, concerns remain 
regarding long term accumulation and toxicity effects of inorganic materials, particularly 
for therapeutic applications. 
1.2.2 Polymeric Materials as Enzyme Mimics 
Using synthetic polymers, which might be biocompatible and biodegradable, is an 
alternative to the utilization of inorganic materials. Synthetic polymers have advantageous 
characteristics compared to inorganic materials regarding their long-term application in 
biological systems. One big advantage of synthetic materials over biopolymers is the fact 
that they can be produced on a large and industrial scale. 
The preferred utilization of polymers over inorganic materials does not imply full 
exclusion of metals in structures and setups of artificial enzymes. There are many examples 
of enzymes with metal ion-mediated catalysis (1.1, subchapter “Catalytic Activity and 
Mechanisms”) which naturally bind inorganic atoms in their catalytic centers and which 
self-evidently have to be mimicked as well. 
Linear Macromolecules for Biomimetic Catalysis 
Considering the setup of enzymes with their folded peptide chains, linear polymers possess 
certain advantages in order to mimic enzymes. Linear polymer chains can be modified with 
repeating catalytic centers or binding sites, and high cooperativity can be achieved on 
macromolecular scaffolds. Examples of such macromolecular scaffolds are poly(N-
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vinylcaprolactam-co-1-vinylimidazole) (PVCL-Vim) and poly(N-isopropylacrylamide-co-1-
vinylimidazole) (PNIPA-Vim), copolymers which exhibited artificial hydrolase activity.[54] 
The polymers were thermosensitive in water by being soluble at room temperature and 
undergoing phase transition (aggregation) at higher temperatures >35 °C (lower critical 
solution temperature, LCST). The imidazoles within the polymer chains demonstrated 
catalytic activity in the hydrolysis of p-nitrophenyl acetate. It was observed that the 
reaction rate does not follow typical Arrhenius-type behavior which describes an 
exponential increase of the reaction rate with increasing temperature. Instead, in the 
interval of 35-45 °C (above the aggregation temperature) the growth was faster than 
exponential and above 45 °C the rate decreased again. This behavior is often observed if 
copolymers aggregate in aqueous solution. The temperature of aggregation precedes the 
temperature of rapid growth of reaction rate which is associated with adsorption of surface 
active substrate at the contact area of aggregates and the increase in concentration of 
catalytically active imidazole groups on the surface areas. The observed behavior has some 
similarity to natural enzymatic catalysis where substrate is first bound to the catalytic site 
of the enzyme forming a relatively stable complex (Michaelis-Menten enzyme-substrate 
complex, ES, Figure 2a). 
A combinatorial approach based on polyallylamine polymers was reported for 
phosphatase-like catalysis.[55] Eight functional carboxylic acids were randomly reacted 
with the amines of the polyallylamine resulting in amide bonds. Each potential polymeric 
catalyst differed in nature and number of its functional groups. The catalysis of these 
functionalized polymers was investigated in the presence of either Mg2+, Zn2+ or Fe3+ 
cations towards a phosphodiester resulting in 30,000-fold enhanced phosphatase activity 
compared to a natural catalytic antibody for that reaction. The group further improved 
that combinatorial system to carry out elimination reactions based on poly-
allylamine-modified polymers.[56] 
In 2009, Breslow et al. reported an artificial transaminase based on polyvinylimidazoles.[57] 
4-Vinylimidazole and copolymers with 1-dodecyl-4-vinylimidazole were used to trans-
aminate pyruvic acid to alanine, phenylpyruvic acid to phenylalanine, and 
indole-3-pyruvic acid to tryptophan in water at pH 7.5 and 20 °C using pyridoxamines 
carrying hydrophobic side chains as coenzyme mimics. The best enzyme mimic 
demonstrated substrate selectivity in water and accelerated the transamination of 
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indole-3-pyruvic acid by a factor of four million, relative to the rate for the uncatalyzed 
reaction. 
Dendrimers as Artificial Enzymes 
Inspired by the globular shape of enzymes, chemists tried to synthesize macromolecules 
not only as linear chains but rather as three-dimensional structures. Dendrimers are such 
regular branched, tree-like macromolecules. Growing from a core with repetitive units in 
a radial symmetry and branching, dendrimers form spherical structures (Figure 6a). First 
dendrimers were synthesized in 1978[58] in divergent synthesis methods. Hereby, the 
dendrimer is assembled from a multifunctional core which extends outwards in the 
respective generation. In the 1990s, first dendrimers were synthesized with convergent 
methods.[59] This technique describes their building from small molecules which end up at 
the surface of the sphere and the ongoing reactions proceed inward. In 1995, their first use 
as catalysts was published and the term “dendrizyme” was introduced in a literature 
review.[60] Dendrimers can be either carrying the catalytic active site as a single copy 
within their core or in multiple copies at the dendritic surface. In the first case, catalysis 
within the core is often compared to the pocket of the enzyme where the transformations 
take place. Dendrimers provide a favorable local microenvironment for catalysis in the 
core and selectivity effects of the dendritic shell. They possess overall shielding properties 
in complex surroundings, e.g. cell plasma. In the second case, the attachment of multiple 
catalysts to the end of the branches leads often to cooperativity effects. 
 
Figure 6: (a) Dendritic structure with a tree-like macromolecule starting from a core (G0) with growing 
branches (generations). Reprinted from Lukin (creative commons). (b) PAMAM (poly(amidoamine)) 
dendrimer structure (c) PAMAM dendrimer with pyridoxamine unit in the core for transamination reactions 
and various spacer units to optimize the transamination reaction rates. Reprinted with permission from Liu 
et al.[61] 
The mimic of thiamine-diphosphate-dependent enzyme pyruvate oxidase was one of the 
first dendrimer-based artificial enzymes. It was created by introducing dendritic branches 
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on thiazoliocyclophanes.[62] The so-called dendrophane promotes an aldehyde to ester 
oxidation supported by a flavin cofactor. However, the reaction was two orders of magni-
tude slower than with the parent cyclophane. 
One widely used dendrimer is the PAMAM (poly(amidoamine)) dendrimer (Figure 6b).[63] 
An artificial transaminase model was created by locating one single pyridoxamine unit in 
the core of water-soluble PAMAM dendrimer (Figure 6c).[61] The structure and size of this 
enzyme model was tuned to obtain great transamination rates for the synthesis of alanine 
and phenylalanine from pyruvic and phenolpyruvic acid. In fact, the reaction rate 
was1000-fold rate enhanced compared to pyridoxamine alone. PAMAM-based dendrimers 
were over time further refined for applications in demanding and complex systems.[64] 
Hemin, an iron–porphyrin complex that can mimic the catalytic properties of horseradish 
peroxidase (HRP), was encapsulated within the dendrimer. By adding a zwitterionic shell 
consisting of primary amines and carboxyl groups the enzyme-like system was able to 
operate in biological medium. The mimic was highly water-soluble, pH-sensitive and 
biocompatible while retaining its catalytic activity. 
An artificial peroxidase for the oxidation of aromatic compounds in non-aqueous media 
was created by a dendritic porphyrin.[65] The core composed of a porphyrin group with 
the catalytic iron center was surrounded by a dendritic, branched network of 
3,5-dihydroxy benzyl alcohol up to G4 size. The dendrimer demonstrated outstanding 
catalytic properties in the oxidation of 2,6-dimethoxyphenol and 3,4-dimethoxy-
benzyl(veratryl) alcohol with the oxidation substrate m-chloroperoxybenzoic acid. 
Compared to the natural enzyme lignin peroxidase which carries out the same reaction, 
the enzyme mimic displayed a higher reduction potential and full functionality in organic 
solvents. 
An alternative to inorganic dendritic catalysts are end-group functionalized 
poly(propylenimine) dendrimers (PPI-dendrimers) containing multiple catalysts in form of 
imidazole groups on their surface.[66] An esterase-like activity with general acid/base 
mechanism was described for the hydrolysis of 2,4-dinitrophenyl acetate in water. A 
cooperative effect was investigated by increasing the number density on the surface of the 
dendrimer by increasing the dendrimer generation and thereby decreasing the distance 
between functional imidazole groups however not resulting in enhanced activity. 
Imidazole groups in histidines as catalytic cores were also used by Reymond et al. in 
peptide-based dendrimers.[67-69] His group reported several examples of catalytically active 
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dendrimers.[70-71] Peptide dendrimers with the repeating unit of Dap-His-Ser (Dap= 
diamino propionic acid, His=histidine, Ser=serine)[72] which displayed a strong dendritic 
effect for the catalysis of 8-acyloxypyrene 1,3,6-trisulfonates performed with enzyme-like 
kinetics in aqueous medium.[73] The enzyme-like activity was specific for this kind of ester 
(substrate specificity), the substrate binding investigations demonstrated that three 
histidines optimally bound one substrate and multiple catalytic turnovers were possible. 
Based on these results, the first dendrimers with protease reactivity were reported by 
Reymond et al.[74] Proteolysis of proteins and peptides is essential to their biological 
function and thus an important feature to artificial enzymes as well. Trypsin and 
chymotrypsin reactive sequence motifs were used as cleavage sites. Control over 
proteolysis was gained by topology of dendrimers by placing different numbers of amino 
acids between the branching points. Dendrimers with two or three amino acids between 
the branching points were readily cleaved, in contrast to dendrimers with only one amino 
acid as spacer molecule which showed sometimes complete resistance to proteolysis. 
The main restrictions of dendrimers are their synthetic difficulty and the limited size 
availability.[75] For these reasons, the scientific research on dendrimers is declining after 
reaching its zenith in the middle of the new millennium (around 2005). Therefore, most 
cited literature describing the state of the art of enzyme-like dendrimers was published 
during that time. 
Star Polymers as Containers for Catalysis 
Star polymers represent an alternative readily accessible class of branched materials.[76] In 
contrast to dendrimers, they contain one central core which radiates multiple linear arms, 
synthesized by chain growth polymerization techniques. Within these linear arms, no 
branching is observed. Star polymers share similar advantages with dendrimers but they 
feature additional benefits such as efficient preparation, straight forward synthesis, a 
larger number of terminal groups[77] and low intrinsic viscosities.[78] In most studies, a star 
polymer is synthesized by either an “arms-first” or a “core-first” method. Star polymers 
have been recently reviewed[79] and a few outstanding examples will be presented in here. 
Inspired by nature, Fréchet et al. explored the use of star polymers to combine normally 
incompatible catalysts in one-pot sequential reactions.[80] They encapsulated both acidic, 
represented by para-toluenesulfonic acid (PTSA), and alkaline groups, represented by 
4-(dialkylamino)pyridine, within well-defined core-shell structure of the star polymers. 
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The star polymers were synthesized in the arm first approach by radical polymerization. 
In the chemical cascade reaction, an acid-catalyzed acetal hydrolysis and a nucleophilic 
amine-catalyzed Baylis–Hillman reaction were carried out. Both reactions are normally 
incompatible but due to site segregation within the star polymer cores, sequential catalysis 
is possible. 
The same group used the combination of multiple, otherwise incompatible catalysts for 
asymmetric cascade reactions that involve iminium, enamine, and H-bonding catalysis.[81] 
The strategy allowed straightforward access to all possible stereoisomers of the cascade 
product individually by proper choice of catalyst chirality. With this enzyme-like catalysis, 
it was possible to generate cascade products with multiple chiral centers. 
Rodionov et al. described the synthesis of a family of polymer catalysts from modular star 
polymers with “clickable” cores.[82] The hydrophobic core was formed by polystyrene with 
azide functional groups which was surrounded by water-soluble PEG arms (Figure 7). 
 
Figure 7: (A) Synthesis of (PS(N3))-PEG star polymer with microemulsion polymerization followed by 
Cu-promoted click chemistry with PEG. (B) DLS data for (PS(N3)) and (PS(N3))-PEG in water. (C) AFM phase 
image of (PS(N3))-PEG. (D) TEM image of (PS(N3))-PEG stained with sodium phosphotungstate. Reprinted 
with permission from Rodionov et al.[82] 
The azide-containing core provided a facile functionalization with various alkyne-
containing payloads such as large hydrophobic groups like pyrenes (used to determine the 
number of reactive azide groups), organocatalysts, metal complexes or dyes like Nile Red. 
The catalytic activity of the material was investigated by using a model Knoevenagel 
condensation reaction between benzaldehyde and ethyl cyanoacetate in water. The 
reaction did not occur uncatalyzed at room temperature and was superior compared to 
catalysis with a linear PEG-modified catalyst. Moreover, the catalyst was recycled multiple 
times with no loss in activity. A similar approach as described in the previous paragraph 
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for acid/base site isolation was used here by combining an acid catalyst with an amine 
catalyst. Hydrolysis of dimethyl benzaldehyde was first carried out by the proline-modified 
polymer star, followed by Knoevenagel condensation of benzaldehyde with ethyl cyano-
acetate by PTSA-modified (PS(N3))-PEG. 
Using star polymers as polymer catalysts containing ruthenium complexes are one further 
alternative. Stars were used for the oxidation reaction of alcohols to ketones.[83] The metal 
catalysts were directly encapsulated during metal-catalyzed star synthesis in living radical 
polymerization (ATRP). Synthesis of this star polymer started with the Ru-catalyzed 
(RuCl2(PPh3)3) ATRP reaction of methyl methacrylate (MMA). When monomer conversion 
reached 90%, a mixture of ethylene glycol dimethylacrylate (EGDMA) and diphenyl-4-
styrylphosphine (serving as the cross-linker and ligand for Ru(II), respectively) was added 
to yield phosphine core-functionalized star polymers. During polymerization, pure Ru 
metal was encapsulated into the core via ligand exchange. The resulting Ru(II)- 
functionalized star eﬃciently catalyzed the oxidation of a 1-phenylethanol to aceto-
phenone. 
Single-Chain Nanoparticles as Catalytic Devices 
Single-chain nanoparticles (SCNP) are linear polymer chains which collapse or fold into 
architecturally defined nanostructures.[84] Their application as catalytic nanoreactors has 
been recently reviewed.[85-86] Four examples of catalytically active SCNPs will be presented 
here, showing the wide field of application of these structures as enzyme mimics. 
A random copolymer consisting of N,N-dimethylaminoethyl methacrylate (DMAEMA) and 
4-methyl-(7-(methacryloyl)oxy-ethyl-oxy)coumarin (CMA) was synthesized which was 
then cross-linked by the intrachain photodimerization of the coumarin groups (Figure 
8).[87] The photoinduced cycloaddition reaction under λ=310 nm irradiation led to the 
collapse of single polymer chains and to formation of SCNPs. 
The SCNPs were used as a nanoreactor to in situ synthesize colloidal gold nanoparticles 
without any additional reductants. In tetrahydrofuran (THF) the kinetics of AuNP 
formation were sensitive to the polymer chain conformation and mobility which are 
determined by the degree of photodimerization within the coumarin groups. This provides 
the possibility to optically tune kinetics of AuNP formation and having influence on the 
catalytic activity of this artificial enzyme. 
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Figure 8: (a) Schematic illustration of SCNP formation by intrachain photodimerization of coumarin groups 
(orange dots). photo-crosslinking. Reprinted with permission from He et al.[87] (b) Chemical structure of N,N-
dimethylaminoethyl methacrylate (DMAEMA) and 4-methyl-(7-(methacryloyl)oxy-ethyl-oxy)coumarin 
(CMA) random copolymer with different CMA rates and reversible photo-crosslinking reaction activated by 
UV light. Adapted from He et al.[87] 
An aldol reaction in water with Michaelis-Menten kinetics was carried out by an L-proline 
functionalized, catalytic polymer based on a methacrylate random copolymer (Figure 
9).[88] The helical terpolymer (polymer composed of three different monomers) consists of 
10% benzene-1,3,5-tricarboxamide (BTA) units which introduced a structural compartment 
to the polymer that allowed a helical stack assembly. 85% of the polymer were 
oligo(ethylene glycol) units that ensured water-compatibility of the polymer. The 
remaining 5% were catalytic units of L-proline. This catalyst catalyzed a wide range of C-C 
bond forming reactions but its activity in water was very poor due to a lack of hydrophobic 
shielding.  
 
Figure 9: Methacrylate random copolymer functionalized with catalytic active L-proline (green dot) 
moieties. The helical terpolymer formed by the structural element benzene-1,3,5-tricarboxamide (BTA) entity 
(red y-shape) carried out the aldol condensation of cyclohexanone and p-nitrobenzaldehyde. Only in its 
folded conformation, the SCNP was catalytically active because of the hydrophobic pockets that were formed 
around the L-proline centers. Reprinted and modified with permission from Huerta et al.[88] 
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The folding of the polymer provided a new environment for catalysis formed by the 
hydrophobic pockets of L-proline and thus generating a catalytically active polymer with 
a similar behavior comparable to an enzyme. 
Based on this helical terpolymeric system, catalytically active SCNPs were recently tested 
for their biological compatibility and application in complex cellular environments.[89] As 
catalytic sites, a porphyrin-based structure was attached to the polymer for the 
photocatalytic generation of singlet oxygen from molecular oxygen within the cell. For an 
application in extracellular space, organometallic loaded SCNPs with Cu+ and Pd2+ 
demonstrated an efficient depropargylation of protected rhodamine. The described system 
was able to perform and remain its functionality in living cells and thus provides a platform 
for artificial enzyme mimics performing in vivo. 
Introduction of inorganic complexes to SCNPs is one possibility to mimic metalloenzymes. 
In 2015, a tunable synthetic [FeFe] hydrogenase mimic was reported by using click 
chemistry to conjugate a single diiron cluster to a methyl methacrylate (MMA)/anthracene 
methylmethacrylate (AMMA) copolymer.[90] SCNPs were formed after irradiation of the 
polymer at λ=310 nm by an intrachain [4πs+4πs] cycloaddition reaction. The iron 
complexes were conjugated with their introduced allyl or propargyl functional group via 
thiol-ene/thiol-yne click chemistry to the polymeric scaffold. This hydrogenase-mimic has 
potential to catalyze the production of H2. 
Other metalloenzyme-mimicking SCNPs are imidazole-functionalized copolymers of 
P(MMA-coHPMA), poly(methyl methacrylate-co-3-imidazolyl-2-hydroxypropyl meth-
acrylate), that were used for a selective hydroxylation reaction of phenol.[91] Copper ions 
were coordinated by imidazole groups to drive the self-folding of the random copolymer. 
SCNPs demonstrated a selectivity for the hydroxylation reaction of phenol to catechol over 
>80% with high turnover frequencies. 
Overall, the impact of SCNPs lies especially in the defined construction of a polymeric 
pocket around the catalytic active cores for substrate recognition and catalysis. Thus, they 
are very well mimicking the catalytic pockets of enzymes. Main drawbacks and concerns 
remain regarding the random polymer synthesis, in other words the variation of the 
individual polymer chains in composition and length. Also large scale production of SCNPs 
remains challenging. 
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1.2.3 Supramolecular Structures as Enzyme Mimics 
A third, already widely investigated strategy for artificial enzymes are supra-
molecular-based structures. Supramolecular chemistry describes molecular interaction 
between host and guest. The basis of these binding events are non-covalent interactions 
such as hydrogen bonds, coulomb-, and π-stacking forces as well as charge-transfer 
interactions. The literature reveals a vast number of supramolecular catalysts either as 
small molecules or as nanomaterials such as micelles, host-guest polymers or 
supramolecular coordinated polymers for diverse applications (Figure 10a).[92-97] Herein, 
only a few outstanding examples and most important results will be shown, before in 
particular focusing on one specific group of supramolecular catalysts which are important 
for this thesis. 
 
Figure 10: (a) Different approaches for the design of artificial enzymes based on supramolecular scaffolds. 
Reprinted with permission from Wang et al.[93] (b) Chemical and three-dimensional cavity structure of 
cyclodextrins with 6-8 monomeric saccharide units. Reprinted with permission from Zhou et al.[98] 
Enzymes utilize supramolecular interactions to form powerful complexes with substrates 
and ligands. However, study of enzymes and proteins is often challenging due to their 
intricacy. Furthermore, the study of non-covalent interactions and their impact is crucial 
to the understanding and imitation of enzyme-substrate interactions. Hence, a perfect way 
to understand and mimic these effects are small bioorganic model systems and 
coordination assemblies.[94, 96] Popular supramolecular materials include already 
preformed macrocycles and container molecules like calixarenes, cyclodextrins, 
cucurbiturils and crown ethers.[97] Cavity forming entities seem in particular suitable to 
mimic substrate specific pockets of enzymes. They allow a substrate preorganization and 
accelerate chemical transformations. Cyclodextrins (CD) (Figure 10b) represent a class of 
6-8 membered oligo-saccharide rings that form catalytic macrocycles and features a conical 
cavity that is essentially hydrophobic in nature. So far, they are the most popular and 
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successful scaffolds for the creation of enzyme mimics and models.[99] The inner diameter 
of the cavity varies from 0.5-1 nm, has a depth of about 0.8 nm and the oligosaccharide 
rings are even catalytically active without catalytic moieties.[100-101] Compared to synthetic 
cavity species like calixarenes or synthetic macrocycles, cyclodextrins have the advantage 
that they have a readily available geometry. The sugar hydroxyl groups can be used to 
attach other catalytic and functional groups. Ronald Breslow performed pioneering work 
in this field by publishing in 1970 the first artificial enzyme approach by combining a metal 
catalytic group with the hydrophobic binding cavity of a modified-cyclodextrin.[102] Over 
the years, he published several modifications of cyclodextrins for enzyme-like catalysis 
such as a model for ribonuclease[103] with β-cyclodextrinyl-bisimidazoles or the 
chlorination of anisole, catalyzed by α-cyclodextrin which delivers the chlorine.[104]  
More recent literature describes a cyclodextrin dimer catalyst with a metallo-
phenanthroline linking group that complexes Zn2+ ions.[105] The diesterase-like activity of 
the dimer was investigated towards 4-nitrophenyl acetate and bis(4-nitrophenyl) 
phosphate (BNPP) which is often used as a DNA model compound (Figure 11). The 
cyclodextrin dimer demonstrated a high catalytic efficiency and the hydrophobic 
interactions between catalyst and substrate were figured out to play an important role in 
catalytic hydrolysis. 
 
Figure 11: Cyclodextrin dimer connected with a metallophenanthroline linking group that catalyzes the 
hydrolysis of 4-nitrophenyl acetate and BNPP, a DNA model compound. Reprinted with permission from 
Zhou et al.[105] 
The supramolecular oxidation of aromatic amines and benzylic alcohols in the presence of 
hydrogen peroxide was carried out by a bridged cyclodextrin derivative.[106-107] The 
cyclodextrin consists of a core of either α- or β-CD with dihydroxyacetone attached to the 
primary rim through ester bonds. At neutral pH and ambient temperature, the CDs mediate 
the conversion of H2O2, which is bound to the ketone and forms a hydroperoxide adduct, 
and the benzylic alcohols, which is bound in the hydrophobic cavity, with an extraordinary 
reaction rate (kcat/kuncat = 60000).  
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Cyclodextrins are not only used as small molecules, they are often attached to polymeric 
scaffolds to recreate the size and complexity of natural enzymes. For example, Zhang et al. 
synthesized a star-shaped polymer with a β-CD core as a molecular recognition moiety 
and multiple poly(N-isopropylacrylamide) (PNIPAAm) arms.[108] The CD core was 
modified with 2-bromo-isobutyric bromide to obtain a fourfold modified CD core (4-Br-β-
CD) which was then used as the starting point for ATRP-mediated polymerization with 
PNIPAA. This part of the system served as the guest for supramolecular interaction with 
an adamantane-modified PEG. The self-assembling system with its thermoresponsive 
properties of the PNIPAAm arms was further used in a slightly modified variant as a mimic 
of both superoxide dismutase (SOD) and glutathione peroxidase (GPx) (Figure 12).[109] 
 
Figure 12: Preparation of enzyme model with superoxide dismutase (SOD) and glutathione peroxidase (GPx) 
activity. The system is based on a star-shaped polymer which networks with a porphyrin core by 
supramolecular interactions. The whole system is distinguished by its temperature sensitivity. Reprinted 
with permission from Yu et al.[109] 
The enzyme mimic used a Mn(III) porphyrin, Mn(III)meso-tetra[1-(1-adamantyl methyl 
ketone)-4-pyridyl] porphyrin (MnTPyP-M-Ad), as the supramolecular linker in the core of 
the polymer star as well as efficient active site for the SOD-like enzyme. The temperature 
responsive block copolymer (β-CD-PEG-b-PNIPAAm-Te) with incorporated tellurium 
moieties in the PNIPAAm chain was utilized as GPx active sites. The system demonstrated 
stable SOD-like activity and high GPx catalytic efficiency with temperature sensitivity. 
The highest GPx activity was achieved close to body temperature.[109] 
Supramolecular chemistry is of course not limited to the interactions of small and low-
molecular-weight molecules. Equally, the already described systems from the previous 
chapters can be studied under the aspects of supramolecular interactions. Examples for 
such supramolecular interactions in nanometer-sized objects are reported in the literature. 
Capsules[110], micelles, vesicles, nanotubes[111] or the already described 
dendrimers[112]were used as scaffolds.[113-114] For example, an artificial nuclease, based on 
a DNA scaffold was reported.[115] The enzyme model system was based on a tetra cationic 
pyridylimine metallosupramolecular cylinder which bound strongly to DNA (Figure 13a). 
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The cylinder is a dinuclear double-helical metallosupramolecular scaffold that was 
assembled by copper(I) centers (Figure 13b and Figure 13c). In the presence of peroxide, 
the cleavage of DNA plasmid was observed. The cleavage occurred as a double-stranded 
cleavage at the same site which can so far not be explained in detail. 
 
Figure 13: (a) Tetra cationic pyridylimine-based ligands for the formation of metallosupramolecular 
cylinders. (b) Possible conformations of cylinders in a metallocyclophane or helicate formation. (c) Models 
for iron(II) cylinder [Fe2(L3)]4+ (I) and copper(I) cylinder [Cu2(La)2]2+ (II). This cylinder binds strongly to DNA 
and acts in the presence of peroxide as a nuclease. Reprinted and adapted with permission from Childs et 
al.[115] 
Another DNA-based artificial enzyme is a hybrid catalyst of salmon testes DNA and an 
iron (III) complex of cationic meso-tetrakis(N-alkylpyridyl)porphyrin.[116] The system was 
used for carbene-transfer reactions in water under mild conditions featuring especially a 
large DNA-induced rate acceleration. The system was utilized for the catalytic 
enantioselective cyclopropanation of styrene derivatives. Corresponding cyclo-
propanation products were obtained in high stereochemical yields. 
A different recently reported approach used tetrahedral cages for the catalysis of a 
bimolecular aza-Prins cyclization with the unexpected feature of a 1,5-hydride transfer 
(Figure 14).[117-118] The tetrahedral cage was formed by metal coordination of Ga3+ in 
which naphthalene spacers served as ligands. The generated host molecule was highly 
anionic and hydrophobic, which favors the entrapment of cationic compounds. The 
synthetic cocatalyst enhanced the reaction rate of the bimolecular reaction of a factor of 
seven and represented a rare example of high divergence in product selectivity. 
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Figure 14: Tetrahedral cage of an organometallic complex formed by Ga3+ and naphthalene spacers. The 
host molecule served as an ideal environment for a biomolecular aza-Prins cyclization which featured a 
1,5-hydride transfer reaction. Reprinted with permission from Kaphan et al.[117] 
The described examples demonstrate the wide application of supramolecular catalysis in 
varying contexts. The focus in the following part will be now on one specific supra-
molecular catalyst which has a possible direct application in cells. 
ATPase Mimics as Supramolecular Catalysts 
Macrocyclic polyamines are one specific group of supramolecular catalysts which are able 
to act as artificial ATPases. ATPases are among the most abundant enzymes with an 
involvement in almost all cellular pathways.[119] The name ATPase is a generic term for 
enzymes that cleave ATP which is the “molecular unit of currency” of intracellular energy 
transfer[1] and does not describe one specific enzyme. The chaperone systems, all motor 
proteins responsible for cargo transfers, cell motilities and muscle contractions, as well as 
DNA helicases or enzymes in the DNA replication complex, some gene regulation enzymes 
or enzymes responsible for protein assembly are examples of various ATPases. Almost all 
ATPases contain well conserved amino acid sequences for nucleotide binding and 
hydrolysis.[119] 
ATP, discovered in 1899 at Harvard Medical School[120], is composed by the base adenine, 
the sugar ribose, and three inorganic phosphate groups (Figure 15a). The bonding 
between the three inorganic phosphate anhydrides stores enough energy to make ATP the 
energy source of most metabolic reactions in cells. The cleavage of one inorganic 
phosphate (Pi) releases an energy of 32.2 kJ mol-1. Hence, the hydrolysis of ATP releases 
energy which can be used by other enzymes to promote their reactions. Reactions which 
are driven forward by the hydrolysis of ATP are e.g., the transport of ions (Na/K-ATPase) 
or the contraction of muscle fibers (myosin ATPase). Due to the wide variety of ATPases, 
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the well characterized myosin is chosen to describe the mechanism of ATP cleavage in 
more detail. 
 
Figure 15: (a) Structure of ATP with the base adenine, the sugar ribose and three inorganic phosphate 
groups. The cleavage of one phosphate releases ADP and Pi and an energy of 32.3 kJ mol-1. (b) Myosin protein 
as an example for a natural ATPase and its function in muscle contraction. Reprinted from the Northern 
Virginia Community College (creative commons)[121] 
Myosin consists of a conserved head domain, located close to the N-terminus, which 
carries out the ATP hydrolysis and generates the movement (Figure 15b). The second part 
is a mostly variable tail domain which arranges the orientation of the biomolecule.[122] 
Myosin has several deep clefts and pockets. The nucleotide binding takes place in one of 
these areas. Another important cleft splits the myosin head into two domains which allow 
the binding to the actin filament, like a pair of pliers. ATPases belong to the group of 
hydrolases which use acid-base-mediated catalysis for the cleavage of the phosphate 
groups. For myosin, no amino acid is involved in the cleavage, instead the nucleotide acts 
as a base and the water transfers its proton directly to the γ-phosphate which is primarily 
cleaved off.[122] However, the binding and cleavage of ATP is not the primary cause for the 
movement of the myosin. At the beginning myosin-ADP is bound to the actin filament 
(Figure 15b). The release of this ADP and the binding of new ATP lead to dissociation of 
myosin from actin which is triggered by a conformational change in myosin through the 
binding of the γ-phosphate group. This change induces a movement of about 11 nm along 
the actin filament. Then, the ATP is hydrolyzed, and ADP and Pi remain first bound to 
myosin. Thus, a binding of myosin to actin is again possible and Pi diffuses from myosin 
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which induces another conformational change. After diffusion the interaction of myosin 
and actin increases again, and the myosin head moves back to its original position. Then 
the cycle starts from the beginning. This example demonstrates the mechanism and impact 
of natural ATPases in biological context. 
Such a universal molecule as ATP, being so important to cellular processes, attracted 
researchers interest for long time. In 1966, Miller et al. described their first investigations 
of the hydrolysis of ATP.[123] In particular, the role of the adenosine group was previously 
not clearly defined, hence he investigated the hydrolysis of γ-phenylpropyl di- and 
triphosphates and compared it with the hydrolysis of ATP. Over the years the mechanism 
of ATP cleavage became clearer[124] by studying the role of involved ions[125] or with 
isotope-labeling experiments.[126] Since metal ions such as magnesium or calcium ions take 
part in the enzymatic hydrolysis, the role of metal-ion-promoted hydrolysis in artificial 
approaches was examined.[127-128] After using Cu2+, Zn2+ or Mn2+ ions[129] with few success, 
the coordination of Cu3+ ions led to significant rate enhancements. Suzuki et al.[130] and 
later Hediger et al.[131] figured out that Co3+ complexes, trichlorodiethylene-
triaminecobalt(III) [CoCl3dien], accelerated effectively and specifically the ATP hydrolysis. 
However, “natural” ATP hydrolysis by ATPases occurs by the interaction of peptides 
within the active sites of enzymes. Until 1983, very little was known about the ATP 
hydrolysis carried out by organic molecules. A strong electrostatic binding of the 
negatively charged nucleotides to various biological polyamines such as putrescine, 
spermidine or spermine (Figure 16), which are mostly positively charged, was observed 
but with no detectable catalytical properties.[132] Solely, the polyamines pentaethylene-
hexamine and tetraethylenepentamine (Figure 16) enhanced the ATP hydrolysis rate by 
considerable factors.[133] The enhancing effect of hydrolysis increases with the number of 
nitrogen atoms in the polyamines, although spacing between the carbons plays also an 
important role. The hydrolysis reaction products were always adenosinediphosphate 
(ADP) and inorganic phosphate (Pi), no adenosinemonophosphate (AMP) or 
orthophosphate (PPi) were observed which supports the specificity of hydrolysis. 
Macrocyclic polyamines and dioxo polyamines demonstrated strong binding to AMP, ADP 
or ATP, with enzyme-substrate like affinities and a stronger binding as reported for linear 
polyamines (spermidine or spermine). [134-135] In 1983, Hosseini, Lehn and Mertes reported 
the first study of ATP hydrolysis carried out by macrocyclic polyamines (Figure 16) with 
various ring sizes and oxygen contents.[136] The highest catalytic rates for ATP hydrolysis 
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were observed for [24]N6O2 (Figure 16). The O-bisdien macrocycle was able to keep rate 
kinetics nearly at the same speed and constant over a wide pH range compared to 
hydrolysis without a catalyst which dramatically increases below pH 3. Over pH 8.5 the 
rate decreased rapidly to the same speed as the uncatalyzed reaction between pH 0 and 3. 
The protonation degree of the macrocycles plays consequently an important role. 
 
Figure 16: Linear and cyclic polyamine structures for binding and catalysis of nucleotides such as ATP. 
The so-called “macrocyclic effect” was observed by comparing pentaethylenehexamine 
with its cyclic variant [18]N6 which carried out the hydrolysis 3 times faster. In the 
following years, several papers on the outstanding performance of [24]N6O2 were 
published.[137-139] First, mechanistic studies were carried out to examine the exact reaction 
mechanism of ATP hydrolysis and figure out important structural parts of the catalysts.[137] 
For [24]N6O2, it was shown that catalytic efficiency is insensitive to ionic strength and that 
at neutral pH the reaction mechanism occurs via nucleophilic catalysis (Figure 17). 
Regarding the structural set-up of the catalyst, variants without oxygen [22]N2C4 or the 
oxygen replaced by amino groups [24]N8 enhanced the reaction rate at pH 3 by a factor of 
300. Furthermore, a phosphorylated reaction intermediate which transfers the phosphoryl 
group was detected. This fact was used in the subsequent paper to describe the 
pyrophosphate synthesis from acetyl phosphate mediated by macrocyclic polyamines 
which are not only able to catalyze bond-breaking but also bond-making reactions.[138] In 
this case, the first substrate, acetyl phosphate is first bound to the macrocycle, then a 
covalent intermediate is formed (the phosphorylated catalyst). The second substrate, a 
phosphoryl acceptor, binds also to the catalyst and finally, a second intramolecular 
phosphoryl transfer occurs. This example demonstrates that the simultaneous binding 
(ammonium) and transformation (amine) sites are located next to each other within the 
same macrocyclic scaffold. 
28 1.2 Artificial Enzymes 
 
Figure 17: Proposed, catalytic cycle of ATP cleavage by [24]N6O2. ATP and the macrocyclic polyamine are 
in an equilibrium (upper part). As soon as ATP is in supramolecular interaction with the macrocycle, a 
nucleophilic attack of nitrogen takes place and cleaves the Pi from the remaining ADP. The cleaved molecules 
leave the host and a new guest ATP molecule gets into the equilibrium. Redrawn from Hosseini et al.[137] 
In 1989 and 1990, the catalytic investigations of the macrocycles were intensified regarding 
a comparison between the ATPase-like enzyme mimic and the natural enzyme.[139-140] The 
results justified for several reasons a comparison to natural ATPases: The macrocyclic 
polyamines carry out hydrolysis reactions in aqueous medium and have affinity constants 
for binding between macrocycle and substrate that are similar to those found for natural 
enzymes. In addition, the reaction can be catalyzed by metals which are usually present 
during biological transformations. Competitive inhibition was observed by substrate 
analogs, and most importantly it was possible to measure Michaels-Menten kinetics for 
the macrocyclic polyamines. The same Michaelis-Menten constant of Km of 10-4 M was 
determined for the natural ATPase and the macrocyclic polyamine [24]N6O2. The kcat 
measured for the uncatalyzed reaction (no catalyst present = autohydrolysis) was 
2.5·10-4 min-1, for the natural ATPase 3.2·104 min-1 and for [24]N6O2 a kcat of 
6.4·10-2 min-1.[140] By comparing the catalytic efficiency the still wide gap between both 
catalysts becomes evident because the value for the natural enzyme is 3.2·108 min-1·M-1 and 
for the artificial ATPase, it is 6.4·102 min-1·M-1. In order to improve these numbers, further 
investigations on macrocyclic ring sizes from a 21-membered [18]N6 to 36-membered 
[36]N12 were carried out.[141] A 21-membered [21]N7 showed best catalytic activities at the 
pH examined. In general, the group of Bencini et al. found that catalytic rates increase with 
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the degree of protonation (lower pH) but decrease with increasing macrocyclic size. In 
order to further investigate and to improve catalytic activity of the macrocycles and 
introduce additional functionalities, other, additional functional groups were attached to 
the macrocycles. The first approach was reported by Hosseini et al. in 1990 who designed 
a multifunctional macrocycle for molecular recognition as well as catalysis (Figure 
18a).[142] They used an acridine side-chain for stacking interactions with the base adenine 
which supported the anion binding site of the macrocyclic polyammonium moiety and 
hence led to a double recognition within one molecule. The modified catalyst did not show 
higher catalytic rates than [24]N6O2 but a better hydrolytic selectivity between ATP and 
ADP and a tighter binding to the nucleotides, as also later confirmed for the modification 
with two acridine groups.[143] 
 
Figure 18: (a) Acridine side chain-modified [24]N6O2 for molecular recognition and catalysis.[142] (b) 
Macrocyclic polyamine containing a benzene spacer demonstrated very high rate enhancements for ATP 
hydrolysis.[144] (c) Cone-shaped calix[4]arene platform with four guanidine moieties at the upper rim for 
ATP hydrolysis in a wide pH range. Reprinted with permission from Salvio et al.[145] 
One of the highest rate enhancements for ATP cleavage was observed by Aguilar et al.[144] 
They synthesized a macrocycle with an aromatic ring that demonstrates a multipoint 
binding scheme to ATP (Figure 18b). π-stacking between adenine and the benzene spacer, 
confirmed by NMR studies, leads to a guided orientation of polyphosphate chain and 
macrocycle, resulting in high catalytic efficiency. Also, a high degree of specificity for the 
conversion of ATP to ADP was detected. 
More recently, the ATP cleavage by cone-tetraguanidinocalix[4]arene was reported.[145] 
Salvio et al. designed a cone-shaped calix[4]arene platform with four guanidine moieties 
at the upper rim (Figure 18c). The catalyst hydrolyzed ATP in a pH range from 8.8 to 10.4. 
Three protonated guanidines provide the electrostatic driving force for the substrate 
binding. The fourth guanidine stayed in a neutral state to be used in nucleophilic catalysis. 
The effective catalysis arises from combined action of two moieties. However, most of the 
reactions had to be carried out in DMSO/water mixtures and at high temperatures (80 °C). 
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So far, all potential ATPase mimics were investigated without a concrete application in 
biological systems. In 2003, Frydman et al. reported cyclopropane-containing polyamine 
analogs that demonstrated efficient growth inhibition of human prostate tumor xenografts 
in nude mice.[146] At that time, no correlation to the ATP balance was seen. However, the 
ATP pool in cells can be one target for ATPases and artificial ATPases. Derived from the 
budmunchamine alkaloid family[147], the same group showed that some macrocyclic 
polyamines have the ability to diminish the ATP level of cells by cleaving ATP and 
depleting so inner cellular ATP levels.[148] Most cancer cells produce their ATP in aerobic 
glycolysis compared to mitochondrial oxidative phosphorylation in healthy cells. This 
effect is called Warburg effect.[149] In solid tumors, when O2 partial pressure goes down 
below 10 mm Hg, the ATP concentration diminishes due to the Warburg effect. Since 
tumor cells have lowered ATP levels compared to normal cells, macrocyclic polyamines 
were used to inhibit tumor cell proliferation. All of the synthesized budmunchamine-based 
macrocycles hydrolyzed ATP in vitro in a malachite green-based assay. Frydman et al. 
demonstrated their inhibition of cell proliferation in two different human prostate cell lines 
but more important was the shown decrease of ATP levels by two orders of magnitude 
after 72 hours. Both effects correlated and resulted in a high efficacy of cell toxicity. 
Summing up, the current limitations and challenges for the production of artificial 
enzymes are the one-dimensional focus on either core-shell structures (dendrimers, star 
polymers with low or no catalytic activity) or on active site imitation of enzymes (e.g. by 
nanozymes or supramolecular cages). Combined approaches for enzyme-like reactions 
inside of cells by using biocompatible nanocarrier systems have not been carried out yet. 
Important factors for the combined approach are prolonged stability, cellular uptake and 
high activity of the catalytic site. 
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1.3 Enzymatic Cascade Reactions 
The following chapters focus on multifunctionality of enzymes in clusters and networks. 
The scope is broadened from one enzyme considered individually as an operative unit to 
larger functional entities with multiple functional sites. In the first section, some examples 
of nature’s highly specific and complex catalytic tools will be displayed, starting with small 
enzymes with two functionalities up to extraordinarily organized, functionalized 
molecular machines. All presented systems have in common that their assembly serves for 
the proceeding of cascade reactions. A closer look at cascade reactions and their definition 
will be presented in the second section. Different artificial approaches to mimic molecular 
machines are reviewed and provide a short overview of the latest and most important 
results. 
1.3.1 Multifunctional Enzyme Clusters and Molecular Machines 
As described in 1.1, enzymes can be classified according to the reaction they carry out. 
Almost all enzymes are specialized for single transformations. There are only a few 
examples of enzymes that can perform two different reactions at a time. The human 
enzyme paraoxonase-2 (PON2), an important enzyme in innate immunity, atherosclerosis, 
and cancer, shows lactonase activity (hydrolase) which hydrolyzes bacterial signaling and 
serves as protection against pathogenic offenses. In addition, it has peroxidase activity 
(oxidoreductase) for the reduction of reactive oxygen species.[150] Thus, it reduces cellular 
oxidative damage and has an influence on signaling occurring via reactive species. By 
introducing several point mutations into the enzyme, the exact mechanism of the relation 
between both functionalities was investigated. However, both activities showed that they 
act separately and have no obvious, reasonable interaction. 
Another example is the microsomal cytochrome P-450 which can be found in adrenal, 
testis, ovary and placenta, and assists the biosynthesis of steroid hormones.[151] The main 
function of the enzyme is to work as an oxidoreductase for binding and reduction of 
oxygen in order to introduce a hydroxyl group in hormones. In addition, it also features a 
lyase function. However, exactly involved structural elements for catalysis are still 
unidentified. 
In nature, fusion of single enzymes to greater, functional entities can be observed to meet 
the requirements of more complex and demanding transformations. Proteins often cluster 
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and work together in multifunctional molecular machines. These complexes range from 
small, few single proteins containing enzymes to highly sophisticated enzymatic 
assemblies which carry out multiple functions. 
The tryptophan synthase is a simple, but still very effective model of a multienzyme 
complex. It carries out the final two steps in biosynthesis of L-tryptophan.[152] The enzyme 
consists of mainly two individual functional subunits, the monomeric α-subunit (2α, 
protein A with 29 kDa) with a TIM barrel conformation and the dimeric β-subunit 
(β2, protein B with 90 kDa) (Figure 19a). Separated subunits catalyze a lyase reaction with 
the cleavage of indole-3-glycerolphosphate to indole and glyceraldehyde-3-phosphate at 
the monomeric α-subunit. The reaction is followed by a ligase reaction with the reaction 
of indole and L-serine to L-tryptophan at the dimeric β2-subunit. In the presence of the 
reassembled αβ2α complex, the rate of these partial reactions is 30-100 times higher than 
with individual subunits. Through assembly, a conformational change occurs which 
triggers this rate acceleration.[153] Both active centers have only a spacing of 3 nm and are 
connected with a tunnel.[154] The tunnel has a length of 2.5 nm and its diameter matches 
with the diameter of the hydrophobic indole.[155-156] It allows rapid flow of the respective 
products and substrates and prevents their escape by passive diffusion via the hydrophobic 
cell membrane. 
 
Figure 19: (a) Tryptophan synthase with two monomeric α-subunits (cyan) and the dimeric β-subunit (blue). 
Both subunits are linked with a 2.5 nm tunnel (red dotted line) allowing the rapid transfer of intermediates 
in the cascade reaction. (b) Nitrogenase with homodimeric Fe protein (rose) (dinitrogenase reductase) and 
heterotetrameric MoFe protein (dinitrogenase) which consists of two α-subunits (light grey) and two 
β-subunits (dark grey). 
Another example is nitrogenase, a multienzyme complex consisting of two enzymes that 
reduces atmospheric nitrogen (N2) to ammonia (NH3).[157] Reduced nitrogen plays an 
important role in the biosynthesis of nucleic acids and proteins. However, only a few 
microorganisms such as cyanobacteria can use some of the 79% nitrogen (N2) in the earth’s 
atmosphere in their nitrogen fixation reaction. The process allows utilization of nitrogen 
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in biochemical reactions and biosynthesis. The multienzyme complex consists of two 
interacting enzymes: dinitrogenase and dinitrogenase reductase (Figure 19b). The latter 
is a homodimeric Fe protein (60-64 kDa) that transfers the required electrons for the 
reaction from reducing agents such as ferredoxin or flavodoxin.[158] The dinitrogenase is a 
heterotetrameric MoFe protein (240-250 kDa) which then performs the reduction of 
nitrogen to ammonia in its core MoFe8S7-cluster. 
The clustering of several enzymes can be observed in the fatty-acyl-CoA synthase (Figure 
20), a multienzyme with eight enzymatically active centers.[159-161] The complex, mainly 
found in brain, lung, and liver, catalyzes the biosynthesis of fatty acids, in particular, the 
synthesis of the most common fatty acid palmitoyl-CoA (16 carbons) by using one 
acetyl-CoA and seven malonyl-CoA. The reaction is the key step in lipogenesis and 
provides molecules that are primary components of cellular membranes or used for 
posttranslational protein modifications. These modifications are necessary for the 
complete functionality of proteins. Saturated fatty acids serve as “energy storage” 
molecules. 
 
Figure 20: (a) Structure, architecture and organization of fatty-acyl CoA synthase (FAS) with α- and 
β-subunits. (b) Cyclic reaction scheme of fatty acid synthesis with initiation (green), elongation (yellow) and 
termination (red) of fatty acid synthesis and eight corresponding enzymatic functionalities. Reaction 3-8 are 
repeated seven times before releasing palmitoyl-CoA in step 9. Reprinted and adapted with permission from 
Lomakin et al.[162] 
The complex consists of two multi-functional subunits: alpha and beta.[163] The subunits 
are arranged in an α6β6 structure and form a barrel-shaped complex with a molecular 
weight of 2.6 MDa.[162] The six α-subunits assemble in an equatorial disk, which divides 
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the barrel into two separate cupolas, each consisting of three β-subunits. The α- and β-
subunits represent three, sterically isolated reaction chambers per cupola and contain eight 
catalytic centers. The assignment of the subunits to their reactions and their contributions 
in fatty acid biosynthesis is shown in Figure 20. The complex biosynthesis of the fatty 
acids can only occur in a perfectly coordinated and intense interaction of the subunits.  
Increasing the number of involved enzymatic functionalities and catalytically active 
domains leads to highly specific molecular machines. For example, ribosomes are big, 
functionally clustered entities that contain ribosomal RNA and approximately eighty 
proteins with enzymatic activity.[164] Ribosomes are granular particles with a diameter of 
20-25 nm. They are composed of about one-third ribosomal proteins and have two different 
subunits which vary in size and functionality. The entire ribosome has a molecular weight 
of 4.2 MDa whereas the bigger subunit consists of about 49 proteins and has a molecular 
weight of 2.8 MDa. The smaller subunit contains 33 proteins and weighs 1.4 MDa. The 
cooperation of those various, different enzymes enables the readout of messenger-RNA 
during translation. The translation reaction plays an important role in complete gene 
expression and protein biosynthesis.[165] 
A last example of a complex molecular machine which has been recently discovered and 
studied extensively is the CRISPR/CAS system.[166-167] The system is based on an adaptive 
antiviral defense mechanism of bacteria (CRISPR; Clustered Regularly Interspaced Short 
Palindromic Repeats).[168] It cuts precisely DNA at particular positions. allowing the 
specific cut-off and introduction of gene sequences. Hereby, the CAS9 protein complex 
plays a key role during cutting.[169] Briefly, the simplest method for artificial gene 
modification uses RNA injected in the cell which codes for the CAS9 and a random re-
cognition sequence. The cell translates the RNA, synthesizes the protein which then finds 
the added recognition sequence. CAS9 cuts double-stranded DNA at exactly the position 
which is determined by associated recognition sequence. Afterwards, natural DNA 
reparation mechanisms occur, and the cut DNA is assembled again. If during that process 
unbound DNA with loose ends is present, this variable DNA sequence is incorporated into 
the gene leading to an irreversible change of the genome. This highly complex machinery 
represents the high specificity, accuracy, and efficacy of nature’s molecular machines 
which can only perform these highly demanding reactions if all involved enzymes are 
subjected to extraordinary interaction. 
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1.3.2 Cascade Reactions Performed by Artificial Enzymatic Clusters 
Looking more closely at general functions of the previously described molecular machines, 
it can be observed that their assembly is mainly favorable for the proceeding of enzymatic 
cascade reactions. Generally, these types of reactions combine several enzymatic 
transformations in concurrent one-pot processes without isolation of intermediates.[170] 
Cascade reactions can be divided into two groups: domino reactions and consecutive 
reactions.[171] A domino reaction, also called tandem or cascade reaction, is defined by a 
serial reaction of at least two (or more) reactions in which the formed product is directly 
used in the following reaction step. No intermediates can be detected and in a strict form 
of the definition, the reaction conditions (solvents or temperature) do not change during 
the domino reaction. In contrast, a consecutive reaction requires addition of an extra 
reagent, a catalyst or a mediator after the first reaction occurred. This group includes the 
reactions which take place at modified reaction conditions like enhanced temperatures. 
Multi-enzymatic cascade reactions in solution have several advantages like decreased time 
exposure, reduced costs and chemicals for product recovery, and the use of toxic, harmful 
or chemically unstable compounds can be lowered to minimal amounts. These biocatalytic 
transformations allow the synthesis of enantiomerically enriched alcohols,[172] amines[173], 
and amino acids.[174] However, single enzymes are floating within the reaction mixtures 
and have no comparable properties with nature’s molecular machines. In order to mimic 
natural, enzymatic cascade reactions with artificial methods, it is necessary to bring 
different enzymes in close proximity called metabolic channeling.[175] This ensures fast 
transfer of unstable compounds from one catalytic site to the other without diffusion as 
shown for example for the tryptophan-synthase[154] with its hydrophobic channel (Figure 
19a). There are several approaches to achieve a small spatial distance between catalytically 
active reaction centers which will be presented in the following paragraphs. 
Immobilization of Enzymes in Close Proximity 
Enzymes can be immobilized by using various techniques[176] and different scaffolds.[177] 
Hereby, immobilization guarantees for spatial approximation but at the same time enables 
in some cases an enhanced enzyme activity, stability, and selectivity.[178] Immobilization 
can be distinguished by non-specific, random placement on the scaffold as well as specific, 
controlled arrangement within the biocatalytic assembly. 
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The first example of two non-specific, co-immobilized biocatalysts was reported in 
1970.[179] Hexokinase and glucose-6-phosphate dehydrogenase were both covalently 
bound to Sepharose 4B and in addition to an acrylamide-acrylic acid polymer, respectively. 
A cascade reaction was carried out using glucose, ATP and NADP+ monitoring the 
development of NADPH per time (Figure 21). Comparing the immobilized enzyme’s 
activity with the activity of both enzymes in solution, an increased development of 
NADPH was observed for both matrices. Spatial proximity of both enzymes decreases the 
possibility of diffusion for the intermediate glucose-6-phosphate. 
 
Figure 21: Cascade reaction carried out by immobilized hexokinase (HK) and glucose-6-phosphate 
dehydrogenase (G-6-PDH) leading to an increased formation of NADPH compared to the single enzymes in 
solution. Adapted from Schoffelen et al.[180] 
Polymer-enzyme hybrid structures with a polymeric backbone and covalently attached 
enzymes carrying out a cascade reaction are one further example for co-immobilization of 
enzymes on a polymeric scaffold (Figure 22).[181] Hereby, a polymer chain of 
polymethacrylate was synthesized with 2000 repeating units. The polymer has an 
enormous number of amino groups which are protonated below pH 9, making the polymer 
backbone polycationic and water-soluble. For the attachment of the enzymes, a bis-aryl 
hydrazine (BAH) linkage was used. The linkage connects a polymer-bound aryl hydrazine 
with an introduced benzaldehyde group on the enzyme’s surface.[182] The advantage of this 
conjugation method is the simple observation of the reaction with UV/Vis spectroscopy 
measuring the absorption band at 354 nm for the newly formed bond. It allows direct 
quantification of attached enzymes resulting in 60 attached superoxide dismutases (SOD) 
and 120 attached horseradish peroxidases (HRP). Several fluorescein molecules were 
linked in the same way for quantification of the polymer and for possible imaging. The 
attached enzymes remained fully active after conjugation. The individual activity of HRP 
was tested with H2O2 as oxidant and ABTS2- as oxidable substrate.[183] The enzymatic 
functionality of SOD was investigated with superoxide radical anions which are 
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transformed by SOD in a disproportionation reaction in dioxygen and hydrogen peroxide. 
In a cascade reaction, both reactions were combined, demonstrating an almost similar 
efficiency compared to free enzymes. By binding the two enzymes to the polymer 
backbone, local proximity for a cascade reaction was enabled. 
 
Figure 22: Polymer-enzyme hybrid structure with a polymethacrylate backbone and attached superoxide 
dismutases (SOD) and horseradish peroxidases (HRP). The cascade reaction occurs first at the SOD 
transforming superoxide radical anions generated by pulse radiolysis to hydrogen peroxide. In a peroxidase 
reaction at the HRP, the colorful ABTS dye is generated which confirms the successful proceeding of the 
cascade. Reprinted with permission from Grotzky et al.[181] 
In further approaches, e.g. two different enzymes, acid phosphatase and 
fructose-1,1-diphosphate aldolase, were immobilized on methacrylate polymeric beads for 
the synthesis of complex chiral carbohydrates.[184] Also, glucoamylase and α-amylase were 
co-immobilized on magnetic chitosan beads. The beads were applied for consecutive starch 
liquefaction and saccharification.[185] As last example, immobilization of glycerol 
dehydrogenase and xylose reductase to nanoparticles made of methyl methacrylate, 
methyl acrylic acid, and ethylene dimethylacrylate will be mentioned.[186] Hereby, a 
parallel cascade system was created demonstrating the simultaneous generation of 1,3-di-
hydroxyacetone and xylitol from glycerol and xylose. The immobilized multi-enzyme 
system did not only demonstrate a significantly increased stability compared to enzymes 
in solution but rather increased their turnover numbers and catalytic efficiencies.  
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The above mentioned examples describe researcher’s approaches to bring enzymes via 
immobilization in close proximity. However, there is limited control over distribution of 
enzymes on scaffolds. Even if the biocatalysts are on the same polymer or nanoparticle, 
there might still be a large distance between individual enzymes. Mimicking nature’s 
models, it is necessary to regulate and dominate construction of the assemblies. On the one 
hand, a direction of the enzyme’s position and its conjugation technique to the scaffold is 
desirable to prevent interference or hindrance with residues that are important for 
enzyme’s activity. On the other hand, the orientation of multiple enzymes to each other is 
of great importance to ensure a smooth and direct transfer of substrate within the cascade 
reactions. 
One possibility for specific immobilization is the use of affinity tags.[187] The common 
histidine tag can be introduced to enzyme’s C- or N-terminus with genetic methods and 
allows for an interaction with Ni2+. In one example, multiple enzymes for the synthesis of 
UDP-galactose were immobilized in controlled fashion via their hexahistidine tags onto 
nickel agarose beads.[188] The seven involved enzymes performed much better when 
immobilized compared to the single enzymes in solution. Recent literature reports even 
regulated orientation of a barrel protein on matrix and tunable binding strength when 
using histidine tags (Figure 23).[189] 
 
Figure 23: Controlled protein surface orientation by using hexahistidine tags.[189] Illustration of five possible 
variants and the corresponding end-on and side-on binding to the surface. Immobilization on the surface 
occurs via Ni2+ and NTA (nitrilotriacetic acid) complexation. Reprinted with permission from Wasserberg et 
al.[189] 
A further tag is cellulose-binding domain (CBD). Pantothenate kinase (PanK), phospho-
pantetheine adenylyltransferase (PPAT), and dephosphocoenzyme A kinase (DPCK) were 
expressed in bacteria with CBD.[190] Their immobilization on cellulose enabled effective 
and straightforward synthesis of coenzyme A and coenzyme A analogs. 
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The attachment of enzymes to scaffolds either non-specific or directed leads often to an 
undesirable decrease in enzyme’s activity. By using chemical conjugation methods, the 
structure often alters, leading to a modification of the active center and hence to reduced 
catalytical activity. One possibility to avoid chemical linkage is encapsulation or 
entrapment of enzymes into nanostructures. 
Non-covalent Encapsulation or Entrapping of Enzymes 
Multiple enzymes can be encapsulated in so-called nanoreactors.[191] For example, 
nitrobenzene nitroreductase (NBNR) and glucose-phosphate dehydrogenase (G-6-PDH) 
were co-encapsulated and co-localized in silica particles.[192] Encapsulation leads to a 
significantly increased stability of NBNR and was used for continuous reduction of 
nitroaromatic compounds (Figure 24a). In a recycling reaction, NADP+ was reused by 
G-6-PDH in situ. Both enzymes did not show a reduction of activity after encapsulation. 
 
Figure 24: (a) Nitrobenzene nitroreductase (NBNR) and glucose-6-phosphate dehydrogenase (G-6-PDH) are 
co-encapsulated in silica particles. Nitrobenzene is continuously reduced to hydroxylaminobenzene whereas 
at the same time NADP+ is recycled by G-6-PDH to NADPH in the oxidation reaction of glucose-6-phosphate. 
Adapted from Schoffelen et al.[180] (b) Proteopolymersome with encapsulated bacteriorhodopsin (BR) and 
F0F1-ATP synthase in their formed membrane. The light-induced proton gradient generated by BR enables 
ATP synthesis from ADP and inorganic phosphate. Reprinted with permission from Choi et al.[193] 
Another approach is the use of proteopolymersomes.[193] Two enzymes, bacteriorhodopsin 
(BR) and F0F1-ATP synthase were encapsulated into the membrane formed by an 
amphiphilic triblock copolymer, PEtOz-PDMS-PEtOz [poly(2-ethyl-2-oxazo-line)-b-
poly(dimethylsiloxane)-b-poly(2-ethyl-2-oxazo-line)] (Figure 24b). BR contains a 
photocycle which activates a proton pump. Consequently, a proton gradient is generated 
across the polymersome’s membrane. The gradient is used by ATP-synthase to synthesize 
ATP from ADP and inorganic phosphate. 
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One last example is encapsulation of three enzymes performing a cascade reaction into a 
bacteriophage P22 virus-like particle.[194] The three enzymes are CelB, which is a 
tetrameric β-glucosidase enzyme carrying out hydrolysis of a wide range of disaccharides, 
ATP-dependent galactokinase (GALK) and dimeric ADP-dependent glucokinase (GLUK), 
which perform phosphorylation of galactose to galactose-1-phosphate and glucose to 
glucose-6-phosphate (G6P), respectively. The sequence performed by these three enzymes 
is the start of glycolysis and provides information for studies in sugar metabolism and 
biofuels generation. Here again, spatial proximity of encapsulated enzymes leads to an 
increased activity of enzymes compared to single enzymes in solutions. 
However, the use of polymeric scaffolds or encapsulation materials is not always 
preferable. Often, immobilization or entrapment comes along with the presence of a large 
amount of non-catalytic material or with the use of expensive and complex carrier 
material. Therefore carrier-free methods were developed which are described in the 
following paragraphs. 
Covalent Linkage of Enzymes with Each Other 
In order to mimic the close proximity of catalytic centers in nature’s molecular machines, 
direct covalent conjugation of enzymes suggests being a promising approach. The first 
section demonstrates a few examples of linking enzymes using various chemical concepts. 
The second paragraph deals with gene fusion. This method is using nature’s biochemical 
methods for covalently conjugated multi-enzyme systems. 
Cross-linked enzyme aggregates (CLEAs) have been developed as one model for covalently 
linked enzymes without using a solid carrier.[195-197] One advantage is that very high 
enzyme activities per volume can be obtained because no non-catalytical material is 
present. The method uses direct precipitation from aqueous solution and cross-linking 
with glutaraldehyde in millifluidic reactors as shown exemplarily in Figure 25a for one 
aggregate. An example is the widely studied combination of glucose oxidase (GOx) and 
horseradish peroxidase (HRP) to perform enzymatic cascade reactions in CLEAs.[198] Here, 
the reaction starts with the oxidation of glucose by GOx. The resulting H2O2 is then 
reduced to water by the heme group of HRP. The activated form of HRP can catalyze the 
formation of fluorescence dyes. This way, the initial concentration of sugar can be 
determined by measuring the amount of produced dye. Additionally, enzymes like 
β-glucosidase or β-galactosidase can be added to this system to achieve three-step cascades 
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by breaking down complex carbohydrates such as starch or glycogen into their monomers 
prior to the oxidation reaction.[199-200] In combi-CLEAs of HRP and GOx[198], the distance 
between the enzymes is supposed to be very small. When adding catalase (CAT), a 
peroxidase which quickly decomposes H2O2, to the CLEAs, the reaction rate of the cascade 
reaction decreased only by 19%. This is only possible if the distance between HRP and GOx 
is very small and the transfer of H2O2 occurs fast. The combi-CLEA particles with a size of 
250 nm, were used as a colorimetric sensor for glucose. 
A further CLEA system is the combination of (S)-selective oxynitrilase (HnL) and 
non-selective nitrilase (NLase) for the synthesis of enantiomerically pure (S)-mandelic 
acid.[201] Both enzymes were precipitated with 1,2-dimethoxyethane and cross-linked with 
dextran polyaldehyde which was then reduced with sodium borohydride (NaBH4). Starting 
from benzaldehyde, the (S)-specific HnL introduces a cyano group sterically correct at the 
aldehyde group. The reaction cascade is followed by hydrolysis carried out by non-specific 
NLase resulting in enantiomerically pure (S)-mandelic acid. The conversion occurred very 
fast, but upscaling of the synthesis route remained challenging. Besides the use of dextran 
polymer introduces non-catalytic, high molecular weight, material to the system. 
The two-described system both contained two enzymes within their CLEAs. A CLEA 
system which incorporates five enzymes was established for the synthesis of nucleotide 
analogs (Figure 25a).[202] It contains both a purine nucleotide analog pathway and an 
auxiliary ATP recycling system. The pathway is shown in Figure 25b. The enzymes 
ribokinase (RK), phosphoribosyl pyrophosphate synthetase (PPS), and hypoxanthine 
phosphoribosyl transferase 8B3PRT (8B3) represent the part of the cascade which catalyzes 
in a last step the addition of purine nucleobases to the activated sugar, providing a variety 
of nucleotide analogs. The synthesis requires ATP, releasing ADP and Pi. These 
components are recycled in an ATP recycling system consisting of adenylate kinase (AK) 
and pyruvate kinase (PK) using phosphoenolpyruvate (PEP) as a source of activated 
phosphate. This CLEA system carrying out five reactions, not all in a one-directional 
cascade, however, combining two different reaction cycles is a good example for a more 
complex and sophisticated, artificial molecular machine mimicking in first attempts 
nature’s models of enzyme clusters. 
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Figure 25: (a) General procedure for the formation of cross-linked enzyme aggregates (CLEA) using the 
example of Scism et al.[202] (b) Reaction cycle proceeding in mentioned CLEA system for the synthesis of 
nucleotide analogs. The three enzymes ribokinase (RK), phosphoribosyl pyrophosphate synthetase (PPS) and 
hypoxanthine phosphoribosyl transferase 8B3PRT (8B3) catalyze the synthesis of purine analogs whereas an 
ATP recycling system is linked to the three-step cascade reaction. The ATP regeneration cycle provides ATP 
for the first two reactions of the cascade using adenylate kinase (AK) and pyruvate kinase (PK). Adapted 
with permission from Scism et al.[202] 
The formation of CLEAs is one concept of generating covalently linked enzymes. The 
method uses mainly abundant ε-lysine residues of the conjugated enzymes and might lead 
to uncontrolled cross-linking at multiple positions resulting in reduced catalytic activities. 
To meet this challenge a few approaches have been published such as the use of amino 
acid residues which are mainly present on the surface to a limited extent of the protein 
like cysteines, tyrosines, and tryptophans.[203] The cross-linking of bovine serum albumin 
(BSA) to a TLL lipase was carried out using click chemistry.[204] The lipase was selected 
because it has only one free accessible lysine on its surface which was then modified in an 
EDC coupling with an acetylene group. BSA on the other side only has one free accessible 
cysteine which was azide-modified. In a Cu+-catalyzed [3+2] Huisgen cycloaddition 
reaction, both proteins were reacted in a controlled reaction procedure and used for the 
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preparation of protein dimers. The dimers demonstrated a higher catalytic activity than 
the lipase alone and a higher long term activity. Click chemistry is also used in the coupling 
of two immunoglobulin-binding protein G domains.[205] Azide and alkyne groups were 
introduced to the proteins by native chemical ligation reactions (NCL). The thioesters for 
NCL reactions at the N-termini were expressed in fusion proteins. The last example 
demonstrates the synthesis of streptavidin (SAv)-BSA polymer conjugates.[206] Biotin-
maleimide telechelic polymers were synthesized which are able to bind site-specifically to 
the two different proteins. The dual functionality enables the conjugation of SAv and BSA 
to one polymer chain and in this manner a controlled cross-linking which might have a 
positive influence on the possible enzyme’s activity. 
 
Figure 26: Reaction scheme of the reaction carried out by a fusion protein of malate dehydrogenase (MDH) 
and citrate synthase (CS). Both enzymes are expressed with a linker containing 3 amino acids (AA). The 
presence of the competing enzyme aspartate amino transferase (AAT) demonstrated the high efficacy of the 
protein fusion being a less potent competitor of the reaction intermediate. Adapted from Schoffelen et al.[180] 
A completely different approach of linking enzymes without using chemicals is gene 
fusion. Genes, normally encoding for one specific enzyme, are joined with other enzyme 
genes resulting in a chimeric gene. The new gene codes for a polypeptide chain which has 
two active centers. The concept and first examples were described in 1991.[207] Generally, 
coalesced enzymes are prepared by removing the translational stop signal at the 3’-end 
and ligated into the start codon (ATG) of a second gene. The decision in which order 
enzymes are linked is chosen gratuitous. The linkage between both enzymes has a length 
of 3-10 amino acids because for longer spacers proteolytic degradation was observed. For 
example, two enzymes of the citric acid cycle were expressed as a fusion protein.[208] 
Mitochondrial citrate synthase (CS) and malate dehydrogenase (MDH) are expressed with 
a linker, containing three amino acids, in bacteria (Figure 26). The resulting dienzyme 
demonstrated in particular good activity once the cascade reaction was challenged by a 
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competing enzyme (aspartate amino transferase, AAT). AAT showed to be less effective 
when compared to free CS and MDH in reacting with the intermediate of the cascade. 
Another example is the fusion of dihydroxyacetone kinase (DHAK) and fructose-1,6-
bisphosphate aldolase (FBPA) to a bifunctional aldolase/kinase enzyme.[209] The linked 
enzyme system carried out a C-C bond formation starting from dihydroxyacetone (DHA). 
Both enzymes retained their structural integrity shown by circular dichroism (CD) 
spectroscopy and their activity. The proximity of the active centers promotes a 20-fold 
increased activity compared to the single enzymes which can be attributed to substrate 
channeling. This was confirmed by also using a competing enzyme, glycerol-3-phosphate 
dehydrogenase whose activity was almost twice as low when compared to GDH activity 
in the free enzyme system. 
One recently published multi-enzyme is the combination of oxidase and peroxidase via 
gene fusion.[210] One bacterial peroxidase was fused to four different bacterial oxidases 
resulting in a biocatalyst that allows cascade reactions only requiring molecular oxygen. 
All enzymes remained active, able to bind their cofactors and performing a wide range of 
cascade reactions. 
Despite the mentioned examples, gene fusion is mostly limited to the fusion of two, maybe 
three enzymes and not universally applicable. Microorganisms expressing the chimeric 
genes have often problems in folding the multidomain proteins properly and are not 
efficient in expression of large scales of fusion proteins.  
In summary, nature’s molecular machines are all distinguished by a high speed and 
efficiency in shuttling their substrates and products between spatially separated active 
sites. For a successful mimic, it is essential to minimize the distance between individual 
enzymes or functionalities as much as possible. The described artificial systems to mimic 
the cascade reactions are limited by either the bulky nature of enzymes or the use of a 
huge amount of inactive material (immobilization or encapsulation). Furthermore, 
available chemical means to organize and arrange two or several enzymes next to each 
other (CLEAs) and limited possibilities of natural biological systems (gene fusion) are 
major drawbacks in the state of the art of artificial cascade reactions. 
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2 Motivation and Objectives 
Enzymes play an important and decisive role in nature’s cellular processes as without the 
catalytic activity of enzymes, many reactions would not occur. Enzymes catalyze a wide 
range of biochemical reactions by reducing activation energy. Nature’s biocatalysts 
possess outstanding properties which ensure their full functionality in complex and 
demanding biosystems. Their setup with a core-shell structure, often an active site-specific 
seclusion and their interactions with other enzymes in large clusters, raises the interest of 
researchers to mimic and study these special features with artificial methods.[38] The aim 
of this thesis is to mimic the architecture of natural enzymes, their individual catalytic 
activity as well as their interaction with other enzymes in so-called molecular machines. 
In the first project of this thesis, an enzyme will be regarded individually and recreated 
with its outstanding properties. It is planned to attach catalytically active moieties to a 
polymeric scaffold. The goal is to demonstrate catalytic activity of this biopolymeric 
conjugate in simple in vitro assays. In a second project, the aim is to mimic the cooperation 
of different enzymatic reactions in enzymatic clusters and their accomplished cascade 
reactions. 
2.1 Artificial ATPase-like Enzyme 
Inspired by the setup of nature’s enzymes, it is the aim to design an ATPase-like enzyme 
mimic that is based on an innovative nanomaterial conjugate with active catalytic moieties 
(Figure 27). The conjugate allows a possible application in cells due to the utilization of 
highly biocompatible materials. So far, literature only reports efforts to mimic the setup of 
enzymes with their core-shell properties in dendrimers[75] or star polymers[76] with limited 
catalytic activity, or approaches to imitate only the active site of enzymes with inorganic 
nanozymes[40] or supramolecular structures[92-94, 97]. However, all these strategies have 
limitations, especially for a desirable utilization in cells, which could be mitigated by 
combining both approaches in one; a process that has not been carried out prior to this 
thesis. 
As an artificial cleavage site, supramolecular catalysts such as macrocyclic polyamines 
(Figure 27) can be considered for an attachment to a polymeric scaffold using 
bioorthogonal linkage methods. The polyamines have outstanding ATP hydrolysis 
capabilities in cleaving adenosine triphosphate (ATP) to its diphosphate (ADP) and were 
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discovered and intensively investigated in the 1980s by J. M. Lehn.[136-137, 139] In addition, 
the ATP balance is an interesting target for artificial enzyme-like catalysis with ATPases 
following this design principle. The bonding between the three inorganic phosphate 
anhydrides of ATP stores sufficient energy to make ATP the energy source for most 
metabolic cell reactions. Hence, natural ATPases are a relevant and necessary part of 
cellular energy metabolism.[119] However, as previous literature shows, macrocyclic 
amines do not have the possibility for an attachment to a nanomaterial. To overcome this 
limitation, it is the aim to chemically synthesize and modify those supramolecular catalysts 
with a connectable functional group. 
The carrier system of the artificial catalytic site has to ensure the generation of an 
enzyme-like local environment. It is planned to use the polysaccharide dextran as scaffold 
material.[211-212] Similar to the peptide backbone in natural enzymes, the polysaccharide 
represents a polymeric carrier scaffold with multiple attachment points and can be 
functionalized with macrocyclic polyamines. As a result, by attaching the macrocyclic 
polyamine-based catalyst to the dextran-based carrier an entire artificial enzyme can be 
created (Figure 27). 
 
Figure 27: Design of an artificial ATPase-like enzyme which is planned to be based on a dextran carrier 
material and attachable supramolecular polyamine-based catalysts. The carrier material can be further 
modified with PEG chains to create an enzyme-like core-shell structure. It is the goal to demonstrate catalytic 
activity in ATP cleavage in relevant in vitro assays with the designed nanomaterial. 
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Inspired by nature’s core-shell structures, it is planned to attach a poly(ethylene glycol) 
(PEG)[213] shell on top of the dextran carrier. It is the aim to investigate the biocompatibility 
of the system through toxicity screenings in HeLa cells. The catalytic activity, more 
precisely the ATP hydrolysis of the system shall be investigated in in vitro assays by using 
31P-NMR spectroscopy. 
In conclusion, the first main aim of this thesis is the development, chemical synthesis and 
modification of synthetic polysaccharide-based biopolymers to obtain multifunctional 
carrier materials and if possible imitate the core-shell structure of natural enzymes. 
Functionalizing them with supramolecular, catalytically active moieties such as 
macrocyclic polyamines in order to mimic enzymatic activity will lead to entire artificial 
enzymatic structures. Through the study of such a system, significant advances can be 
made towards the creation and understanding of artificial enzymes. 
2.2 Bioinspired Enzymatic Cascade Reactions 
In nature, the association of single enzymes to greater, functional entities can be observed. 
Enzymes often assemble into multifunctional molecular machines, e.g. the tryptophan 
synthase[152] or in ribosomes[164], to meet the demands of more complex reactions. Looking 
more closely at the general function of such molecular machines, one can observe that 
their assembly is mainly favorable to the proceeding of enzymatic cascade reactions. 
Cascade reactions proceed optimally if close proximity between both active centers is 
given. This requirement can be fulfilled by various artificial techniques such as 
immobilization, encapsulation or gene fusion of different enzymes.[180] Nevertheless, there 
are currently no known ways to achieve small spatial distance without using catalytically 
non-active material or losing enzymatic activity.  
In this thesis, a new innovative approach is planned. Catalytically active, short peptide 
sequences will be designed containing histidines, that are known for their esterase-like 
activity.[214-216] Using bioorthogonal conjugation techniques[217], these peptides shall then 
be attached to the surface of an enzyme, for example to cytochrome c (Cyt c), which has a 
distinct peroxidase activity (Figure 28). After conjugation, it is the plan to investigate the 
individual activity of both enzymatic reactions, the peptide-mediated esterase-like and the 
original, intrinsic peroxidase functionality, separately in respective assays. In subsequent 
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experiments, combination of both catalytic functionalities shall lead to the proceeding of 
an artificial cascade reaction. 
In order to demonstrate the transferability of the developed system, enzymes other (or 
different) than Cyt c will be modified with the catalytically active peptide sequence and 
will be investigated towards their additional esterase-like functionality after the 
attachment of the peptide. A comparison regarding the extent of chemical modification 
with the peptide on the surface will be given. 
 
Figure 28: Design of a bioinspired material with multifunctional catalytic activity. The material itself 
consists of either an enzyme with a distinct activity or a protein with no catalytic activity. By attaching a 
short peptide sequence to the surface of the proteins using bioorthogonal linker chemistry, it is planned to 
introduce an additional catalytic activity to the material. 
The second main aim of this thesis is the mild surface modification of enzymes with 
catalytically active peptide structures to obtain a biomaterial with additional functionality. 
If the selected enzyme has already intrinsic activity, it is planned to carry out cascade 
reactions between the catalytic surface layer and the active site of the enzyme. Such an 
artificial enzymatic cascade, performed within one biomaterial, can provide new 
opportunities for mimicking complex biochemical processes and to obtain understanding 
towards the development of novel, improved biocatalysts for industrial and therapeutic 
applications. 
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3 Results and Discussion 
3.1 Artificial ATPase-like Enzyme 
This first part of this chapter describes the design of an artificial enzyme-like system that 
mimics the function of ATPases. In a polymer-based approach, setup and features of a 
natural enzyme structure will be imitated. A new conjugate of a polysaccharide-based 
carrier material and a macrocyclic polyamine catalyst will be developed to obtain artificial 
ATPase-like enzymes. The synthesis, modification and evaluation will be established and 
described in the following chapters. 
3.1.1 General Approach 
The composition and architecture of natural enzyme structures are described in chapter 
1.1. As mentioned, previous approaches to mimic enzymes are limited to the use of either 
polymeric material with limited activity or supramolecular catalysts that imitate only the 
active sites of the enzymes. Inspired by nature’s polypeptide chains, a polymeric scaffold 
will be used as a carrier material with multiple attachment points to conjugate 
supramolecular catalysts which have catalytic activity. Thus, a nanomaterial with catalytic 
properties is created. Furthermore, nature’s core-shell organization with a catalytically 
active core and a protecting shield or corona around the active site is transferred to the 
artificial nanosystem. The core with the catalyst is based on the natural polysaccharide 
dextran[212] whose anhydrous glucose units (AGU) are functionalized with bioorthogonal 
reactive groups to allow the attachment of the catalyst and a shielding corona of 
hydrophilic poly(ethylene glycol), abbreviated PEG. The catalytic active sites inside of the 
enzyme mimic is built up by several supramolecular catalysts. Such supramolecular 
catalysts are macrocyclic polyamines which are known to be highly selective in cleaving 
ATP (adenosine triphosphate) to its diphosphate (ADP).[136] 
Bioconjugation Chemistry and Bioorthogonal Reactions 
First of all, the attachment of the active biocatalyst to the dextran-based carrier requires a 
conjugation method. The chemical strategy of linking two molecules of which at least one 
is a biomolecule is called bioconjugation chemistry. Biomolecules such as proteins or 
polysaccharides offer natural functional groups like amino- or hydroxyl groups which can 
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be used for conjugation of small molecules to the biomacromolecules[217] or for 
crosslinking of complex polysaccharide-protein conjugates.[218] Bioconjugation is often 
challenging because the used biomolecules offer only a limited number of functional 
groups and modifications have to be carried out under mild conditions. Room temperature 
or colder is often desired, and aqueous or buffered solutions have to be used. These 
demands are often not compatible with classical organic synthesis methods. A variety of 
reaction possibilities under mild conditions provide amino groups.[217] NHS-ester 
reactions[219] or classical amide formation[220] between acid and primary amine can be 
performed under physiological conditions such as low temperatures, aqueous solutions or 
pH range around 7. Amino groups are by far the most common functional groups present 
in crosslinking or modification reagents. Thus, an amino group-based approach was used 
for the modification of the macrocyclic polyamine and its application as catalytic active 
site. 
However, the introduction of such a multifunctional and versatile group increases the 
possibilities for side reactions and undesired reaction products. Avoiding this issue, 
bioorthogonal chemistry can be used. A bioorthogonal reaction is defined as a selective 
and rapidly occurring reaction in the presence of various other functionalities like thiols, 
amines, carboxylates or sulfates.[221-222] One of the most popular examples is copper-
mediated click-chemistry between azides and alkynes. The 1,4-cycloaddition which was 
developed 20 years ago has been constantly improved. To date copper-free variants[223] 
using strained cyclooctynes (Figure 29) are well known. This bioorthogonal conjugation 
methods allows the application even in living organisms.[224-225] 
 
Figure 29: General cycloaddition reaction of an azide group with a strained cyclooctyne group resulting in 
a triazole. 
A second bioorthogonal reaction is using sulfur chemistry. Right after amino-reactive 
groups, sulfhydryl-containing molecules are the second most common functional group 
used in crosslinking or modification reagents. The reactions occur quite fast and in high 
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yields resulting in stable thioether or disulfide bonds. A common used reaction is the 
nucleophilic attack of thiols with soft electrophilic alkenes such as maleimides (Figure 30) 
or iodoacetamides. Maleimides or more specifically maleic acid imides are formed by the 
reaction of maleic anhydrides with ammonia or primary amine-containing compounds. 
 
Figure 30: Bioconjugation reaction using sulfur chemistry. A thiol reacts with a maleimide resulting in a 
stable thioether bond. 
The pH value matters for the reactivity of the thiol with the maleimides, because only in a 
pH range of 6.5 to 7.5 the reaction is specific for thiols.[226] At pH 7 the reaction is 
approximately 1000-fold enhanced compared to the reaction with amines. If the pH 
increases, side reactions with amino groups can occur.[227] A further disadvantage of the 
reaction is, that at long reaction times maleimide groups can hydrolyze to their open, 
unreactive form. These issues must be considered once applying this bioconjugation 
strategy. 
A third, very selective reaction is the reaction of aldehydes with aminooxy (alkoxyamine) 
groups or hydrazines (Figure 31). In contrast to the reaction of primary amine with 
aldehydes or ketones (Schiff bases) which results in a relatively labile, reversible bonding 
the oxime linkage is a very stable bond. The bond does not require further stabilization 
through reduction as used for the Schiff base formation and has been used in many 
bioconjugation reactions.[228-229] The reaction is not completely considered as bio-
orthogonal because in biochemical process a lot of aldehyde and ketone metabolites are 
present. 
 
Figure 31: Formation of an aldoxime using a type of irreversible Schiff base formation. 
The reaction speeds up if using aniline as catalyst.[230] The aniline reacts first with the 
aldehyde resulting in an imine, which represents an intermediate Schiff base and activates 
the aldehyde. The formed imine is then subsequently replaced by the aminooxy group 
yielding the oxime linkage in high yields.[231-232] 
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The three presented bioorthogonal conjugation methods will be used in the design of the 
artificial enzyme mimic and applied as strategies to connect the supramolecular catalyst to 
the dextran-based carrier as well as the attachment of a shielding corona. 
3.1.2 Modified Macrocyclic Polyamines as Active Sites 
This chapter deals with the synthesis and modification of catalytically active, 
supramolecular structures which can introduce artificial cleavage sites to the enzyme 
mimic. 
As early as the 1980s, J. M. Lehn and co-workers reported the synthesis and properties of 
polyammonium macrocycles as anion receptor molecules[134] and later on their catalysis 
abilities[136] regarding the ATP hydrolysis. The supramolecular investigations of the 
macrocyclic polyamine 1,13-dioxa-4,7,10,16,19,22-hexaazacyclotetracosane called O-bis-
dien or [24]N6O2 1 (Figure 32) with various phosphates[138, 142, 233] were their focus and 
led among other findings to the Nobel Prize in chemistry in 1987. He is said to be one of 
the earliest innovators in the field of supramolecular chemistry and his work is the basis 
for the development of the herein described modifications of macrocyclic polyamines as 
catalytic active sites for artificial enzyme mimics. In the beginning of this PhD project, 
macrocyclic polyamines derived from the budmunchamine family of alkaloids[147] were 
modified for an attachment to a carrier system. Those compounds were already used in 
biological contexts to deplete cellular ATP levels.[148] The results of these syntheses and 
their ATP hydrolysis evaluation are mainly reported elsewhere.[234] In fact, the hereby 
synthesized structures did not lead to desired ATP cleavage, hence other macrocyclic 
polyamines with an aromatic unit were used as basis for the development of an attachable 
macrocyclic polyamine.[144] The cyclophane receptor 2,5,8,11,14,17-hexaaza[18]meta-
cyclophane 2 (Figure 32) has one of the largest rate enhancements for the hydrolysis of 
ATP[144] compared to published macrocyclic polyamines, published by that time.  
The increased rates can be explained by the introduced benzylic unit which forces the 
electrostatic interactions and the π-stacking of host and guest in supramolecular 
cooperation. Before, it has been shown that up to two acridine units attached to O-bisdien 
enhance the ATP binding and hydrolysis.[143] Additionally, the published synthesis route 
of 2,5,8,11,14,17-hexaaza[18]metacyclophane 2 seemed straightforward and alterable. 
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Figure 32: Structures and names of published macrocyclic polyamines with high ATP hydrolysis rates. 
Synthesis of the Reference Compound 2,5,8,11,14,17-Hexaaza[18]metacyclophane 
In order to have a comparable, reference compound for further studies regarding especially 
the ATP cleavage measurements, the literature known macrocyclic amine (MCA), 
2,5,8,11,14,17-hexaaza[18]metacyclophane 2 was synthesized (Figure 33). Another reason 
was, that the synthesis route for the amino-modified polyamine should be based on the 
one for MCA 2. Additionally, getting used to the handling of the polyamines and their 
purification was a positive side effect. For the synthesis, the published route by Aguilar et 
al.[144] was overall optimized. In particular the first step, the protection of the polyamine 
and the last step, the remove of the protecting groups were transferred from other 
molecules. First, the protection of the 3,6,9,12-tetraazatetradecan-1,14-diamine 3 with 
p-toluene sulfonic acid 4 was evaluated and optimized based on different literature 
procedures. The tosyl protecting group is used here because it is a relatively bulky 
protecting group that shields the secondary amines and allows reactions mainly at terminal 
amino groups. 
Published synthesis routes for the protection of analogous, shorter polyamine sequences 
in tetrahydrofuran (THF) with an aqueous solution of the base sodium hydroxide 
(NaOH)[235] as well as a synthesis in diethyl ether (Et2O) at 0 °C[236] afforded either no 
desired product or product in yields below 5%. However, the protection carried out in 
pyridine at 50-60 °C and a slow addition of 3,6,9,12-tetraaza-tetradecane-1,14-amine 3 [237] 
led to the protected polyamine 5 as a beige solid in 40% yield. The structure was confirmed 
by standard techniques like nuclear magnetic resonance (NMR) analysis, in particular 1H, 
13C, DEPT-135 (distortionless enhancement by polarization transfer), COSY (homonuclear 
correlation spectroscopy), HSQC (heteronuclear single quantum coherence) and HMBC 
(heteronuclear multiple bond correlation) spectra.[238-240] Mass spectrometry (LC-MS) and 
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if applicable infrared spectroscopy (IR) were utilized as standard analytical methods for 
structure determination of organic compounds and will not further be highlighted if used. 
The macrocyclic amine MCA 2 was prepared by K2CO3 templated cyclisation of the linear 
tosylamide precursor 5 with 1,3-bis(bromomethyl)benzene 6.[144, 235] In a nucleophilic 
substitution reaction the free electron pair of the protected terminal amino groups attacks 
the positively polarized methyl carbon in the 1 and 3 position of the aromatic unit. The 
reaction occurs in the nonpolar solvent acetonitrile with high excesses of the base K2CO3. 
1,3-bis(bromomethyl)benzene 6 was highly diluted and added during 18 h considering the 
Ruggli-Ziegler dilution principle which implies that the intramolecular reaction is favored 
compared to the intermolecular reaction if the reaction is carried out in high dilutions. The 
principal bases on the fact that the probability of the end to end reaction of the 
corresponding molecules (intramolecular reaction) is independent of the concentration of 
the molecules. However, the probability that two different molecules meet (intermolecular 
reaction) decreases with dilution. With the help of the principle, the already low yields of 
cyclisation reactions can be optimized and afforded 2,5,8,11,14,17-hexakis(p-tolylsulfonyl)-
2,5,8,11,14,17-hexaaza[18]metacyclophane (MCA(Ts)6) 7 as a white solid in 65% yield. 
The release of the free, secondary amino groups after deprotection can be performed in 
various synthesis routes.[241] A Birch-similar reduction in condensed ammonia at –70 °C 
with lithium is one possibility[144] as well as the detosylation with phenol and 48% HBr[236]. 
2,5,8,11,14,17-Hexaaza[18]metacyclophane 2 was received after the latter procedure. After 
refluxing 7 in 48% HBr at 130 °C for 50 h and washing of the aqueous phase with 
chloroform (CHCl3), the strongly acidic, aqueous solution of the bromide salt of the 
deprotected polyamine was cooled to 0 °C. The pH was gradually increased up to 12 while 
a significant color change from purple to yellow occurred, demonstrating the change of 
the electron density and distribution in the aromatic system. The product 2,5,8,11,14,17-
hexaaza[18]metacyclophane (MCA) 2 was again extracted with CHCl3 and obtained as a 
yellow oil in 37% yield. The ATP hydrolysis of MCA 2 was successfully evaluated with 
31P-NMR resulting literature comparable kinetic rates (see for details 3.1.6).[144] The 
described synthesis of 2,5,8,11,14,17-hexaaza[18]metacyclophane 2 was used as the basis 
for development and synthesis of a macrocyclic polyamine that can be linked to the 
dextran-carrier. 
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Figure 33: Synthesis of published macrocyclic amine 2 in a slightly modified procedure of Aguilar et al.[144] 
Especially the first and the last step of the synthesis was optimized. 
Synthesis of Functionalized Macrocyclic Amines 
As described in the paragraph on Bioconjugation Chemistry, introduction of an amino 
group to the aromatic ring unit of 2,5,8,11,14,17-hexaaza[18]metacyclophane 2 (Figure 34) 
provides a powerful tool for further conjugation possibilities. As an ideal position for the 
amino group the meta position referring to the -(CH2)-Br groups was considered. In first 
experiments, various nitration strategies of 1,3-bis(bromomethyl)benzene 6 were 
evaluated. The nitro group serves as a precursor for amino groups at aromatic compounds 
because the nucleophilic aromatic substitution proceeds very slowly compared to the 
electrophilic aromatic substitution with a nitrosyl cation. The introduced nitro group can 
be easily reduced to an amine afterwards. The reaction in pure 65% HNO3 at –5°°C[242] 
yielded no separable product, only mixtures of miscellaneous mono-substituted 
1,3-bis(bromomethyl)-nitrobenzenes were obtained. Such mixtures were obtained with 
reaction mixtures of Ac2O and 65% HNO3 at –20 °C[243] and as well the classical nitrating 
solution[244] consisting of a mixture of concentrated sulfuric acid and nitric acid at 0 °C. 
Since introduction of an amino group via direct nitration of 1,3-bis(bromomethyl)benzene 
6 failed, the synthesis of the desired molecule was approached in a different way. Already 
1,3,5-substituted aromatic amino compounds were used as starting point for modifications. 
As one example, 3,5-dimethylaniline was brominated with N-brom-succinimide (NBS) 9 
and azobisisobutyronitrile (AIBN)[245] in dichloromethane (DCM) in a radical substitution 
process. This reaction resulted in multiple bromine-substituted product mixtures even 
substituted at the aromatic protons probably due to the +M (mesomeric) effect which is 
here significantly higher than the –I (inductive) effect. The reaction did obviously not 
occur in a radical mechanism rather in a typical electrophilic substitution. The reaction 
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was also carried out in carbon tetrachloride (CCl4), a nonpolar solvent in which the 
developed succinimide precipitates and can be easily removed. However, those reactions 
conditions led also to a substitution at the aromatic core. In order to have a different 
aromatic environment, in particular, a different distribution of the electron density at the 
aromatic ring, a further approach was the protection of the amino group of 3,5-
dimethylaniline with a protecting group hoping that this leads to the desired substitution 
pattern. The protection of the amino group was successfully carried out with benzyl phenyl 
carbonate (Cbz) as well as tert-butyloxycarbonyl (Boc) intolerably yields. However, the 
subsequent radical substitution reactions with NBS and AIBN led to a substitution at the 
aromatic core and not to the desired substitution with bromine at the 1,3-methyl groups. 
The combination of both evaluated strategies – using a nitro group and bromination with 
NBS and AIBN – led finally to the successful synthesis of 1,3-bis(bromomethyl)-5-
nitrobenzene 10 (Figure 34). 
5-nitro-1,3-xylene 8 was used as starting material in a modified radical substitution with 
NBS 9 and benzoyl peroxide (BPO) in CCl4 after a published procedure.[246] The product 
was obtained in 27% yield after column chromatography. The low yield can be explained 
by the various developed side products. All of them were isolated in different fractions and 
analyzed after the purification process demonstrating the appearance of multiple 
substituted brominated methyl groups in not negligible yields. Various attempts were 
carried out to increase the yield of 1,3-bis(bromomethyl)-5-nitrobenzene 10 but either 
different amounts of NBS 9 nor altered reaction times or temperatures led to yields over 
30%. 
The second building block, the 1,4,7,10,13,16-hexakis(p-tolylsulfonyl)-1,4,7,10,13,16-
hexaaza-hexadecane 5 was synthesized as described for 2,5,8,11,14,17-hexaaza[18]meta-
cyclophane 2.[237] (Figure 34). 
The cyclisation of 1,3-bis(bromomethyl)-5-nitrobenzene 6 with 1,4,7,10,13,16-hexa-
kis(p-tolylsulfonyl)-1,4,7,10,13,16-hexaaza-hexadecane 5 was carried out in a similar 
manner as described for the precursor described above.[144] In this case, the reaction is 
supported by the strong –M and –I effect of the nitro group which additionally withdraws 
electron density from the aromatic ring.  
After 2 days of refluxing the reaction mixture was purified by column chromatography 
and 2,5,8,11,14,17-hexakis(p-tolylsulfonyl)-21-nitro-2,5,8,11,14,17-hexaaza[18]metacyclo-
phane (NO2-MCA(Ts)6) 11 was obtained as a colorless solid in 35% yield. The formation of 
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the side products, like the polyamine chain with two aromatic units at each end was 
observed as well as bigger macrocyclic products. 
 
Figure 34: Synthesis of the amino-modified macrocyclic amine 13 (NH2-MCA). 
The next step was the reduction of the nitro group to an aromatic amine group. Therefore, 
various reduction methods were evaluated. In order to keep as much as possible of the in 
multistep synthesized compound NO2-MCA(Ts)6 11, 5-nitro-1,3-xylene 8 was used as a 
model molecule. First, the typical reduction conditions with tin powder in hydrogen 
chloride (HCl 36%)[244] under reflux for 1 h was carried out. However, this failed for the 
reduction of 2,5,8,11,14,17-hexakis(p-tolylsulfonyl)-21-nitro-2,5,8,11,14,17-hexaaza[18]-
metacyclophane 11 because of the bad solubility of the starting material in aqueous 
solutions. As an alternative, the reduction was tried with hydrogen (H2) and palladium (Pd) 
on carbon in methanol (MeOH).[247] Palladium on carbon (Pd/C) is a form of palladium 
distributed on activated carbon to maximize its surface area and its activity. The successful 
reduction in a hydrogenation pressure vessel was shown by the ninhydrin reagent which 
colors primary amines in a significant purple color. The reaction process can be observed 
by comparing the starting material’s color with the product’s dye. However, this reduction 
method failed for 11, since the compound is not soluble in MeOH. One possible solvents is 
ethyl acetate (EtOAc) which was tested with H2 and Pd/C in the hydrogenation vessel but 
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leading mainly to the development of acetic acid and dioxane which did not show any 
conversion of the starting material. Nevertheless, the use of dioxane as possible solvent for 
11 led finally to a successful reduction. With the application of 4 M HCl solution in 
1,4-dioxane and tin granulate the complete reduction was achieved after 5 h under reflux 
and a slightly yellow product of NH2-MCA(Ts)6 12 was obtained in 98% yield. 
The almost quantitative yield was obtained after optimization of the work-up procedure 
in which instead of column chromatography the organic phase was washed with an 
aqueous sodium hydroxide as well as aqueous sodium chloride solution. 
The final synthesis step, the deprotection of the tosylated macrocyclic amines 
NH2-MCA(Ts)6 12 was first carried out in a same manner as successfully accomplished for 
the unfunctionalized MCA 2. NH2-MCA(Ts)6 12 was refluxed for 48 h in 48% HBr with 
phenol and extracted with chloroform (CHCl3) to remove the water-insoluble, cleaved 
tosyl residues. After a pH change from acidic to basic, the product was attempted to be 
extracted with CHCl3. For MCA 2 this worked well, however, the yields were not very 
good. With the introduction of an additional, seventh amine to the compound the solubility 
in CHCl3 decreased so much, or rather the solubility in the basic aqueous phase increased 
so much that this extraction strategy did not work as well as before. The product 21-amino-
2,5,8,11,14,17-hexaaza[18]metacyclophane (NH2-MCA) 13 remained in the aqueous phase 
with a lot of different salt ions from the HBr deprotection and the pH increase with 1 M 
NaOH. Lyophilization of the aqueous phase resulted in a significant mass increase but it 
was not possible to separate the organic compound 13 from the salts in any extraction 
method due to the high solubility of 13 in aqueous environment. 
Alternative purification methods were evaluated however the common isolation as a 
chloride or bromide salt was no option because of the later application in ATP hydrolysis. 
Compagnone et al. reported the use of an anionic exchange resin after detosylation.[248] The 
resin contains uniform particle size beads consisting of a poly(styrene-co-divinylbenzene) 
gel with the functional group of a quaternary amine (-NH4+) on its surface. Hydroxide ions 
are bound as counterions in the shipped form and can easily be exchanged through other 
stronger binding ions in the described case here through the bromine ions. Figure 35 
displays the exchange of counterions which takes place on the surface of DOWEXTM 
MARATHONTM A resin. The exchange of the ions can be pursued by checking the pH 
value of the resulting product. As a bromine salt, the aqueous solution reacts strongly 
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acidic. As soon as the bromide ions are then exchanged against hydroxide ions, an aqueous 
solution of 13 reacts basic as expected for such amine rich compounds. 
 
Figure 35: Purification of bromide salt of NH2-MCA 13 with DOWEXTM MARATHONTM A resin. The anion 
exchange gel beads (brown sphere) carrier quaternary amine groups on their surface with hydroxide ions as 
counter ions. By incubating the bromide salt of NH2-MCA with the beads, the hydroxide ions are exchanged 
to the bromide ions, releasing H2O and the purified, uncharged NH2-MCA 13. 
Since the application of the resin in a column format did not result in a complete exchange 
of all ions and did not result in a basic solution, respectively, the DOWEX beads were 
incubated with the aqueous phase of NH2-MCA 13 which was obtained after the 
detosylation reaction with 48% HBr and phenol. After regeneration of the anion exchange 
resin with 5% NaOH, the incubation and washing had to be repeated several times. 21-
amino-2,5,8,11,14,17-hexaaza[18]metacyclophane 13 was obtained as a brown oil in 86% 
yield. Structural clarification with NMR analytics confirmed the successful synthesis of 
NH2-MCA 13. The NMR of the bromide salt and the uncharged polyamine demonstrate a 
significant difference in shift due to the disparate electron density within the aromatic and 
the whole macrocyclic amine (Figure 36). The charged molecule was measured by LC-MS 
mass spectrometry with a mass to charge relation of 350.5 m/z which comes along with 
the calculated molecular weight of 349.53 g mol-1. The successful synthesis of 21-amino-
2,5,8,11,14,17-hexaaza[18]metacyclophane (NH2-MCA) 13 provides an amino group-
modified version of 2,5,8,11,14,17-hexaaza[18]metacyclophane (MCA) 2. The functional 
group enables either the direct attachment to a carrier system using amine-based 
conjugation techniques or establishes new possibilities for further conjugation strategies 
like click-chemistry or thiol-maleimide reactions via bifunctional linker systems. Both last-
mentioned approaches are used in 3.1.4 to connect the supramolecular catalysts as a 
catalytically active moiety to their dextran-based carrier systems. 
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Figure 36: The 1H-NMR displays significant shifts of the signals of protonated form of NH2-MCA 13 (a) and 
uncharged structure (b). 
Interaction of Amino-modified Macrocyclic Polyamine with ATP 
The binding of nucleotides to macrocyclic polyamines has been shown over 35 years 
ago.[134] The interaction of ATP with the amino-modified MCA 13 is studied in 1H-NMR 
(Figure 37). By comparing the spectra of ATP, NH2-MCA 13 and the mixture of both 
compounds, significant signal shifts are observed. The signal of the anomeric proton of the 
ribose of ATP is shifted 0.11 ppm downfield as soon as NH2-MCA 13 interacts with ATP. 
The adenine protons are also shifted downfield by 0.1 ppm. The benzene protons 
demonstrated even a signal splitting with a shift of 0.47 ppm and 0.21 ppm downfield, 
respectively. The shift of the single aromatic proton (Figure 36, Signal d) is remarkable. 
The demonstrated three shifts prove the involvement of π-stacking in the stabilization of 
the supramolecular complex. The signals of the ethylene bridges are also significantly 
shifted by 0.93 ppm which displays their interaction with the three phosphate groups of 
ATP. 
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Figure 37: 1H-NMR spectra of ATP (a), an equivalent mixture of NH2-MCA 13 and ATP (b) and pure 
NH2-MCA 13 (c) in same concentrations measured in D2O. The shifts of the indicated signals of the adenine, 
the benzene and the anomeric proton prove π-stacking between the aromatic ring of NH2-MCA 13 and 
adenine of ATP. The shift of the ethylene bridges occurs after interaction with the phosphate groups. 
Cyclooctyne-modified Variant of Macrocyclic Amine 
In order to have a macrocyclic amine that allows bioorthogonal conjugation, NH2-MCA 13 
was further reacted with (1R, 8S, 9s)-bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl 
carbonate 14, short BCN-NHS (Figure 38). The hetero-bifunctional linker has an amine-
reactive NHS-ester on one side and an azide-reactive cyclooctyne structure on the other 
end. The cyclooctyne part enables the utilization of copper-free click chemistry which is 
supposed to be important while working with macrocyclic polyamines (Figure 29). The 
six-membered nitrogen rings are capable of complexing copper and eliminate the 
transition metal, which is absolutely necessary for the azide-alkyne-cycloaddition reaction. 
Besides free electron pairs of macrocyclic amines are not able to interact in supramolecular 
catalysis with the ATP if they complex copper. Hence, a possible cleavage of ATP is 
excluded. 
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Figure 38: Reaction of NH2-MCA 13 with BCN-NHS 14. A cyclooctyne-modified macrocyclic amine 15 was 
obtained after the conjugation. 
BCN-NHS 14 was reacted with NH2-MCA 13 in a 1.1:1 (BCN-NHS: 13) molar ratio at 0 °C 
overnight. This ratio allows, on one hand, full modification of the aromatic amine and 
prevents, on the other hand, modification of secondary amines within the macrocyclic ring 
which has been observed in former experiments of that kind of reaction. The purification 
of the reaction product turned out to be very challenging due to the amphiphilic behavior 
of NH2-MCA 13 and its reaction product, the BCN-modified macrocyclic polyamine 15. 
Before, the purification was possible with extraction methods shown in literature,[225] but 
in a reaction mixture of the BCN-modified 15 and the unmodified version 13, this is not 
applicable. Standard column chromatography on silica, which was used for BCN-derived 
molecules,[249] was also challenging because of the smearing behavior of the amines. All 
amines can take on different protonation stadia which make a separation of the different 
species almost impossible. The use of concentrated ammonia in the solvent mixture of the 
column can overcome this issue by trying to keep a constant protonation environment. 
However, high amounts of ammonia can destabilize the product molecules which are on 
the column to be purified. For 15, purification was tried several times with different solvent 
mixtures and furthermore with various purification methods like preparative HPLC (high-
performance liquid chromatography). The product BCN-MCA 15 was always confirmed 
by NMR and LC-MS, but isolated in very low yields (<10%) which could not be improved. 
However, unpurified reaction mixtures were used for the click chemistry approach of the 
conjugation of catalyst and carrier (see chapter 3.1.4). 
Maleimide-modified Variant of Macrocyclic Amine 
An alternative bioorthogonal conjugation method is the thiol-maleimide Michael addition 
reaction (Figure 30). For this, the amino-modified macrocyclic amine NH2-MCA  13 was 
modified with a heterobifunctional linker 16 (Figure 39). The SM(PEG)4-linker (NHS-
PEG(4)-Mal) 16 has an amine-reactive NHS-ester on one end and a thiol-reactive 
13 
14 
15 
3 Results and Discussion 63 
maleimide on the other end. Both functional groups are connected via four amphiphilic 
PEG units. 
 
Figure 39: Reaction of NH2-MCA 13 with SM(PEG)4 (NHS-PEG(4)-Mal) linker 16. A maleimide-modified 
macrocyclic amine 17  was obtained after the conjugation. The reaction product was not isolated but rather 
used for the attachment to a thiol-modified material. 
It was not possible to purify and isolate the reaction product, because of the challenging 
handling with the free secondary amines of the macrocyclic polyamine as described in the 
previous paragraph. However, LC-MS measurements confirmed the successful synthesis 
of the maleimide-modified macrocyclic amine Mal-MCA 17 (6.2.2). The 
maleimide-modified variant was used for a thiol-maleimide conjugation approach in the 
development of the enzyme mimic. 
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3.1.3 Modified Dextrans as Carrier Materials 
This chapter describes the design and synthesis of carrier and an additional corona for the 
shielding of the artificial cleavage sites of the enzyme mimic. The polysaccharide dextran 
18 is functionalized with chemical groups that facilitate bioorthogonal chemistry. In detail, 
two different approaches will be demonstrated for the attachment of the synthesized 
supramolecular catalysts, as well as the possibility for further conjugation of a shielding 
layer to the polymeric scaffold. 
The Polysaccharide Dextran 
Dextran 18 is a water- and organic soluble polysaccharide. It is one of the most important 
polysaccharides used for biomedical applications[250] and in drug delivery (Figure 40).[211] 
Dextran belongs to the group of neutral polysaccharides and consists of an 
α-(1,6)-D-glucose main chain with varying proportions of linkages and branches which can 
be at all three remaining hydroxyl groups at position 2, 3 or 4 (Figure 40). Different 
bacterial strains, mostly gram-positive, can synthesize dextran from different varieties of 
sucrose. These bacteria were discovered in 1861 by Pasteur[251] and in 1878 van Tieghem 
termed them Leuconostoc mesenteroides.[252] The bacteria strains are found in fermented 
foods of plant origin. The name “dextran” was given by Scheibler.[253] Nowadays, dextran 
is established especially in the medical field due to its excellent solubility in water as well 
as in other solvents like DMSO or DMF. Dextran is a physiologically harmless biopolymer 
due to its biocompatible, biodegradable, non-immunogenic and non-antigenic properties. 
Dextran is already used in aqueous solution as blood plasma expander where it replaces 
blood proteins like albumin in preventing colloid osmotic pressure collapses. [254] 
 
Figure 40: Detail structure of dextran 18 with α-(1,6)-glucose main chain and branching point in 4-position. 
Dextran can be obtained with different molecular weights. Native dextran is generally of 
high average molecular weight ranging from 9·106 to 5·108 g·mol-1. Hereby, polydispersity 
18 
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increases with molecular weight which is due to increasing branching density. In the 
following project, dextran 18 with a molecular weight of 10000 g·mol-1 is used. It has 
61.68 anhydrous glucose units (AGU) and one glucose unit has ideally three hydroxyl 
groups which are available for chemical modifications. To determine the number of 
chemical modifications the degree of substitution (DS) was introduced. The degree of 
substitution is the average number of introduced functional groups per dextran chain. 
Oxidized Azide-modified Dextrans  
The widely used polysaccharide dextran 18 (Figure 40) serves as starting material for the 
construction of a polymeric scaffold for the artificial catalytic site. It offers with its 
hydroxyl groups many derivatization possibilities[255] however modification of 
polysaccharides in general is challenging. Quantification and structural analysis of the 
modified chain by 1H-NMR is difficult because of the wide distribution and high intensity 
of all sugar proton signals, often overlaying the signal of attached small molecules. Mass 
spectrometry is limited because of high molecular weights and IR spectroscopy can only 
provide partly information once significant groups are present. Besides, dextran is only 
soluble in limited organic solvents, most suitable is DMSO or water. 
The experiments which led to the introduction of an azidobenzoic acid (AZBA) 19 group 
to dextran are extensively described elsewhere.[234] Briefly, functionalization was carried 
out after a published DCC/DMAP coupling procedure[256] and the resulting material 
Dex-(N3)9 20 was fully characterized by NMR, IR and UV-Vis spectroscopy (Figure 41). 
 
Figure 41: Reaction of dextran (Dex) 18 with azidobenzoic acid (AZBA) 19 in a DCC/DMAP coupling 
procedure.[256] 
The azidated dextran Dex-(N3)9 20 was obtained as a white, fluffy powder. With NMR 
spectroscopy the degree of substitution (DS) was determined to be 9.35 (Figure 42). Since 
the 1H signals of the aromatic ring structure are located between 7.1 and 8.1 ppm and thus 
beyond the intense sugar proton signals. The integrals of those signals can be set in relation 
to the anomeric proton signal, resulting in a DS of 9.35. According to that result, every 
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sixth to seventh AGU is esterified. This result was confirmed by UV-Vis spectroscopy using 
the absorbance of the aromatic azide at 276 nm (6.2.3). 
 
Figure 42: 1H-NMR of Dex-(N3)9 20 (a) and unmodified Dex 18 (b). By comparing the integrals of the two 
aromatic signals c and b and the anomeric proton a, the degree of substitution (DS) was determined to 9.35. 
Furthermore, introduction of an azide group was confirmed by IR spectroscopy (Figure 
47) due to the appearance of a characteristic azide bond at 2124 cm-1.[244] The IR spectra 
shows an additional bond at 1270 cm-1 which can be assigned to the C-O-C valence of 
esters which is an extra confirmation for the successful reaction with the acid. 
As part of this PhD thesis, experiments for improvement of the DS with azidobenzoic acid 
19 were carried out but no enhancement was achieved. The Dex-(N3)9 20 backbone was 
further oxidized with sodium periodate (Figure 43). This modification of polysaccharides 
is known since the 1950’s[257-258] and often used for the introduction of a secondary, 
different target structure to the sugar scaffold.[259] Aldehyde groups represent important 
reactive sites because they offer a variety of reactions such as hydrazine linkage, Schiff 
base formation, reductive amination, Mannich condensation or oxime linkage.[217] 
However, analytics of the oxidized material is difficult because there are barely 
characterization methods. Since the NMR and IR spectra did not show a significant change 
concerning the functional azide group, the successful periodate oxidation was assumed for 
OxDex-(N3)9 21. 
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Figure 43: Periodate mediated oxidation of Dex-(N3)9 20 resulting in accessible aldehyde groups on dextran 
backbone. 
Dextran-PEG Polymer Brush as Full Shielding Corona System 
The esterification of hydroxyl groups with azidobenzoic acid 19 and the subsequent 
oxidation of the polysaccharide backbone led to a biomaterial with two disparate target 
structures for bioconjugation (OxDex-(N3)9 21). The azide group is reserved for the 
attachment of the artificial cleavage site and the aldehyde group can be used for the 
conjugation of a further shielding corona to the dextran backbone. Similar to nature’s 
core-shell approach, linear arms of poly(ethylene glycol)(PEG), can be attached to the 
linear dextran chain resulting in a comb-like nanosystem (Figure 44). With formation of 
such a polymer brush the architecture of natural enzymes with their core-shell properties 
can be mimicked more precisely. 
 
Figure 44: Formation of a full shielding corona system by combining the OxDex-(N3)9 21 backbone with end 
group functionalized PEG chains 26 resulting a comb-like nanosystem which then forms a random core-shell 
structure. 
Similar dextran-PEG conjugates were already published in 2004 for the application as long-
circulating pharmaceutical carrier.[260] PEG 22 is a polyether compound with many 
applications in pharmaceutical research and industry.[261] It is described as a hydrophilic 
compound with stealth properties and often used as shell or corona material.[213, 262-263] 
Due to the extensive description of its properties and the diverse applications found in 
20 21 
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literature, PEG will not be further discussed in the present thesis. The published dextran-
PEG conjugate was synthesized by activating the hydroxyl groups with carbonyl-
diimidazole (CDI) followed by the subsequent reaction with ethylenediamine. The 
introduced amino groups are then able to react with NHS-ester end group-functionalized 
PEGs. This approach was tested elsewhere[234] but did not lead to a successful synthesis of 
a biomaterial with two disparate, addressable target functionalities. For the bioorthogonal 
modification of the dextran-based backbone, described in this new approach here, a 
different modification strategy was applied. 
First, PEG mono methylether 2000 (2 kDa) 22 was functionalized at its hydroxyl group-end 
with an aminooxy group similarly to a published literature protocol.[264] The modification 
allows the use of the oxime ligation strategy (Figure 31). In a Mitsunobu reaction[265], the 
end group was first activated with N-hydroxyphthalimide (NHP) 23 using the Mitsunobu 
reagents diisopropyl azodicarboxylate (DIAD) and triphenylphosphine (PPh)3 (Figure 45). 
After reaction overnight, the product PEG-NHP 24 was purified and obtained as a rose 
solid in 77% yield. The NMR displayed complete activation of all PEG chains with NHP. In 
a second reaction step, the phthalimide moiety was cleaved using hydrazine monohydrate 
25. 
 
Figure 45: End-group functionalization of mPEG 2000 22 (n=45.5). In a Mitsunobu reaction the end group is 
first activated with N-hydroxyphthalimide (NHP) 23 and then replaced by hydrazine monohydrate 25. 
After addition of the diamine, the mixture was stirred for further 30 min. A white 
precipitate of phthalylhydrazine occurred during the reaction. The precipitate was filtered 
off over glass wool and removal of solvent under reduced pressure resulted in a white solid 
of aminooxy-modified PEG 26 with 82% yield. NMR analytics demonstrated full conversion 
of the activated chain end group. Additionally, aminooxy-modified PEG 26 was stained 
with ninhydrin on a TLC plate resulting in a purple color compared to the starting material 
mPEG 22 and the intermediate PEG-NHP 24 which had no significant coloration. Synthesis 
was likewise successfully carried out with mPEG 5 kDa but not yet applied for the design 
of a core-shell material. 
The polymer brush based on the dextran backbone was then completed by the oxime 
ligation reaction of OxDex-(N3)9 21 and aminooxy-modified PEG 26 (Figure 46). The 
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reaction was carried out in pH 6.5 buffered solution using aniline as a catalyst[230] in 
equivalent amounts to the aminooxy-modified PEG 26 . After a first reaction of aniline 
with the aldehydes of the dextran backbone for 45 min, the end-group functionalized PEG 
26 was added to the stirring solution and stirred for further 7 h. After purification by 
extensive dialysis first in a dialysis tube with molecular weight cut-off (MWCO) of 12–
14 kDa followed by using a dialysis tube with MWCO 50 kDa, the product 
OxDex-(N3)9 (PEG)16 27 was obtained after lyophilization as a colorless powder with a 
2.5-fold mass increase. 
 
Figure 46: Reaction of OxDex-(N3)9 21 with aminooxy-modified PEG 26 resulting in comb-like polymer 
brush of OxDex-(N3)9 (PEG)16 27. 
NMR spectroscopy confirmed attachment of the PEG chains 26 to the dextran-based 
backbone 21. By comparing the integrals of the anomeric proton of the dextran AGUs and 
the methyl end group of PEG, DS can be determined to 16.5. Molecular weight of the 
resulting polymer brush amounts thus to 43000 g mol-1. This molecular weight was 
confirmed by size exclusion chromatography (SEC, same as gel permeation 
chromatography, GPC).[266] The technique separates analytes on the basis of their sizes and 
is often used for the analysis of polymers.[267] SEC measures rather the molecular volume 
than the retention time on the column. Using comparable standards, the relative molecular 
volume values are used to determine the molecular weights within ±5% accuracy. Often, 
polystyrene is used as standard. Due to difficult comparability of dextran and polystyrene 
measured and calculated molecular weight can only be used as an encouraging information 
not as an absolute indicated value. 
In addition, IR spectroscopy was carried out to compare the spectra of the linear 
OxDex-(N3)9 21 with the polymer brush 27 (Figure 47). The azide signal at 2124 cm-1 was 
preserved after reaction with PEG-O-NH2 26. Besides the polymer brush 27 has a 
significant increase in signal at 2880 cm-1 which can be clearly assigned[244] to the valence 
of methyl ethers. Dextran samples show already a weak signal due to the glycosidic bond 
21 27 
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between the AGUs which is similar to such an ether bond. However, intensity of signal is 
clearly intensified which confirms the introduction of PEG arms to the dextran backbone. 
 
Figure 47: IR spectra of dextran 18, azide-modified dextran 20 and polymer brush OxDex-(N3)9(PEG)16 27. 
The azide group has a significant signal at 2124 cm-1 and after the conjugation with the PEG, a methylether 
signal appears at 2880 cm-1. 
Furthermore, the core-shell nanosystem was visualized by transmission electron 
microscopy (TEM). This microscopy technique uses an electron beam that transmits an 
ultrathin sample (<100 nm) or a suspension on a grid. The images of the samples are 
formed by the different densities and compositions of the samples and allow high 
resolutions of the specimen up to 0.045 nm.[268] Figure 48 displays the TEM images of the 
dextran-based polymer brush 27. The structures are between 0.5-1 µm in size and have 
similarity to published [(PEG16-alt-PCL21)4-S-S-(PEG16-alt-PCL21)4 polymer brushes.[269] 
The PEG arms are visible as linear structure elements. The magnification illustrates their 
linkage to one central point which is most likely the supercoiled dextran backbone. It looks 
like that the whole polymer brush is relatively coiled and in a bulky arrangement on the 
copper carbon grid.  
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Figure 48: TEM image of dextran-based polymer brush 27 with attached linear PEG chains. The shown 
structures have a size of approximately 500 nm. 
Thiol-modified Dextrans 
As alternative to the previously described click-chemistry approach and further 
introduction of linear PEG arms to the dextran backbone, another bioorthogonal 
conjugation was used. Aiming to use thiol-maleimide Michael addition reaction (Figure 
30), the polysaccharide was functionalized with sulfuric groups. First attempts were 
carried out using reductive amination on the aldehyde enriched dextran backbone. 
Cysteamine (2-aminoethanethiol) 28 was reacted with oxidized dextran forming the 
unstable imine structure. The addition was followed by the reduction of the Schiff base 
with either sodium borohydride (NaBH4) or sodium cyanoborohydride (NaBH3CN). 
However, multiple experiments with different reaction conditions were carried out, no 
successful introduction of thiol groups to the polysaccharide was observed. Besides, 
structure determination and analytics of the synthesized compound turned out to be 
challenging since neither NMR due to the wide distribution and high intensity of sugar 
proton signals overlaying the signal of the attached cysteamine nor mass spectrometry due 
to the high molecular weight could be applied. Thus, the synthesis route was changed to a 
published procedure.[270] In a first step, hydroxyl groups of dextran 18 are activated with 
4-nitrophenyl chloroformate 29 using pyridine as basic catalyst (Figure 49).[271] The 
reaction is carried out in dimethylformamide (DMF) with the addition of lithium chloride 
(LiCl). As illustrated before the solvents are limited when working with dextran. The 
solubility in DMF is only possible as soon as LiCl is added in a concentration of at least 2% 
of solvent amount. Besides, the solution has to be heated up to 90 °C. LiCl has an 
extraordinary solubility in organic solvents in contrast to other ionic salts due to the small 
72 3.1 Artificial ATPase-like Enzyme 
size of the Li+ cation. Using LiCl while dissolving dextran, the salt enhances solubility of 
the polysaccharide with its properties.[272] Since an activated carbonate structure in the 
reaction with 4-nitrophenyl chloroformate 29 is formed which can be easily hydrolyzed, 
the reaction has to be carried out in very dry solvents and water-free chemicals have to be 
used. The modification was carried out at 0 °C for 2 h and the product purified with 
precipitation yielding a colorless, fluffy powder after drying under reduced pressure. The 
introduction of aromatic nitro groups is relatively easy to track with NMR spectroscopy 
(Figure 53). The aromatic protons can be used to determine the DS of the polymer as 
described earlier for the modification with azidobenzoic acid yielding a DS of 7.5 per 
dextran chain. IR spectrum of Dex-(4-NC)7.5 30 showed typical appearance of acyclic 
carbonates at 1765 cm-1 and no cyclic carbonates within one glucose unit at 1805 cm-1 as 
described in literature (Figure 54).[271] The amount of activated carbonates group within 
dextran was increased with the use of large excess 4-nitrophenyl chloroformate 29 up to 
a DS of 27. However, such a high activation of hydroxyl groups led in the following 
substitution step with cysteamine to a water-insoluble product which was useless for the 
application as carrier material in the enzyme mimic system. 
 
Figure 49: Synthesis of thiol-modified dextran Dex-(SH)7 31. Dextran is first activated with 4-nitrophenyl 
chloroformate 29 and then subsequently reacted with cysteamine 28 resulting in Dex-(SH)7. 
In a second step activated hydroxyl groups of Dex-(4-NC)7.5 30 were subsequently reacted 
with cysteamine. The reaction was again carried out in extra dry DMF/LiCl solvent 
mixture. With the addition of cysteamine 28 the solution turned immediately yellow 
demonstrating the release of p-nitrophenol. The reaction was stirred for 16 h and reduced 
with tris(2-carboxyethyl)-phosphine (TCEP) before lyophilization to ensure the reduction 
of all possible formed disulfide bonds. The thiol-modified dextran Dex-(SH)7 31 was 
obtained as a colorless powder. 
The DS was determined by 1H-NMR to 7 cysteamine groups per dextran chain (Figure 53). 
However, this analysis method can only be considered as an approximated value due to 
the overlaying proton signals of sugar backbone and introduced cysteamine (as described 
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previously). Additionally, amount of addressable thiol groups in the dextran sample was 
determined by an Ellman’s assay.[273] The assay uses water-soluble 5,5’-dithiobis-
(2-nitrobenzoic acid) (DTNB), called Ellman’s reagent, for the reaction with free sulfhydryl 
groups at neutral pH (Figure 50). 
 
Figure 50: Reaction of Ellman's reagent (DTNB2-) with a thiol-containing compound resulting in the yellow 
product TNB2-. 
The reaction releases the water-soluble yellow product TNB2- (2-nitro-5-thiobenzoic acid) 
whose absorbance can be measured at 412 nm. Using N-acetylcysteine as a standard the 
quantification of thiol groups in Dex-(SH)7 31 sample resulted in a DS of six which roughly 
confirms the DS measured with NMR spectroscopy. 
This chapter described the successful chemical modification of the polysaccharide dextran 
with two different functional groups (azide and thiol) that allow in the following step 
bioorthogonal conjugations of the synthesized catalysts (3.1.4). Comparing both modified 
materials, it was possible to introduce more azide functional groups to Dex-(N3)9 20 than 
thiol functional groups to Dex-(SH)7. The main reasons for this are the different synthetic 
strategies for the modifications. 
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3.1.4 Conjugation of Catalyst and Polymeric Carrier Material 
In this chapter the two components, the dextran-based carrier and the macrocyclic 
polyamine-based catalyst are linked to each other. Using both, the click-chemistry as well 
as the thiol-maleimide strategy, a full artificial enzyme-like nanosystem will be established. 
Click Chemistry Approach 
This conjugation strategy used BCN-modified macrocyclic amine BCN-MCA 15 as an 
artificial cleavage site and the OxDex-(N3)9 21 as a carrier (see similar to Figure 29). For 
the click reaction the linear dextran backbone was chosen solely without the linear PEG 
arms in order to simplify the system (Figure 51). Besides PEG arms were expected to work 
in their original purpose as a real shielding corona which complicates the access of the 
small BCN-MCA 15 to the azides inside of the nanosystem. As described in chapter 3.1.2, 
it was not possible to isolate the BCN-MCA 15 in high yields. In order to use the 
appropriate excesses compared to present azido groups, large amounts of 15 were needed. 
This was not compatible with the found synthetic route, why in first click experiments, 
non-purified reaction mixtures of the BCN-MCA 15 were used. The click reaction was 
carried out under various conditions following published reaction procedures for similar 
cyclooctyne-based click reactions.[225, 249, 274-276] However, in none of the experiments a 
water-soluble product was obtained. Mostly, the purification procedure with dialysis 
against water started with clear solution and after several hours slightly yellow precipitate 
occurred. Dialysis against DMSO first, followed by dialysis against water was no helpful 
alternative in purification. Resulting colorless, fluffy powder after lyophilization was not 
water-soluble which excludes its application as artificial enzyme mimic since the solubility 
in water is an unconditional, necessary criterion for the designed ATPase like system. It is 
most likely that the reaction between the aromatic azide group of the dextran backbone 
and the BCN, yielding a triazole, results in the formation of a very hydrophobic structure 
element. This water-repellent part of the nanosystem leads probably to the precipitation 
of the whole system in water and cannot be compensated by the hydrophilic hydroxyl 
groups of dextran nor by the introduced macrocyclic amines. The phenomenon of a 
water-insoluble dextran-backbone due to only small modifications and the attachment of 
few small molecules is also described in the previous chapter for the synthesis of Dex-(SH)7 
31. 
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Figure 51: Cu-free click reaction of OxDex-(N3)9 21 and BCN-MCA 15. The product BCN-Dex 32 was not 
obtained as a water-soluble compound. 
Due to this failed synthesis with a water-insoluble product, this approach was no longer 
pursued, and no evaluation of the conjugated nanomaterial has been carried out. The 
project based on the click chemistry strategy was ceased on this stage of development. 
Thiol Maleimide Approach 
This conjugation strategy used maleimide-modified macrocyclic amine Mal-MCA 17 as an 
artificial cleavage site and thiol-modified dextran Dex-(SH)7 31 as carrier material. For 
reaction the Mal-MCA 17 was generated in situ right before the reaction and used in a 
5-fold excess to the present thiol groups (Figure 52).  
 
Figure 52: Reaction of Dex-(SH)7 31 with Mal-MCA 17. 
The Michael addition reaction was carried out for 48 h and the Dex-(S-Mal-MCA)6 33 
product was obtained as a slightly brown, fluffy powder. 1H-NMR was used to determine 
the number of six macrocyclic amines attached to the dextran backbone (Figure 53). 
Ninhydrin coloration was used a qualitative evidence resulting in a deep purple coloration 
of 33 compared to Dex-(SH)7 31. An Ellman’s assay comparing the number of thiols before 
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and after the reaction illustrates the disappearance of all thiol groups present on the 
dextran backbone. 
 
Figure 53: Stacked NMR spectra of dextran 18, Dex-(4-NC)7.5 30, Dex-(SH)7 31 and Dex-(S-Mal-MCA)6 33 
showing the appearance and disappearance of significant signals like the aromatic protons of Dex-(4-NC)7.5 
30 at 8.65 and 7.85 ppm or the thiol protons of Dex-(SH)7 31 at 2.7 ppm. Also, the polyamine protons of the 
conjugate Dex-(S-Mal-MCA)6 33 are visible between 2.7 and 3.13 ppm. 
In addition, comparing the IR spectra of all dextran-modified compounds it can be 
demonstrated that the appearance of a carbamate bond at 1699 cm-1, primary and 
secondary amine bonds at 1633 cm-1, and secondary acid amides at 1546 cm-1 as shown in 
Figure 54 support the attachment of Mal-MCA 17 to Dex-(SH)7 31. 
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Figure 54: IR spectra of dextran 18, Dex-(4-NC)7.5 30, Dex-(SH)7 31 and Dex-(S-Mal-MCA)6 33 displaying 
the appearance and disappearance of significant carbamate and primary and secondary amine bonds. 
With the successful linkage of catalyst and carrier, a nanomaterial was established which 
has multiple artificial cleavage sites attached to a polymeric scaffold. The material was 
fully characterized and evaluated concerning its application in vitro and its functionality. 
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3.1.5 Biocompatibility of Enzyme Mimics 
In order to investigate how realistic an application of the designed artificial enzyme-like 
structures in cellular environment is, a first step is to prove their biocompatibility and their 
toxicity, respectively. Thus, modified dextran samples were incubated with HeLa cells, a 
cervical carcinoma cell line, and the cell viability was investigated with MTT assay.[277] 
The assay uses MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) which 
is a water-soluble, bright yellow salt that is reduced by cellular oxidoreductase enzymes. 
The product of reduction, the water-insoluble purple formazan which is dissolved in 
organic solvents after reaction, can be measured at 595 nm (Figure 55). The amount of 
released formazan is an indicator for the functioning metabolism of the HeLa cells and 
corresponds to the number of living cells. If the modified dextran materials are toxic, the 
metabolism of the cells will slow down or even worse lead to cell death. The HeLa cells 
were incubated for 48 h with dextran samples in ranging concentrations from 62.5 µg up 
to 1 mg mL-1 before the MTT assay was carried out. 
 
Figure 55: Conversion of tetrazine salt to formazan by mitochondrial reductase. The formed formazan is an 
insoluble purple compound which after dissolving in organic solvents has a specific absorption at 595 nm. 
Click Chemistry Approach 
Although the conjugation of Dex-(N3)9 20 and BCN-modified macrocyclic amine 15 led to 
a water-insoluble product as shown in chapter 3.1.4, starting materials for conjugation as 
well as the full dextran-PEG polymer brush 27 were tested towards their cytotoxicity 
(Figure 56). These experiments were carried out long way before conjugation of carrier 
and biocatalyst and for reasons of thoroughness the results are presented in here. 
Figure 56 shows the cell viability of Dex-(N3)9 20 and the dextran-PEG polymer brush 27 
at commonly used dilutions from 31.25 µg mL—1 up to 1 mg mL-1. For both materials no 
cytotoxicity can be observed at applied concentrations. The cell viability over 100% can be 
explained by the fact, that HeLa cells can use dextran and the modified versions of it as an 
additional food and energy source which leads to an increased growth. Due to 
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water-insolubility of the click conjugated dextran 32, it was not possible to test the new 
bioconjugate towards its cytotoxicity. However, the results shown in Figure 56 show that 
the Dex-(N3)9 20 and the dextran-PEG polymer brush system 27 represent fully 
biocompatible systems for possible further applications. 
 
Figure 56: MTT assay of Dex-(N3)9 20 and OxDex-(N3)9 (PEG)16 21 demonstrating the very good 
biocompatibility of the designed polymeric nanosystem. 
Thiol-Maleimide Approach 
This work was mainly carried out in cooperation with Matthias Konhäuser (JGU Mainz). 
Figure 57 shows the cell viability of Dex-(SH)7 31, Dex-(S-Mal-MCA) 33 and solely the 
amino-modified macrocyclic amine NH2-MCA 13 at concentrations from 62.5 µg mL-1 up 
to 1 mg mL-1. The concentration of NH2-MCA 13 was adjusted to the corresponding 
number of macrocyclic polyamine attached to the dextran backbone of 33 After 48 h, all 
samples show at all concentrations no cytotoxicity in HeLa cells. The possible cell viability 
over 100% was explained in the previous paragraph. 
The illustrated cell viability experiments show that these established dextran-based 
nanomaterials are uncritical regarding their further application in vitro as artificial 
enzyme-like systems. 
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Figure 57: Cell viability of HeLa cells after incubation with Dex-(SH)7 31, the bioconjugate Dex-(S-Mal-
MCA)6 33 and adjusted concentrations of NH2-MCA 13 similar to the number of macrocyclic polyamines 
attached to the dextran scaffold. No toxicity can be observed for all applied concentrations and the artificial 
ATPase demonstrated its high biocompatibility. 
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3.1.6 Evaluation of ATPase-like Functionality 
ATP Hydrolysis Determination by 31P-NMR Spectroscopy 
The artificial enzyme-like functionality was investigated by using 31P-NMR 
spectroscopy.[278] The 31P phosphorous is a common NMR nucleus because it has an 
isotopic abundance of 100% and a relatively high gyromagnetic ratio. The spin of ½ makes 
the nuclei highly sensitive. ATP contains three different phosphorus species with 
characteristic splitting (Figure 58a). The α- and the γ-phosphorous have two duplet 
signals whereas the β signal has a triplet signal since it couples with both other 
phosphorous nuclei. As soon as the α-phosphorous is cleaved from the ATP, three new 
signals develop. The leftover ADP has two duplet signals which couple with each other 
(Figure 58b). The inorganic phosphate (Pi) has a characteristic singlet signal downfield of 
the ATP and ADP signals at around 0 ppm. 
 
Figure 58: 31P-NMR of ATP with respective assignment (a). After hydrolysis, a new peak of Pi develops 
which can be used to calculate catalytic rates (b). 
The comparison of the integral ratio of the Pi and the β signal allows the determination of 
the amount of hydrolyzed product. Since, hydrolyzed ATP releases exactly one Pi, the total 
concentration of [Pi]+[ATP] stays constant during the reaction. The remained amount of 
ATP can be determined by integrating the characteristic β triplet peak of ATP at -23 ppm 
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(ADP has no triplet signal); the amount of Pi can be determined by integrating the Pi singlet 
peak. The equations of the calculations are: 
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The kinetic of the hydrolysis of ATP can be best described by first-order kinetics. Herein, 
the reaction rate depends on ATP, water and a fixed number of catalyst like MCAs or in 
the case of autohydrolysis just H+. Water is disregarded in the kinetic equation because it 
is used as solvent and present in great excess. The reaction depends on the pH value 
because H+ catalyzes the reaction and thus the pH has to be set in advance of the cleavage 
experiments. The first order kinetics are described by 
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in which [ATP]t describes the ATP concentration at the time point t and [ATP]0 the ATP 
concentration at the start of the reaction (t=0). 
Thus, the reaction rate can be mathematically expressed by 
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By rearrangement, the calculation yields the reaction rate k 
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in which [ATP]t can be calculated by using equation 1.1. 
The displayed mathematic equations are used in the following sections to calculate the 
catalytic activity of the artificial ATPase measured in time-course NMR experiments. 
Catalytic Activity of Modified Macrocyclic Polyamines and Artificial ATPases 
Kinetic measurements of ATP hydrolysis were carried out by investigating the time-
dependent change of the significant Pi and the β-signal. Table 2 displays the measured rate 
constants for a first-order kinetics of ATP hydrolysis at pH 5.2 and 40 °C. This temperature 
was chosen because it is close to body temperature where much enzymes perform and at 
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the exact body temperature of 37 °C no literature was published so far. The pH of 5.2 was 
chosen because the hydrolytic activity of the macrocycles is raising with a decreasing pH. 
The presence of more H+ protons facilitates the electrostatic interactions of the then 
charged nitrogens with the polyphosphate chain. A pH value of 5.2 was considered as a 
reasonable middle between optimal ATP hydrolysis at low pH and realistic pH values 
which can occur in the body, e.g. in lysosomes with 4.5–5.5.[1] Although, comparisons with 
the literature have to be made carefully because the hydrolysis with the supramolecular 
structures is a sensitive system that depends much on concentration of catalysts, ionic 
strengths and adjusted pD for NMR measurements.[140, 144] Considering these issues, the 
published rate constant for MCA 2 is k=0.023 min-1 at pH 5.2 and 40 °C and thus slightly 
higher than k=0.016 min-1 which was measured in this thesis (Figure 59, Table 2). For the 
original [24]N6O2 1 much slower rate constants were published, such as k=0.0037 min-1 at 
pH 3.6 and 50 °C.[137] Only at 60 °C and 70 °C the catalyst [24]N6O2 1 reaches similar values 
as the rates measured here with k=0.011 min-1 and k=0.029 min-1, respectively. 
 
Figure 59: Chemical structures of all investigated compounds in 31P-NMR spectroscopy. 
Table 2: Rate constants k of ATP hydrolysis in equimolar concentrations at pH 5.2 and 40 °C by macrocyclic 
polyamines and the entire artificial ATPase system. 
 rate constant k (min-1) 
MCA 2 0.016 
NH2-MCA 13 0.015 
Dex-(S-Mal-MCA)6 33 0.012 
Dex-(SH)7 31 - 
The modification of MCA 2 with the amino group to NH2-MCA 13 led to a slight, negligible 
rate decrease to k=0.015 min-1 which is within the inaccuracy of the measurement (Table 
2, 6.2.1). In a first conclusion, a new supramolecular catalyst with a functional group that 
allows an attachment to a carrier system with similar catalytic activity was created with 
this thesis. 
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The conjugation of NH2-MCA 13 to Dex-(SH)7 31, using a linker, led to the entire artificial 
ATPase system Dex-(S-Mal-MCA)6 33 (Figure 59). The conjugate demonstrates catalytic 
activity with a rate constant of k=0.012 min-1 which is in the range of the unbound catalyst 
NH2-MCA 13 with k=0.015 min-1 (Table 2). Figure 60 displays the time-course 31P-NMR 
experiment of Dex-(S-Mal-MCA)6 33 and visualizes the ATP cleavage carried out by the 
nanomaterial. 
 
Figure 60: Time-course 31P-NMR experiment of ATP cleavage of ATPase-like system Dex-(S-Mal-MCA)6 33. 
The sample contains 30 mM ATP and the respective amount of catalytically active compounds. The 
developing of the Pi signal at 0.45 ppm and the decrease of the β-signal of ATP (as described in Figure 58) 
at -20.82 ppm can be observed. In the middle the change of the α- and γ-signals to α’ and γ’ is noticeable. 
For the kinetic measurement the concentration of Dex-(S-Mal-MCA)6 33 was adjusted to 
the same amount of catalyst as in the samples of MCA 2 and NH2-MCA 13. Compared to 
the kinetic rate of MCA 2 and NH2-MCA 13 a slight decrease of 0.004 min-1 and 0.003 min-1 
is observed, respectively. This can be attributed to the bulky nature of the conjugate. 
Compared to the unbound catalysts MCA 2 and NH2-MCA 13 diffusion decreases, and the 
reachability of the macrocyclic polyamines is aggravated. 
To ensure that the pure carrier material Dex-(SH)7 31 (Figure 59) has no ATPase-like 
functionality, the polymer was also investigated in 31P-NMR spectroscopy. As expected, it 
did not demonstrate any catalytic activity (Table 2, 6.2.1). 
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By comparing the here shown artificial ATPase systems with other macromolecular 
structures such as a dendrimer, which showed similar ATPase behavior[279] or cone tetra-
guanidinocalix[4]arenes[145], the outstanding properties of Dex-(S-Mal-MCA)6 33 become 
clear. Literature known systems only perform well at high temperatures (70 °C or 80 °C) or 
with high amounts of organic solvents (80% DMSO), whereas Dex-(S-Mal-MCA)6 33 
catalyzes the hydrolysis of ATP at moderate temperatures and in pure aqueous solution. 
Thus, the new designed bioconjugate provides a new promising approach for artificial 
enzymes. Not only its excellent performance under physiological conditions and its 
literature comparable catalytic activities make the artificial ATPase Dex-(S-Mal-MCA)6 33 
an outstanding catalytic nanomaterial. The material allows even further chemical 
modification of its carrier to optimize the catalytic activity to achieve a possible in vitro 
application in the future. 
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3.2 Peptide-Enzyme Conjugates for Cascade Reactions 
The previous chapter demonstrated an artificial approach to mimic the setup, architecture 
and functional activity of one single enzyme. The following section will describe an 
artificial approach to nature’s molecular machines and enzymatic clusters. A dual 
enzymatic activity of cytochrome c (Cyt c) was achieved by attaching a hexapeptide to the 
surface of the enzyme. By combining the esterase-like peptide with the peroxidase 
functionality of the protein, a unique artificial enzymatic material has been created which 
allows the efficient performance of an enzymatic cascade reaction. 
Most of the following data is submitted for publication. Herein, the results are described 
and discussed in greater detail. Besides, first results of the transfer of the developed system 
to other proteins are displayed demonstrating the wide application potential of this 
approach. 
3.2.1 Mild Surface Modification of Cytochrome c 
Design and Synthesis of an Esterase-like Peptide 
The design of the peptide was inspired by the esterase-like performance of imidazole[280-
281] as part of histidine units.[282-284] Enzymatic activity of imidazoles has been first reported 
by Hartley et al. when he observed the ester cleavage of p-nitrophenyl acetate by 
N-benzoyl-L-histidine.[285] Similarly, β-cyclodextrinyl-bisimidazole has been described as a 
model for ribonucleases for the cleavage of cyclic phosphate substrates.[103, 286] In all cases, 
the imidazole residue provides hydrogen bridges with donor and acceptor characteristics 
and shows activity both in nucleophilic or base mediated catalysis.[287] In nature, histidine 
is the only natural amino acid containing an imidazole unit in its side group and often 
occurs in the catalytic center of enzymes as an acid-base catalyst. Examples are serine 
proteases like chymotrypsin or thrombin which contain the catalytic triad aspartic acid, 
histidine and serine.[1] The catalytic features of histidines were utilized over the years in 
several artificial systems by the introduction of histidines in short peptide sequences to 
obtain esterase-like functionality.[282, 284] In 2007 for example, a self-assembled nanofiber 
system with esterase-like activity has been reported.[215] Peptide amphiphiles, based on a 
long palmitoyl tail were functionalized with peptides containing 6-8 amino acids. The 
conclusive amino acids within the peptides were histidines. These peptide amphiphiles 
aggregated in nanofibers with 15-20 nm diameter and were able to catalyze the hydrolysis 
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of a p-nitrophenyl ester. Zaramella et al. have shown that self-assembled layers of small 
peptides containing mainly histidines on the surface of gold nanoparticles have the 
capability to cleave esters.[214] Recently, a peptide-nanoparticle conjugate has been 
published which is catalytically active on its surface.[288] Gold nanoparticles were modified 
with a peptide designed after the heterodimeric α-helical coiled-coil principle. Histidines 
on the surface of the particles showed catalytic activity in ester hydrolysis. 
For this reason, the designed peptide for this thesis was supposed to contain exactly three 
histidines, the first being capped at the amino-terminus with an acetyl group. In a first 
approach, the hexapeptide sequence was completed by three glycines on the side of the 
carboxy terminus. The peptide was synthesized using an Fmoc-Gly-HMPA-resin, which 
releases the carboxy terminus of the peptide from the resin. The conjugation strategy was 
to use common carbodiimide crosslinker chemistry with EDC (1-Ethyl-3-(3-dimethyl-
aminopropyl)-carbodiimide) and sulfo-NHS (N-hydroxysulfosuccinimide) to conjugate the 
carboxy terminus with the amino groups presented on the surface of the Cyt c enzyme.[217] 
Cyt c has 19 nucleophilic ε-amino groups of lysines on its surface (PDB ID: 1HRC) which 
can easily be functionalized, as is known in literature.[289] This approach seemed 
reasonable after successful conjugation of PEG-COOH (poly(ethylene glycol) end group 
functionalized with a carboxy group) as a dummy molecule to the surface of Cyt c. 
However, it was not possible to attach the synthesized peptide to the protein. 
In a second approach, a different bioorthogonal conjugation was chosen. The catalytically 
active peptide still contains three histidines followed by two glycines as spacer molecules. 
The peptide sequence ends with a cysteine to provide a thiol group to allow for 
biorthogonal conjugation to the protein surface (Figure 61).[290] The six amino acids 
containing peptide Ac-His-His-His-Gly-Gly-Cys-NH2 (HHHGGC) was synthesized using 
standard Fmoc-based solid phase peptide synthesis (SPPS). For this purpose, an automated 
batch peptide synthesizer with a Rink-amide-aminomethyl-polystyrene resin was used 
releasing the peptide amide. Cleavage from the resin was followed by manual acetylation 
of the amino-terminus affording the pure hexapeptide HHHGGC in 95% yield. 
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Figure 61: Structure and label of designed, synthesized hexapeptide with catalytically active imidazole 
residues (purple) in the histidines and a thiol group for bioorthogonal conjugation (yellow). 
Conjugation of Peptides to Cytochrome c 
The designed and synthesized short peptide HHHGGC was attached to the surface of Cyt c 
using thiol-maleimide chemistry. The chosen enzyme is obtained from horse heart and 
plays an important role in the transfer of electrons in the respiratory chain in 
eukaryotes.[291] It has one single peptide chain with 104 amino acids. Thus, it has a low 
molecular weight of 12.4 kDa which allows for easy monitoring of the extent of chemical 
modification.[292-293] Cyt c contains a heme group as a prosthetic group which is covalently 
bound via two thioether bridges to the polypeptide chain. The central iron ion is 
coordinated octahedrally by the 4 nitrogen atoms of the porphyrin ring in the equatorial 
plane and additionally by one histidine and one methionine residue in the vertical axis. 
Furthermore, as previously described 19 nucleophilic ε-amino groups of lysines are 
available for conjugation on the surface of Cyt c. For the attachment of synthesized peptide 
HHHGGC a heterobifunctional crosslinker was introduced (Figure 62). The linker 
contains an NHS (N-hydroxysuccinimide) ester for conjugation with the amines on the 
enzyme surface and a maleimide function required for Michael addition with the free thiol 
of the synthesized peptide.[294] In this case, a PEG-containing linker (NHS-PEG(4)-Mal) was 
chosen, since the commonly used hydrophobic sulfo-SMCC linker (sulfosuccinimidyl 
4-(N-maleimidomethyl) cyclohexane-1-carboxylate) led to the precipitation of the protein 
as a red solid in a colorless solution. The reaction of the linker with the protein was 
followed by several centrifugation steps in which excess linker was removed. During 
purification of the maleimide-functionalized Cyt c, named Cyt(Mal), the peptide was 
prepared for conjugation by reducing the cysteine thiol with tris(2-carboxy-
ethyl)phosphine (TCEP).[295] Excess of TCEP was neutralized with azidobenzoic acid 
(AZBA) because it was shown that TCEP can react with maleimides as well.[296] 
Conjugation of the peptide to the surface modified enzyme was performed in phosphate 
buffer over 16 h. 
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Figure 62: Modification of Cyt c with hexapeptide using an NHS-PEG(4)-Maleimide linker. The thiol of the 
peptide is reduced with TCEP which is neutralized by AZBA. 
To ensure the complete oxidation of the iron core of Cyt c, 1 mM H2O2 solution was added 
before purification. The provided Cyt c contains ca. 10% Fe2+ which is unfavorable for later 
application (chapter 3.2.3). After lyophilization of the purified peptide-protein conjugate, 
red crystals of Cyt(CGGHHH)14 were obtained. The material will be in detail characterized 
in the following chapter, specifically regarding the amount of introduced peptide on the 
surface of the enzyme. 
3.2.2 Properties of Modified Cytochrome c 
The peptide-modified protein Cyt(CGGHHH)14 and its maleimide-modified precursor 
Cyt(Mal) were analyzed in terms of their increased masses by SDS-PAGE and MALDI-ToF 
MS measurements. Furthermore, the number of modified amines on the surface was 
determined by a TNBS assay. Dynamic light scattering (DLS) was used to determine the 
physical size of the protein after modification. Finally, Cyt(CGGHHH)14 was investigated 
regarding its structural integrity using CD spectroscopy. 
Molecular Weight Analysis by SDS Gel Electrophoresis 
A commonly used technique for the determination of molecular masses is SDS-PAGE 
(sodium dodecyl sulfate-polyacrylamide gel electrophoresis).[297] With this technique, 
mixtures of charged molecules are separated in an electric field due to their different 
electrophoretic mobility. The latter is a function of length, conformation and charge of the 
molecule. All protein samples are denaturized by heat and addition of mercaptoethanol. 
The anionic surfactant, SDS (sodium dodecyl sulfate) covers the intrinsic charges of the 
proteins. The porous polyacrylamide gel used leads to longer proteins moving more slowly 
than the shorter ones causing separation by chain length proportional to the protein’s 
mass. Figure 63 displays the SDS-PAGE of unmodified Cyt c, maleimide-functionalized 
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Cyt c and peptide-modified protein Cyt(CGGHHH)14. A protein ladder with proteins in 
different sizes ranging from 15-170 kDa is used as a reference. The native, unmodified 
Cyt c shows a sharp protein band at approximately 13 kDa and a light dimer formation at 
25 kDa. Cyt(Mal) displays a first increase in molecular mass with a broadened band slightly 
below the 15 kDa marker band. The dimer of this sample can be clearly seen below 35 kDa. 
The significant mass increase occurs once Cyt(Mal) is modified with the hexapeptides. 
Cyt(CGGHHH)14 shows a broad band around 25 kDa and a dimer formation at around 50-
55 kDa, which refers to the introduction of about 14 peptides to the surface of Cyt c. This 
calculation is based on the molecular weight of the peptide attached to the linker: 
MW (peptide) + [MW(NHS-PEG-Maleimide)-MW(NHS-OH)] = 687.27 g/mol + (513.50-
112.62) g mol-1 =1088.15 g mol-1. In both lanes of the modified proteins, no remains of 
native Cyt c can be observed. 
 
Figure 63: SDS-PAGE of native Cyt c, Cyt(Mal) and Cyt(CGGHHH)14 demonstrating the mass increase of 
the modified enzymes. 
Molecular Weight Analysis by MALDI-ToF MS Measurements 
The exact molecular weight of Cyt(CGGHHH)14 was determined by using matrix-assisted 
laser desorption/ionization time of flight mass spectrometry (MALDI-ToF MS). Herein, a 
matrix containing the co-precipitated sample absorbs laser energy leading to the 
generation of ions with minimal fragmentation.[298] The applied ionization technique is 
very mild and has been used for the analysis of biopolymers such as peptides or proteins 
which are likely fragile or tend to fragment if harsher ionization techniques are applied.[1] 
The MALDI-ToF MS spectra of native Cyt c and Cyt(CGGHHH)14 are shown in Figure 64. 
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The native sample displays a typical mass spectrum of an unmodified protein with a sharp 
peak at 12.37 m/z. The spectrum of Cyt(CGGHHH)14 shows two distinct peaks at 26.37 m/z 
and 52.3 m/z. As the protein is singly charged in this case, Cyt(CGGHHH)14 has a 
molecular weight of 26.37 kDa. The peak around 52-53 kDa can be assigned to the dimer 
of the modified protein. The results obtained and shown in Figure 64 allow to determine 
the exact number of peptides on the surface of Cyt c as 14 individual attached peptide 
chains. 
 
Figure 64: MALDI-ToF MS of native Cyt c (a) and Cyt(CGGHHH)14 (b). 
Modified Amino Groups on the Surface of Cyt c 
The number of attached peptides described in the previous paragraph was confirmed by 
performing a TNBS (2,4,6-trinitrobenzene sulfonic acid) assay to determine the number of 
remaining free amino groups on the surface of Cyt c. Primary amines can react with TNBS 
to form a highly chromogenic orange-colored derivative that can be measured at an 
absorbance of 335 nm.[299-300] The assay was able to detect 5 free amino groups based on 
originally 19 available lysine groups on the surface of Cyt c. This result concurs with the 
molecular weight measurements and confirms the attachment of 14 peptides. 
Hydrodynamic Diameter of Cyt(CGGHHH)14 
Dynamic light scattering (DLS) was applied to determine the physical size of the protein 
after modification with the hexapeptide.[301] A hydrodynamic diameter of 3.25 ± 0.76 nm 
for Cyt(CGGHHH)14 compared to 2.09 ± 0.54 nm for the unmodified Cyt c was measured 
for the native protein in PBS buffer pH 7.4 (Figure 65). Literature describes native Cyt c 
with a diameter of 3.4 nm[302-303], but a precise description of DLS measurement conditions 
e.g. applied buffers or salt concentrations is missing. However, size comparison of the 
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native protein and Cyt(CGGHHH)14 shows a slight increase after the modification which 
was confirmed by measurements using various different sample concentrations. 
 
Figure 65: Dynamic Light Scattering (DLS) studies to determine size distribution of the hydrodynamic 
diameter of native Cyt c (red line) and Cyt(CGGHHH)14 (orange dashed line). 
Analysis of Structural Changes by Circular Dichroism Spectroscopy (CD) 
Structural integrity of the modified proteins Cyt(Mal) and Cyt(CGGHHH)14 was analyzed 
by circular dichroism spectroscopy. CD spectroscopy is an absorption measurement of left-
handed and right-handed circularly polarized light. Asymmetric molecules like proteins 
interact differently with light depending on the direction of circular polarization. 
Especially if the chromophores of the amides of the amino acid backbone are adjusted in a 
specific arrangement, their optical transitions are drifted or broken into numerous 
changeovers resulting from different exciton interactions.[304] This phenomenon leads to 
different CD spectra of α-helix, β-sheet or random coil formations of a protein. Therefore, 
CD spectra can be used to predict and estimate secondary structural elements. More 
precisely, the far UV area (170 nm-250 nm) was used to investigate the structural integrity 
of the modified enzymes. Proteins with dominant α-helical structural elements like Cyt c 
have negative bands at 222 nm and 208 nm and a positive band at 193 nm.[305] Each protein 
has its own individual CD spectrum and a loss in secondary structural elements such as α-
helix or β-sheet leads in general to an increase in the number of unordered segments. 
Figure 66 shows the CD spectra of Cyt c (red line), Cyt(Mal) (purple dotted line) and 
Cyt(CGGHHH)14 (orange dotted line). No significant change of the structure of Cyt c after 
linker attachment to the amino groups of the protein was detected. Introduction of the 
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hexapeptides, led to a slight decrease of α-helices and an increase of unordered structure 
elements. 
 
Figure 66: Far-UV spectra of Cyt c (red line), Cyt(Mal) (purple dotted line) and Cyt(CGGHHH)14 (orange 
dashed line). The reaction with NHS-PEG(4)-Maleimide has no effect on secondary structure at all. However, 
the second modification step with the peptide leads to a slight alteration of secondary structure elements. 
These qualitative considerations can be confirmed by calculations of the secondary 
structure elements using DICHROWEB[306-307] and the CONTIN-LL method with reference 
set 7 for the appropriate far-UV area (Table 3).[308] 
Table 3: Calculated percentages of secondary structure elements for Cyt c, Cyt(Mal) and Cyt(CGGHHH)14; 
Results calculated with DICROWEB using the CONTIN-LL method (reference Set 7). 
 Cyt c Cyt(Mal) Cyt(CGGHHH)14 
α-helix 61.8 57.0 52.8 
β-sheet 2.4 3.4 3.4 
turns 15.3 14.5 12.2 
unordered 20.6 25.3 31.5 
Linker attachment leads to a slight decrease of α-helices and an increase of unordered 
structure elements. This change continues with the conjugation of the hexapeptides to the 
linker modified surface of Cyt c. Compared to native Cyt c the α-helices decreased about 
10% whereas the unordered structures increased from 20.6% to 31.5%. The β-sheet and turn 
elements changed only marginally. Overall it can be concluded that the structure was 
mostly unharmed when compared to the native enzyme[309] and all essential secondary 
structure elements are preserved after surface modification. 
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3.2.3 Evaluation of Catalytic Activity 
Peroxidase Functionality 
Cyt c is known for its peroxidase activity due to the iron core containing heme group in 
the catalytic center of the protein.[310] The heme group is covalently bound by two 
thioether groups provided by Cys14 and Cys17. The iron in the center of the heme group 
is coordinated in an octahedral arrangement surrounded by four equatorial nitrogens of 
the pyrroles in the porphyrin ring and optimally present in the oxidized Fe3+ form. The 
amino acids Met80 and His18 are coordinating with their residues in axial positions. As 
the mechanism is extensively described in literature it is not discussed in detail herein. 
Briefly, peroxidase uses four steps to eliminate the harmful peroxide.[310] The sequence of 
reaction steps allows the use of a chromogen to measure the enzyme’s activity. The 
catalytic parameters such as Michaelis-Menten constant KM, turnover rate kcat and catalytic 
efficiency (kcat/KM) (described in 1.1) can be determined by using 2,2’-azinobis-(2-ethyl-
benzothiazoline-6-sulfonate) (ABTS) as a chromogen and H2O2 as substrates (Figure 
67).[311] 
 
Figure 67: Formation of green ABTS radical cation with Cyt(CGGHHH)14 and H2O2. 
The assay was performed in order to test if the peroxidase activity of the modified 
cytochrome c is preserved after the peptide conjugation. For this, a sample of cytochrome c 
called Cyt c* was treated in a parallel fashion like during modification of Cyt(CGGHHH)14. 
This allows a more direct comparison of activity, disregarding possible effects on 
enzymatic activity[312] due to synthetic procedures like centrifugation, stirring overnight 
and lyophilization. Concentrations of Cyt c, Cyt c* and Cyt(CGGHHH)14 were adjusted 
with the absorbance value at 409 nm to ensure that all solutions contain the same amount 
of Cyt c enzyme. In all cases, the peroxidase activity showed typical Michaelis-Menten 
kinetics for H2O2 (Table 4 and 5.3.3). A KM value of 0.297 mm was determined for untreated, 
native Cyt c, compared to an increased value of KM = 5.50 mm for Cyt c* and KM = 7.24 mm 
for Cyt(CGGHHH)14. The Michaelis constant KM is an inverse measurement of the 
substrate’s affinity for the enzyme and thus a higher KM value indicates a reduced substrate 
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binding. In this case here, it can be concluded that the lower affinity of Cyt(CGGHHH)14 
for H2O2 results mainly due to the modification conditions, since Cyt c* shows similar 
kinetic parameters. The slightly lower affinity of Cyt(CGGHHH)14 compared to Cyt c* can 
be explained by the 14 peptide molecules on the surface of Cyt c, most likely due to steric 
shielding around the catalytic center. However, despite the lower affinity for the substrate, 
increasing turnover rates (vmax/enzyme concentration) for Cyt c* and Cyt(CGGHHH)14 
compared to Cyt c can be observed. That means, that at high substrate concentrations and 
when vmax is reached, the conversion of substrates with Cyt c* and Cyt(CGGHHH)14 is 
more rapid than in native Cyt c. The overall catalytic efficiency (kcat/KM) describes how 
efficiently an enzyme works and combines the speed of product formation with the affinity 
for the substrate. Herein, values of 0.14 s-1 mM-1 and 0.13 s-1 mM-1 for Cyt c* and 
Cyt(CGGHHH)14 were determined, respectively. Hence, it can be concluded that the 
attached peptides have no significant effect on the catalytic efficiency of the underlying 
Cyt c. Only the conditions during the modification slightly change the efficiency. 
Table 4: Michaelis-Menten parameters of Cyt c, Cyt c*, and Cyt(CGGHHH)14. All measurements were 
carried out in triplicate.  
 
Michaelis constant 
KM (mM) 
turnover rate 
kcat (s-1) 
catalytic efficiency 
kcat/KM (s-1 mM-1) 
Cyt c 0.30  0.05 0.23 0.77 
Cyt c* 5.50  0.93 0.77 0.14 
Cyt(CGGHHH)14 7.24  1.01 0.93 0.13 
Introduced Esterase-like Functionality 
The conjugation of the hexapeptides to the surface of Cyt c added an additional function 
to the peroxidase active enzyme. This additional feature was investigated independently 
from the original enzyme activity using 4-methylumbelliferyl butyrate (MUF) as cleavable 
substrate.[313] The coumarin-derived ester is a non-fluorescent compound which is 
hydrolyzed by lipases into the highly fluorescent 4-methylumbelliferone (4-MU) (Figure 
68). 
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Figure 68: Ester cleavage reaction of 4-methylumbelliferyl-butyrate by Cyt(CGGHHH)14 resulting in the 
highly fluorescent 4-methylumbelliferone. 
The MUF assay has so far been used mostly for the identification[314] and determination[315] 
of lipases and was not yet associated with esterases or even artificial esterase-like activity. 
Since lipases cleave mainly ester structures and 4-methylumbelliferyl-butyrate is a simple 
ester molecule, the application for the investigation of the induced esterase-like activity 
herein was possible. 
Table 5: Michaelis-Menten parameters for esterase-like functionality of Cyt(CGGHHH)14. For unmodified 
Cyt c no esterase activity was observed. All measurements were performed in triplicate. 
 
Michaelis constant 
KM (mM) 
turnover rate 
kcat (s-1) 
catalytic efficiency 
kcat/KM (s-1 mM-1) 
Cyt c - - - 
Cyt(CGGHHH)14 6.48  0.93 81.92 12.64 
No esterase-like activity of native Cyt c was observed whereas Cyt(CGGHHH)14 showed 
esterase-typical Michaelis-Menten kinetics for the substrate (Table 5, 5.3.3). The KM value 
was determined to a concentration of 6.482 mM and the turnover rate kcat to about 82 s-1. 
Compared to literature known examples of similar artificial esterase-like systems, a 
significantly higher catalytic activity was observed. Examples include gold nanoparticles 
with immobilized peptides[288] or self-assembled peptide nanostructures[316] that show 
turnover rates of kcat=0.00072 s-1 and kcat=0.00441 s-1, respectively. The pure peptide 
HHHGGC alone was also investigated towards its esterase-like activity (6.2.4). The pure 
peptide in similar concentrations as attached on Cyt(CGGHHH)14 displayed also an 
esterase-like activity which was even higher than for the conjugated peptide. This can be 
explained by a higher diffusion of the small molecules compared to more bulky nature of 
Cyt(CGGHHH)14. 
In summary, these results confirm the ability of the peptide to cleave ester structures both 
as individual peptide and also when attached to the surface of Cyt c. This confirms that it 
was possible to introduce an additional, completely new catalytic function to an enzyme. 
3 Results and Discussion 97 
Coupled Stepwise Catalysis of Peptide and Enzyme 
The individual activity of the peroxidase and the esterase-like functionality has been 
described in the previous two chapters. The combination of both functionalities in a 
coupled stepwise catalysis is a new approach for mimicking nature’s enzymatic cascade 
reactions. The hexapeptide-modified enzyme material Cyt(CGGHHH)14 provides with its 
close, spatial proximity of both active sites a good environment for transformations. The 
immediate proximity of both catalytic centers simplifies the quick transfer of respective 
products to the following reaction site. The cascade reaction which combines the esterase-
like and the peroxidase functionality also stands out because it combines two 
fundamentally different types of enzymatic reactions from the enzymatic reaction 
classes[1] in one reaction sequence. As test reaction, a modified version of the oxidative 
coupling of homovanillic acid (HVA) was selected. HVA has been widely utilized in the 
literature for the determination of H2O2 levels[317] or enzyme concentrations of various 
oxidases. [318] HVA is a non-fluorescent molecule which forms a highly fluorescent dimer 
(2,2’-dihydroxy-3,3’-dimethoxybiphenyl-5,5’-diacetic acid) under oxidative conditions, e.g. 
in the presence of free hydroxyl radicals. [319] In detail, the literature-known mechanism 
for the dimerization of HVA occurs via 4 steps. In a first reaction, the hydroxyl radicals are 
formed from hydrogen peroxide by the cytochrome c peroxidase activity. These radicals 
attack in a free radical mechanism the HVA molecule which forms under the release of 
H2O a dimer molecule (Figure 69). The fluorescent product 2,2’-dihydroxy-3,3’-
dimethoxybiphenyl-5,5’-diacetic acid, called HVA dimer, has been in detail characterized 
in the literature. 
 
Figure 69: Literature-known dimerization of non-fluorescent HVA monomer by peroxidases or oxidases in 
the presence of H2O2 to the highly fluorescent HVA dimer. 
For the study here, the HVA ethyl ester (Figure 70) was used in order to analyze the ability 
of the dual functionalized system to perform coupled stepwise reactions. However, the 
exact sequence of the single steps in the cascade reaction is so far undiscovered, it is most 
likely that the reaction starts with the cleavage of the ethyl esters by the peptides on the 
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surface of Cyt(CGGHHH)14 (Figure 70). The resulting HVA is then subjected to an 
oxidative coupling using the peroxidase activity of the Cyt c core, resulting in the highly 
fluorescent HVA dimer (Figure 70). This presumption is based on the relation of 
catalytically active peptides on the surface of Cyt c. The amount of 14 “catalytic centers” 
compared to only one heme group in the center of the enzyme suggests that the esterase-
like activity occurs before the oxidative coupling takes place. 
 
Figure 70: Cascade reaction of Cyt(CGGHHH)14 using the HVA ethyl ester. The presumption is, that first, 
the hexapeptide on the surface of Cyt(CGGHHH)14 cleaves the ester, then the peroxidase functionality forms 
the highly fluorescent HVA dimer. 
The development of a strong fluorescence signal is observed within one hour for the 
reaction of Cyt(CGGHHH)14 with the ethyl ester of HVA (Figure 71). In the beginning, 
the reaction is slightly delayed, but the fluorescence increases steadily over time reaching 
a maximum after 40 min. 
 
Figure 71: Development of fluorescence in the cascade reaction of Cyt(CGGHHH)14 (cyan line). It is 
presumed, that the reaction is first carried out on the surface with the esterase-like reaction of the attached 
hexapeptides then and proceeds to the peroxidase functionality in the core of Cyt(CGGHHH)14. The three 
control reactions (purple dotted, blue dashed line and one not visible) will be discussed in Figure 72. 
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Figure 72: Control reactions of the cascade. (a) The reaction of native Cyt c resulted in the dimer of the HVA 
ester which is only a weak fluorophore. (b) A mixture of Cyt c and non-conjugated peptide resulted in the 
same ester with weak fluorescence. (c) The reaction of the HVA ethyl ester with the pure peptide resulted in 
no fluorescent product. 
The control reactions are in detail described in Figure 72. Surprisingly, the first control 
reaction, the reaction of native Cyt c with the HVA ethyl ester resulted in a fluorescence 
signal, however with much less intensity. Mass spectrometry of the reaction products 
confirmed the formation of the HVA ester dimer, which is a weak fluorophore (Figure 
72a). However, when analyzing the mass products of the cascade reaction carried out by 
Cyt(CGGHHH)14, the dimer of the ester cannot be detected. Only the mass of the highly 
fluorescent HVA dimer is found. 
The mixture of Cyt c and non-conjugated peptide also resulted in the same weak 
fluorophore (Figure 72b). This second control reaction confirms that for an effective 
stepwise cascade reaction close proximity between both catalytic centers is essential. Only 
if the peptides are attached to the surface of the enzyme, the cascade reaction can be 
performed successfully with the cleavage of all ester groups. 
In the third control reaction, the reaction of the pure peptide CGGHHH with the HVA 
ethyl ester (Figure 72c), no fluorescence was observed over one hour which is not 
surprising since no peroxidase functionality is present which could couple the HVA 
molecules. Additionally, blank measurements of the assay were carried out with samples 
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containing no Cyt c/Cyt(CGGHHH)14 or in another blank measurement no H2O2 or lastly 
no HVA ethyl ester. All of these controls did not show a significant fluorescence signal. 
In summary, monitoring the developing fluorescence over one hour, a significantly higher 
fluorescence for the cascade reaction compared to the control reactions is observed. This 
fluorescence difference can only occur in an effective combination of the esterase-like and 
the peroxidase functionality of Cyt(CGGHHH)14 and confirms a successful cascade 
reaction. The comparison between Cyt(CGGHHH)14 and Cyt c mixed with unbound 
peptide demonstrates the necessity of proximity between both functionalities. 
Cyt(CGGHHH)14 represents an enzymatic material with two functionalities in close 
proximity that can carry out a successful stepwise catalysis.  
  
3 Results and Discussion 101 
3.2.4 Transfer of the Cascade System to Other Proteins 
In the following paragraphs, first results of a carryover and extension of the evaluated and 
described system from the previous chapters are presented. As part of his internship, Max 
Scherger evaluated, the modifications of two other proteins with the described hexapeptide 
Ac-HHHGGC-NH2 and carried out first experiments regarding the additional esterase-like 
functionality. 
Modification of Lysozyme with the Hexapeptide Ac-HHHGGC-NH2 
Lysozyme (Lyz) is an antibacterial enzyme which is found in almost all human secretion 
body fluids, e.g. tears, gastric juice, saliva or breast milk. It breaks down the 
β-1,4-glycosidic bond between N-acetylmuramic acid and N-acetyl-D-glucosamine residues 
in the peptidoglycan of gram-positive bacteria and contributes to the destruction of the 
bacteria’s cell walls.[320] It has a well-defined size of 14.3 kDa and seven nucleophilic amino 
groups on its surface which are available for modification. The modification of Lyz was 
carried out in the same manner as described for cytochrome c and is shown in Figure 73. 
During the modification with the NHS-PEG(4)-Maleimide linker, the hexapeptide was 
treated with TCEP to ensure the reduction of the cysteine-thiol. 
 
Figure 73: Modification of Lyz with hexapeptide using an NHS-PEG(4)-Maleimide linker. The thiol of the 
peptide is reduced with TCEP which is neutralized by AZBA. 
The Michael addition resulted in the modified lysozyme Lyz(CGGHHH)5 with a weight 
increase of 31% (3 mg to 3.94 mg). Figure 74 shows the SDS-PAGE of native Lyz, Lyz(Mal) 
and Lyz(CGGHHH)5. A protein marker with proteins ranging from 15-170 kDa is used as 
a reference. The native Lyz forms a sharp band below the 15 kDa marker band which 
confirms its size of 14.3 kDa. Lyz(Mal) displays a slight increase in size with a broadened 
band at around 15 kDa. The conjugation with the peptide leads to an even more significant 
shift with a band between 15-18 kDa. The band broadens compared to the native Lyz which 
is explained by the size distribution and the modification with different quantities of the 
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hexapeptide. No remains of unmodified, native Lyz are found in the lanes of Lyz(Mal) and 
Lyz(CGGHHH)5. In all three sample lanes no dimer formation is observed. 
 
Figure 74. SDS-PAGE of native Lyz, Lyz(Mal) and Lyz(CGGHHH)5. An increase in size can be observed for 
the two modifications of native Lyz. 
For the exact determination of the molecular mass, MALDI-ToF MS was carried out. The 
spectra of native Lyz and Lyz(CGGHHH)5 are shown in Figure 75. The unmodified protein 
has a sharp peak at expected 14.3 m/z which refers to the single charged enzyme and 
corresponds to the mass of 14.3 kDa. The spectrum displays also the dimer at 28.7 m/z. 
 
Figure 75. MALDI-ToF MS of native Lyz (dark blue) and Lyz(CGGHHH)5 (light blue). 
The spectrum of Lyz(CGGHHH)5 shows one significant peak with a maximum at 19.1 m/z 
which refers to the single charged molecule with a molecular mass of 19.1 kDa. Between 
35 and 40 m/z, a slight second peak is observed which belongs to the dimer of the 
peptide-modified lysozyme. The mass increases from 14.3 kDa to 19.1 kDa by 4.8 kDa 
which comes along with the result from the SDS-PAGE and corresponds to about five 
attached peptides on the surface of Lyz. 
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Evaluation of Esterase-Like Functionality of Lyz(CGGHHH)5 
The introduced hexapeptides result in an additional functionality of lysozyme which was 
investigated by the MUF assay. In this case here, a simplified version of the assay was used 
and no Michaelis-Menten parameters were determined for Lyz(CGGHHH)5. The esterase-
like activity was only compared between native Lyz and peptide-modified Lyz at one 
substrate concentration (1.5 mM). Figure 76 shows the autohydrolysis of MUF as a 
reference over the measured time, as well as the esterase-like activity of unmodified, native 
Lyz and Lyz(CGGHHH)5. The sample of native Lyz displays a slight esterase-like activity 
which can be explained by remaining esterases in the native lysozyme sample after 
isolation and purification of the enzyme during manufacturing processes. In summary, 
Lyz(CGGHHH)5 shows a significant 11-fold increased reaction rate towards MUF and 
therefore the additional esterase-like activity of Lyz(CGGHHH)5 was successfully 
demonstrated. 
 
Figure 76. Simplified MUF assay of Lyz and peptide-modified Lyz at a substrate concentration of 1.5 mM 
MUF. 
Modification of β-Lactoglobulin with the Hexapeptide Ac-HHHGGC-NH2 
A further protein which was modified with the peptide was β-Lactoglobulin (BLG). BLG is 
the major whey protein of cow and sheep’s milk with a concentration of ca. 3 g/L and is 
also present in other mammalian secrets except for human beings. At neutral pH, BLG 
forms a hydrogen bridge stabilized dimer.[321] It has a molecular weight of 18.3 kDa and 12 
potential nucleophilic amino groups on its surface. The protein has no known catalytic 
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functionality and is therefore no classical enzyme like cytochrome c or lysozyme. 
However, it belongs to the lipocalin proteins, a family of proteins which transport small 
hydrophobic molecules such as steroids, bilins, retinoids like vitamin A or small lipids.[322-
323] The transport is possible through the unique tertiary structure of the lipocalins with 
its eight-stranded antiparallel beta barrel. The modification of BLG with the hexapeptide 
was carried out using a different linker than before (Figure 77). In contrast to 
cytochrome c and lysozyme, where an NHS-PEG(4)-maleimide linker was necessary to 
prevent the precipitation of the protein, it was now possible to use the common 
hydrophobic sulfo-SMCC linker (sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-
1-carboxylate) for the linkage of the protein amines with the thiols of the peptides. 
 
Figure 77: Modification of BLG with the hexapeptide using a sulfo-SMCC linker. The thiol of the peptide is 
reduced with TCEP which is neutralized by AZBA. 
For BLG the modification with this linker worked successfully as shown in Figure 78. The 
SDS-PAGE shows the comparison of native BLG, BLG(SMCC-Mal) and BLG(CGGHHH)7. 
The native protein forms a sharp band slightly above 15 kDa which is a little bit smaller 
than the literature known molecular weight of 18.3 kDa. However, a dimer formation is 
observed between 35 and 40 kDa which confirms the established weight. BLG(SMCC-Mal) 
displays an increase in molecular weight with a broadened band between 16 and 20 kDa. 
The dimer formation between 37 and 40 kDa is clearly visible. The sample contains 
additionally a huge amount of proteins with high molecular weights between 55 and 
170 kDa. Probably some sample remained in the stacking gel. These large aggregates can 
be explained by crosslinking of BLG proteins. In contrast to Cyt c and Lyz, BLG contains 
five cysteines in its peptide backbone per monomer. Four of these cysteines form two 
disulfide bridges but one is still accessible for chemical modification. The reaction of BLG 
with the s-SMCC linker does not only lead to a modification of the amines on the surface 
of the protein but also to a covalent linkage between two or more full proteins. The 
concentration, storage and multiple dissolving steps of the sample foster this crosslinking. 
Nevertheless, BLG(CGGHHH)7 does not display higher aggregates. The peptide-modified 
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protein has a broadened band between 20 and 30 kDa and a dimer which confirms this 
weight with a mass between 40 and 55 kDa. Both modified BLG samples contain no 
residues of unmodified, native protein sample. 
 
Figure 78. SDS-PAGE of native BLG, BLG with SMCC-Mal linker modified and the peptide modified 
BLG(CGGHHH)7. 
The exact molecular weight was determined by MALDI-ToF MS measurements (Figure 
79). Native BLG has a sharp peak at 18.3 m/z which corresponds to the single charged 
molecule with a molecular mass of 18.3 kDa. The spectrum displays also the doubled 
charged (M2+) protein at 9.2 m/z. 
 
Figure 79. MALDI-ToF MS of native BLG (dark green) and BLG(CGGHHH)7 (light green). 
The peptide-modified BLG (Figure 79b) has a more broadened peak between 21 and 
31 m/z with a maximum at 25 m/z. The increase of the mass by around 7 kDa equals seven 
attached peptides on the surface of the protein and confirms the results shown by 
SDS-PAGE. 
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Evaluation of Esterase-Like Functionality of BLG(CGGHHH)7 
The peptide-modified protein material was also investigated towards its esterase-like 
activity with a MUF assay. For BLG(CGGHHH)7 the simplified version of the assay was 
used without a determination of Michaelis-Menten parameters. Figure 80 compares the 
ester cleavage capability of native, unmodified BLG with BLG(CGGHHH)7. The 
autohydrolysis of MUF under the chosen conditions was also evaluated but no fluorescence 
development is observed. Native BLG shows a slight esterase-like activity, which can be 
again explained by esterases that remain in the isolated protein sample after the 
manufacturing process. However, BLG(CGGHHH)7 shows a five-fold increased rate of 
esterase-like activity compared to the native protein. The assay successfully demonstrates 
that an additional functionality is introduced to the originally non-active BLG protein. 
 
Figure 80. Simplified MUF assay of BLG and peptide-modified BLG at a substrate concentration of 1.5 mM 
MUF. 
In summary, it was possible to successfully transfer the hexapeptide modification as 
described for cytochrome c in chapters 3.2.1 to 3.2.3 to the enzymes lysozyme and 
β-lactoglobulin, resulting in esterase-like protein materials. The comparison of the number 
of peptides on the surface of the respective protein demonstrates significant differences 
between the proteins. Cyt c has 19 amino groups on its surface of which 14 are modified 
with the hexapeptide which corresponds to a modification rate of 74%. For Lyz this number 
reaches almost the same value with 5 modified amino groups out of 7 possible, which 
equals 71%. BLG has a lower peptide modification with 7 modified amines out of 12 possible 
ones, which corresponds to 58%. Overall, the modification has to be considered individually 
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for every protein but first steps of a general transfer of the fundamental research approach 
were successfully carried out. The transfer demonstrates the wide application field of the 
approach, even non-active transport or structural proteins can obtain catalytical functions 
with the small peptide sequences. It is also imaginable to introduce other catalytically 
active peptide sequences or other catalytic small molecules to the surface of the proteins 
to mimic nature’s complex molecular machines with their multiple functionality. 
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4 Conclusion and Outlook 
The main focus of this work was the synthesis and evaluation of bioinspired catalytic 
active materials and artificial enzymatic cascade reactions. Both projects contribute 
significantly to the proceeding of the development of artificial enzyme mimics and the 
imitation of nature’s molecular machines. The demonstrated, innovative approaches 
provide lots of possibilities for the ultimate goal to manipulate the complex and 
fundamental interactions happening in cellular environments. This thesis provides first 
approaches for novel biomimetic approaches to study cellular processes. Future studies in 
this scope have the potential to produce next-generation delivery and manipulation 
platforms for innovative applications in biomedical and pharmaceutical research. 
In detail, an artificial ATPase was designed by conjugating supramolecular structures such 
as macrocyclic polyamines to a polysaccharide-based scaffold with bioorthogonal 
chemistry. New synthetic routes were developed for modified polyamines, containing 
functional groups that enable an attachment to the biopolymer dextran. The new 
biopolymer conjugate showed catalytic activity in cleaving ATP and high biocompatibility. 
In parallel, nature’s complex molecular machines were mimicked by attaching short 
hexapeptide sequences to the surface of cytochrome c. An artificial cascade reaction was 
successfully performed on the surface of the enzyme and then in its inner core. 
The following summary will conclude the most important results and discoveries from the 
two projects. An individual future perspective for each part will be given. 
4.1 Artificial ATPase-like Enzyme 
Successful Modification of Macrocyclic Polyamines with Functional Groups 
The potential ATPase-like activity of polyammonium macrocycles is known for many 
years.[140] Thus, these supramolecular structures, in particular, the extraordinary 
catalytically active 2,5,8,11,14,17hexaaza[18]metacyclophanes, were chosen as artificial 
cleavage sites for the enzyme mimic and were modified with functional groups allowing 
an attachment to a carrier material. As amino groups provide many possibilities for 
functionalization, a published synthesis route for macrocyclic polyamines (MCA)[144] was 
modified in order to obtain amino-modified macrocyclic polyamines. Since a directly 
introduced amino group at the aromatic ring decomposed during the harsh 5-step 
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synthesis route, the indirect way via a nitro group was successfully accomplished. After 
optimization, an amino-modified macrocyclic polyamine with 30% overall yield was 
obtained. In order to allow bioorthogonal chemistry, the amino group was then further 
functionalized with heterobifunctional linkers, that introduced successfully cyclooctyne as 
well as maleimide groups to the MCAs (Figure 81). The successful synthesis of 
functionalized, conjugatable supramolecular structures provides the basis for the 
development of artificial ATPases. 
Effective Synthesis of a Polysaccharide-based Carrier for Active Sites 
Dextran was chosen as ideal carrier material for the artificial enzyme. In combination with 
a further hydrophilic polymer (PEG), a similar setup to nature’s core-shell structures was 
successfully established. Two different approaches were carried out to modify the 
hydroxyl groups of dextran facilitating the attachment of functionalized MCAs with 
bioorthogonal chemistry. In a first approach, azide groups, the counterpart for the 
cyclooctynes, were successfully introduced to the backbone by using DCC/DMAP 
chemistry. After modification, each dextran chain contains seven potentially connectable 
groups. In parallel, the backbone of dextran was oxidized leading to an enhanced number 
of aldehydes which allowed in a bioorthogonal way the attachment of an 
aminooxy-modified PEG shielding corona. Polymer brushes, visualized in TEM images, 
with a molecular weight of about 40,000 g mol-1 and high biocompatibility, shown in 
toxicity tests, were obtained. In a second approach, dextran was functionalized with thiol 
groups, the counterparts for the maleimides. Based on literature[270], a synthesis of 
water-soluble, sulfur-containing dextran was successfully developed (Figure 81). The 
modified dextran contains also seven potentially connectable groups. Both approaches 
provide functionalized polymer scaffolds that serve as powerful carriers for the MCAs. 
Evaluation of ATPase-like Activity 
To complete the enzyme mimic, the supramolecular structures were conjugated to the 
carrier material (Figure 81). In the case of the click chemistry approach, the triazole 
formation led to water-insoluble products. Although, dextran itself and the MCAs should 
ensure water-solubility with their hydrophilic groups, surprisingly the big hydrophobic 
part with the aromatic azidobenzoic acid and the triazole conjugated to the cyclooctyne 
introduce much hydrophobicity to the entire system leading to an insoluble enzyme mimic. 
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The project was successfully accomplished until this point and was ceased here because 
water solubility is an inevitable criterion for an artificial ATPase. In contrast, the 
thiol-maleimide approach was completed successfully and led to a water-soluble enzyme 
mimic system with six attached catalytic cleavage sites. Likewise, the artificial enzyme was 
highly biocompatible and showed no cytotoxicity. The catalytic activity was shown in 
simple in vitro studies by the hydrolysis of ATP in 31P-NMR experiments choosing 
conditions that are similar to the natural environment of enzymes in the body. For the 
amino-modified MCA a similar rate constant was determined as for the unmodified, 
already published MCA. The new ATPase-like bioconjugate demonstrates also catalytic 
activity, albeit with slightly lower reaction rates. However, this decrease can be attributed 
to the slower diffusion and the hindered reachability of the supramolecular catalysts 
within the polymeric scaffold. In contrast to published artificial system, the ATPase here 
performs in aqueous media and at mild temperatures. Thus, the described synthetic 
nanomaterial, based on a thiol-modified dextran that carries multiple macrocyclic 
polyamines as supramolecular catalysts, represents an innovation in the field of artificial 
enzymes. 
 
Figure 81: Chemical synthesis of artificial ATPase with an amino-modified supramolecular macrocyclic 
polyamine catalyst and a dextran-based carrier. Both building blocks are connected with a bifunctional linker 
resulting in a biocompatible nanomaterial that demonstrates catalytic activity in cleaving ATP to ADP and 
inorganic phosphate. 
112 4.2 Peptide-Enzyme Conjugates for Cascade Reactions 
Outlook 
The designed artificial ATPase provides new opportunities for the construction of enzyme 
mimics, based on synthetic biopolymers and chemically synthesized active sites, with a 
potential in vitro applicability. Of course, the catalytic activity of the system can be 
enhanced by attaching more catalysts to the dextran backbone, however the application of 
these enzyme mimics in cellular environment should be the main goal of this project in 
the future. Since the regulation of the ATP-ADP levels is of great importance for almost 
all cellular processes, an artificial "enzyme-like" control is desirable. Such ATPase-like 
enzymes could e.g. if targeted selectively for cancer cells, exhaust their ATP levels and thus 
inhibit uncontrolled cell growth.[148] With their small size below 100 nm, the further 
modification possibilities of the hydroxyl groups of dextran and no cytotoxicity, the 
artificial ATPase designed in this thesis is a distinguished material for such an in cell 
catalysis. The activity of the ATPase can be investigated by a luciferase/luciferin detection 
system in cells which allows a direct quantification of ATP.[324] This detection is dependent 
on the efficacy of the MCAs in catalyzing ATP hydrolysis and correlates the cytotoxicity 
directly to the endogenous ATP levels of tumor cells. Furthermore, the prolonged effects 
of these enzyme-like biopolymers can be evaluated, if the reduced levels of ATP finally 
lead to slower cancer cell growth and death. Hence, a possible new class of cancer 
treatment drugs can be created. 
4.2 Peptide-Enzyme Conjugates for Cascade Reactions 
Dual Functionality of Cytochrome c 
In order to generate a dual enzymatic system, Cyt c was surface-modified with catalytically 
active, short histidine-containing peptide sequences HHHGGC using bioorthogonal 
chemistry (Figure 82). The sequence of the peptide was inspired by the known, 
esterase-like performance of imidazoles and histidines, respectively. Introducing the 
thiol-containing cysteine, the possibility for a bioorthogonal thiol-maleimide conjugation 
was enabled. Cyt c was used as a model compound because of its peroxidase activity and 
its common nucleophilic groups for surface modification. After modification, Cyt c carries 
fourteen peptides on the surface while still preserving its structural integrity and 
peroxidase activity. The introduced esterase-like activity of Cyt(CGGHHH)14 was 
independently shown. Both functionalities were combined in a cascade reaction. The 
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reaction was confirmed by a highly developing fluorescence which can only occur in a 
successful course of the cascade. Remarkable is that the fluorescent product is only 
generated in case that the peptide is conjugated to the surface of the enzyme, supporting 
the importance of a small spatial distance between both functionalities. The 
peptide-modified Cyt c represents a catalytic active artificial biomaterial that combines 
two different enzymatic functionalities within one biomacromolecule. 
Transfer of the Approach to Various Proteins 
The fully evaluated system of Cyt(CGGHHH)14 was then successfully transferred to the 
enzyme lysozyme (Lyz) and the catalytically inactive protein β-lactoglobulin (BLG). The 
two biomacromolecules differ in structure and enzymatic activity. Both proteins were 
successfully modified with the hexapeptide on their surfaces. For both synthesized 
biomaterials an additional esterase-like activity was observed (Figure 82). The proteins 
must be further investigated regarding their structural integrity as well as the conservation 
of their original enzymatic activity (in the case of lysozyme). Nevertheless, these first 
results demonstrate the broad applicability of the approach and can serve as a basis for the 
further advancement in mimicking nature’s cascade reactions. 
 
Figure 82: Successful surface modification of two different enzymes (Cyt c, Lyz) and one protein (BLG) with 
hexapeptide (1, yellow) that demonstrates esterase-like activity. In the case of Cyt c it was possible to perform 
a cascade reaction at the surface and then in the inner core (2, orange) of the enzyme. Both other proteins 
showed an additional esterase-like activity. 
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Outlook 
The successful surface modification of proteins and enzymes with catalytically active small 
hexapeptides to introduce additional functionality to biomaterials offers the opportunity 
for an innovative approach to multifunctional enzymatic structures. As alternative to 
expensive and effortful protein expression with biotechnology, chemical synthesis and 
conjugation methods can be used to create enzymes with multiple functionality. 
Furthermore, catalytic activity can be introduced to proteins with no activity that are 
rather transport proteins such as albumins or the modified β-lactoglobulin. These modified 
proteins can then transport important molecules such as bilirubin, fatty acids, hormones 
or drugs while at the same time catalyzing reactions related to their cargos. In the future, 
more than one additional functionality such as e.g. catalytically active guanidine 
moieties[43, 145] can be introduced to the surface of the enzymes or proteins by using 
bioorthogonal chemistry. These guanidine structures can be attached using e.g. click 
chemistry or aldoxime linkers to introduce a group which has RNAase-like activity. 
Furthermore, the supramolecular catalysts synthesized in the first project of this thesis can 
be attached to the surface to obtain an additional ATPase-like functionality. An enzymatic 
material with two or more different, catalytically active functionalities in close proximity 
opens the opportunity for the development of novel, improved biocatalysts that can carry 
out complex cascade reactions using for example the energy generated from ATP cleavage. 
Consequently, using Cyt c with its peroxidase activity introducing the hexapeptide with 
the esterase-like and the RNAase- or ATPase-like functionality would create an enzymatic 
material with three different functionalities that has similarity to nature’s complex 
molecular machines. New potential, artificial molecular machines can be generated with 
miscellaneous industrial and therapeutic applications.  
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5 Experimental Part 
5.1 Materials 
5.1.1 Reagents and Solvents 
Chemicals, reagents and commercial buffers were obtained from German suppliers unless 
otherwise mentioned. 
Chemical Supplier CAS 
2,2'-Azinobis-(2-ethylbenzthiazoline-6-sulfonate) (ABTS) Alfa Aesar 30931-67-0 
Acetic acid Sigma-Aldrich 64-19-7 
Acetic anhydride Sigma-Aldrich 108-24-7 
Acetonitrile VWR 75-05-8 
N-Acetyl-L-cysteine Sigma-Aldrich 616-91-1 
Ammonium acetate Sigma-Aldrich 631-61-8 
Ammonium hydroxide Sigma-Aldrich 1336-21-6 
Aniline Sigma-Aldrich 62-53-3 
Adenosine triphosphate disodium salt hydrate (ATP) Sigma-Aldrich 34369-07-8 
Azidobenzoic-acid (AZBA) TCI Chemicals 6427-66-3 
Benzoyl peroxide (DBPO) Alfa Aesar 94-36-0 
1,3-Bis(bromomethylene)benzene Alfa Aesar 626-15-3 
(1R, 8S, 9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl 
N-succinimidyl carbonate (BCN-NHS) 
Sigma-Aldrich n.a. 
Boric Acid Sigma-Aldrich 10043-35-3 
tert-Butanol Carl Roth 75-65-0 
n-Butanol Carl Roth 71-36-3 
Chloroform-d Deutero 865-49-6 
Coomassie Brilliant Blue Carl Roth 6104-59-2 
Cysteamine Carl Roth 156-57-0 
Cytochrome c from horse heart Serva n.a. 
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Chemical Supplier CAS 
Deuterium chloride 38% in deuterium oxide Carl Roth 7698-05-7 
Deuterium oxide Deutero 7789-20-0 
Dextran, from Leuconostoc mesenteroides, 10 kDa Sigma-Aldrich, 9004-54-0 
Dicyclohexylcarbodiimide (DCC) Sigma-Aldrich 538-75-0 
Diisopropyl azodicarboxlate (DIAD) Sigma-Aldrich 2446-83-5 
N,N-Diisopropylethylamine (DIPEA) Sigma-Aldrich 7087-68-5 
Dichloromethane anhydrous, ≥99.8%, contains 
40-150 ppm amylene as stabilizer 
Sigma-Aldrich 75-09-2 
Dimethylaminopyridine (DMAP) Sigma-Aldrich 1122-58-3 
Dimethyl formamide (DMF) Sigma-Aldrich 68-12-2 
Dimethyl sulfoxide anhydrous, ≥99.9% Sigma-Aldrich 67-68-5 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) 
Sigma-Aldrich 298-93-1 
5,5’-Dithiobis(2-nitrobenzoic acid) (DTNB, Ellman’s 
reagent) 
Sigma-Aldrich 69-78-3 
DMEM GlutaMAXTM (Dulbecco’s Modified Eagle’s 
Medium high glucose) 
Sigma-Aldrich n.a. 
Ethanol VWR 64-17-5 
Ethyl acetate VWR 141-78-6 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich 60-00-4 
Ethyl Homovanillate (HVA ester) Sigma-Aldrich 60563-13-5 
Fmoc-rink-amide-aminomethyl-polystyrene resin Novabiochem 
Merck Millipore 
n.a. 
Fmoc-Cys(Trt)-OH Iris Biotech 103213-32-7 
Fmoc-Gly-OH Iris Biotech 29022-11-5 
Fmoc-His(Trt)-OH Sigma-Aldrich 1428125-83-
0 
Fetal Calf Serum (FCS) Life Technologies n.a. 
Glycine Sigma-Aldrich 56-40-6 
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Chemical Supplier CAS 
HBTU (2-(1-Benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexaﬂuorophosphate) 
Sigma-Aldrich 94-790-37-1 
Homo vanillic acid (HVA) Sigma-Aldrich 306-08-1 
Hydrazine monohydrate Sigma-Aldrich 7803-57-8 
Hydrobromic acid 48% Sigma-Aldrich 10035-10-6 
Hydrochloric acid 37% Carl Roth 7647-01-0 
Hydrochloric acid 1 M Carl Roth 7647-01-0 
Hydrogen peroxide (H2O2) Sigma-Aldrich 7722-84-1 
β-Lactoglobulin Sigma Aldrich 9045-23-2 
Lysozyme Sigma-Aldrich 12650-88-3 
Methanol Sigma-Aldrich 67-56-1 
4-Methylumbelliferyl butyrate (MUF) Sigma-Aldrich 17695-46-4 
N-Bromsuccinimide (NBS) Alfa Aesar 128-08-5 
N-Hydroxyphtalimide (NHP) Sigma-Aldrich 524-38-9 
N-Hydroxysuccinimide (NHS) Sigma-Aldrich 6066-82-6 
Ninhydrin VWR 485-47-2 
5-Nitro-m-xylene Alfa Aesar 99-12-7 
4-Nitrophenylchloroformate TCI Chemicals 7693-46-1 
PEG2000 Sigma-Aldrich 9004-74-4 
Phosphate buffered saline (10x concentrate, 
BioPerformance Certified) (PBS) 
Sigma-Aldrich n.a. 
Penicillin-streptomycin (5,000 U/mL) Gibco™ (P/S) Thermo Scientific n.a. 
Phenol Sigma-Aldrich 108-95-2 
Potassium carbonate (K2CO3) Carl Roth 584-08-7 
Pyridine Carl Roth 110-86-1 
Rotiphorese Gel Mix 30% Carl Roth n.a. 
RotiLoad Carl Roth n.a. 
SM(PEG)4 (NHS-PEG(4)-Mal) Thermo-Fisher n.a. 
Sodium acetate Sigma-Aldrich 127-09-3 
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Chemical Supplier CAS 
Sodium borohydride Sigma-Aldrich 16940-66-2 
Sodium chloride Carl Roth 7647-14-5 
Sodium deuteroxide 40% in D2O Deutero 14014-06-3   
Sodium hydroxide Carl Roth 1310-73-2 
Sodium hydroxide solution 1 M Carl Roth n.a. 
Sodium (meta)periodate Sigma-Aldrich 7790-28-5 
Sodium phosphate monobasic monohydrate Amresco, USA 7558-80-7 
Sodium pyruvate (100 mM) Gibco™ Thermo Scientific n.a. 
Sodium sulfate (Na2SO4) Carl Roth 7757-82-6 
3-Sulfo-N-succinimidyl 4-(N-Maleimidomethyl) 
cyclohexane-1-carboxylate Sodium Salt (sulfo-SMCC) 
TCI, Belgium 92921-24-9 
TCEP (Tris(2-carboxyethyl)phosphine) Carl Roth 51805-45-9 
Tetraazatetradecane or pentaethylenehexamine Sigma-Aldrich 4067-16-7 
Tetracarbonchloride Sigma-Aldrich 56-23-5 
Tin Carl Roth 7440-31-5 
Toluene VWR 108-88-3 
p-Tolylsulfonyl-chloride Sigma-Aldrich 98-59-9 
Triethylamine > 99,5% Carl Roth 121-44-8 
Trifluoroacetic acid (TFA) Sigma-Aldrich 76-05-1 
Triphenylphosphine (PPh3) Sigma-Aldrich 603-35-0 
2,4,6-Trinitrobenzene sulfonic acid (TNBS) Alfa Aesar 2508-19-2 
Water, sterile-filtered, BioReagent, suitable for cell 
culture  
Sigma-Aldrich 7732-18-5 
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5.1.2 Buffers and Media 
All buffers were prepared in a volume of 0.1 liter and filtered through a sterile syringe filter 
with a pore size of 0.22 µm (CME membrane, Rotilabo®). Aqueous buffers were usually 
stored at room temperature. 
Borate buffer (0.1 M, pH 9) 
6.18 g boric acid (MW 61.83 g mol-1) were dissolved in water and adjusted with NaOH to 
pH 9. 
DMEM for HeLa cells 
DMEM GlutaMAXTM (high glucose) with phenol red was mixed with 10% FCS, 1% pyruvate 
and 1% penicillin-streptomycin. 
Ninhydrin staining solution (acidic) 
0.2 g ninhydrin were dissolved 0.5 mL acetic acid, 100 mL n-butanol and 4.5 mL d-H2O. 
The solution was stored in the fume hood protected from light. 
PBS buffer (pH 7.4) 
PBS 10x concentrate (Sigma-Aldrich, 100 mL) was diluted with dd-H2O (900 mL); 
containing 154 mM NaCl, 8 mM NaHPO4 and 2 mM KH2PO4 with a final pH of 7.4. 
Phosphate buffer (10 mM, pH 7.4) 
120 mg sodium dihydrogen phosphate (Amresco, MW 119.98 g mol-1) were dissolved in 
dd-H2O and adjusted to pH 7.4 with NaOH. 
Phosphate buffer (20 mM, pH 6) 
240 mg sodium dihydrogen phosphate (Amresco, MW 119.98 g mol-1) were dissolved in 
dd-H2O and adjusted to pH 6 with phosphoric acid. 
Phosphate buffer (40 mM, 5 mM EDTA, pH 7.4) 
479.92 mg sodium dihydrogen phosphate (Amresco, MW 119.98 g mol-1) and 186.12 mg 
ethylenediaminetetraacetic acid dihydrochloride (Alfa, MW 133.02 g mol-1) were dissolved 
in dd-H2O and the pH was adjusted to pH 7.4 with NaOH. 
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Phosphate buffer (0.1 M, pH 8) 
1.2 g sodium dihydrogen phosphate (Amresco, MW 119.98 g mol-1) were dissolved in 
dd-H2O and adjusted to pH 8 with NaOH. 
Potassium phosphate (10 mM)/Sodium sulfate (50 mM) buffer (pH 7) 
This buffer was mainly used for measurements of circular dichroism spectra. 212 mg 
potassium phosphate (MW 212.28 g mol-1) and 710.2 mg sodium sulfate (MW 142.04 g mol-1) 
were dissolved in dd-H2O and adjusted to pH 7 with H2SO4. 
5.1.3 Disposables 
Consumables Manufacturer 
CELLSTAR® cell culture flasks 25 cm2, 75 cm2 Greiner Bio-One 
Disposable hypodermic needles (size: 21 G) B.Braun 
Disposable pipettes 2 mL, 5 mL, 10 mL, 20 mL  Sarstedt  
Disposable syringes 1 mL, 2 mL, 5 mL, 10 mL, 20 mL  B.Braun  
Eppendorf Tubes 1.5 mL, 2 mL, 5 mL  Eppendorf  
Eppendorf Tubes 1.5 mL (black) Eppendorf 
Filtropur S 0.2 (sterile, non-pyrogenic) Sarstedt 
Glass pipettes  Carl Roth GmbH  
Locking clips for dialysis  Carl Roth GmbH  
Microplate 12-well, flat bottom, clear, sterile Greiner Bio-One 
Microplate 24-well, flat bottom, clear, sterile Greiner Bio-One 
Microplate 96-well, flat bottom, clear Sarstedt  
Microplate 96-well, flat bottom, clear, sterile Greiner Bio-One 
Microplate 96-well, flat bottom, black Greiner Bio-One 
Microplate 96-well, flat bottom, white Corning-Costar, USA 
NMR tubes  Sigma-Aldrich  
Parafilm  Pechiney Plastic Packing  
Pipette tips 2 µL, 250 µL, 1000 µL  Sarstedt  
Tubes 13 mL, 100x16 mm, PP Sarstedt  
Tubes 15 mL, 120x17 mm, PP Sarstedt 
Tubes 50 mL, 114x28 mm, PP Sarstedt 
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5.1.4 Cell Lines 
HeLa Cells 
An epitheloid cervix carcinoma cell line, established from a cervical cancer tissue sample 
of Henrietta Lacks in 1951. Cells were a kind gift from the group of Prof. Dr. Bernd Epe 
(Institute of Pharmacy and Biochemistry, Johannes Gutenberg-University, Mainz). 
5.1.5 Equipment 
Absorption and Fluorescence Measurements 
Equipment:  Infinite® M200 Pro Plate Reader, Tecan Group Ltd., Switzerland. Analysis 
was carried out using i-control 1.7 software and Microsoft Excel 
Absorption measurements were performed with clear 96-well microplates (flat bottom). 
Fluorescence measurements were performed with black 96-well microplates (flat bottom). 
Bath-Sonicator 
Equipment:  Sonorex Super RK 102 H, Bandelin electronic 
Samples were sonicated until complete dissolving could be observed. Nanoparticles were 
suspended until no aggregates were detectable. 
Centrifuges 
Equipment:  Heraeus™ Multifuge™ X3R, Thermo Scientific 
Heraeus™ Megafuge™ 8 R, Thermo Scientific 
Centrifugation was performed at the indicated times in each experiment. 
Centrifugal Filter Units 
Equipment: Amicon Ultra-4, regenerated cellulose, 3500-10000 g mol-1 MWCO, Merck 
Millipore Ireland 
The separation of low molecular and biopolymers was carried out using centrifugal filter 
units with 4 mL loading capacity. They were centrifuged at 7500 g for 15 min unless 
otherwise stated. 
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Circular Dichroism (CD) Spectroscopy 
Equipment: J-815 Circular Dichroism Spectrometer, JASCO International co., LTD., 
Hachioji, Tokyo, Japan 
The exact settings and procedure are described in chapter 5.3.2. 
Column Chromatography (CC) 
Equipment:  Kieselgel 60, 0.063-0.2 mm, Firma Merck, Darmstadt 
Polygoprep® 60-50 C18, Macherey-Nagel GmbH & Co. KG, Düren 
Column chromatography was performed on either normal phase silica gel (NP-SiO2) or 
reversed phase (RP-C18 SiO2) with the indicated solvent mixtures on columns of different 
diameter and length. Solvent mixtures used for column chromatography are shown in 
volume percent. SiO2 was first suspended then columns were charged wetly. The 
mentioned yields refer to chromatographically purified and spectroscopically pure 
compounds unless otherwise stated. 
Dialysis 
Equipment:  Spectra/Por® 6, regenerated cellulose, MWCO 1,000 g mol-1, Carl Roth 
GmbH 
ZelluTrans Roth, regenerated cellulose, various MWCO, Carl Roth GmbH 
Slide-A-Lyzer® Dialysis cassettes, 0.5-3 mL capacity, various MWCO, 
Thermo Scientific 
Dialysis membranes were pre-swelled in d-H2O for 30 minutes and rinsed with water 
before using. Dialysis was performed against d-H2O unless otherwise stated under 
constant stirring against 1 L water. Water was changed at least every 2 h for 48 h. 
Dynamic Light Scattering Measurements (DLS) 
Equipment:  Malvern Zetasizer Nano ZS 
The exact settings and procedure are described in chapter 5.3.2. 
FT-IR 
Equipment:  Nicolet Avatar 330-IR ATR-Einheit, Thermo Electron Corporation 
The compounds were measured directly on the diamant crystal of the device. The maxima 
are classified into five intensities: vs (very strong), s (strong), m (middle), w (weak), vw 
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(very weak). The signals are reported in [cm-1] and assignments were carried out according 
to the literature.[244] 
High-Performance-Liquid-Chromatography-Mass-Spectrometry (HPLC-MS) 
Equipment: HP Agilent 1100 Series HPLC system 
All HPLC-MS measurements were carried out on an HP Agilent 1100 Series HPLC system 
with a binary pump, a diode array detector, and an automatic sampler. binary pump, a 
diode array detector, and an automatic sampler. The integrated column was an Agilent 
Poroshell 120 EC-C18 (150 · 2.1 mm) 4 µM which was used with MeCN/H2O (+0.1% formic 
acid) solvent mixtures. The attached LC/MSD Ion Trap was from Agilent Technologies and 
the applied column oven temperature was kept at 40 °C. 
Incubator 
Equipment:  Heraeus® BB15 FUNCTION Line, Thermo Scientific 
Cell incubations were performed in a humidified incubator at 37 °C with 5% CO2 
atmosphere. 
Inert Gas 
Equipment:  Argon gas bomb in 99.998% purity N46, Air Liquide Deutschland GmbH 
Argon was used as inert gas to flood flasks and reaction containers. Balloons with attached 
with needles were attached to the reaction flasks to prevent the contact with air. 
Lyophilizer 
Equipment:  ALPHA 1-4 LSC, Martin Christ Gefriertrocknungsanlagen GmbH 
Samples were dissolved or suspended in water, frozen in liquid nitrogen and then stored 
in the lyophilizer for freeze-drying for at least one day. 
Mass Spectrometry (ESI-MS) 
Equipment:  Agilent 6545 Q-TOF-MS, Institute of Organic Chemistry, Johannes 
Gutenberg-University Mainz 
MALDI-ToF (Matrix-assisted Laser Desorption/Ionization Time of Flight) 
Equipment:  Shimadzu Axima CFR MALDI-ToF mass spectrometer, nitrogen laser 
Microscopy 
The exact settings and procedure are described in chapter 5.3.2. 
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Nuclear Magnetic Resonance (NMR) 
Equipment:  Bruker Topspin Fourier 300 MHz 
For standard analytical purpose, 1H-NMR spectra were recorded at 300 MHz and 13C-NMR 
spectra at 90 MHz. The experiments were performed at room temperature using the 
indicated solvents, mostly CDCl3 and D2O. The chemical shifts were reported in ppm 
against the solvent signal of TMS. For the description of the signals, the following 
abbreviations were used: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
br = broad signal. Integrals were calculated by using MestReNova Software. Assignments 
were carried out according to literature. Peaks resulting from solvent residues were 
determined by literature.[325] 
pH Measurement 
Equipment:  SevenCompact™ pH/Ion S220 with an InLab® Micro special electrode, 
Mettler Toledo, Mettler-Toledo Ltd., Beaumont Leys, Leicester, United 
Kingdom 
The pH-meter was calibrated with commercially available buffer standards (pH 4.00, 
pH 7.00, and pH 11.00). 
Rotary Evaporation 
Equipment:  IKA RV06-ML Janke-Kunkel rotavapor; IKA HB4 basic water bath; 
Vacuubrand CVC24 vacuum controller; Vacuubrand 1715550193 Membrane 
pump 
Sample concentration under reduced pressure was performed by rotary evaporation in a 
water bath at 40–50 °C and the adjusted pressure for the used solvent. 
Safety Cabinet 
Equipment:  HERA Safe®, Kendro Laboratory Products, Langenselbold, Germany 
All cell culture experiments were performed in a sterile environment using a safety cabinet. 
Scales 
Equipment:  Mettler Toledo Excellence Plus 
Sartorius™ M-Prove™ Scales AY303, Sartorius, Göttingen, Germany 
Samples below 500 mg were weighed on the fine balance from Mettler. For samples above 
500 mg, the standard laboratory balance from Sartorius was used. 
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SDS Gel Electrophoresis 
Equipment:  Mini Vertical Electrophoresis Unit Hoefer SE260, Hoefer Inc., Holliston, 
Massachusetts, USA 
GelDoc XR+ with Image LabTM Software, Bio-Rad Laboratories Inc., 
Hercules, California, USA. 
The exact procedure is described in chapter 5.3.2. 
Solvents 
All solvents were either bought dry or dried before use. Methanol (Sigma-Aldrich) was 
purified before use by distillation with a rotary evaporator. 
Thin Layer Chromatography (TLC) 
Equipment:  Universal UV-Lampe CAMAG TL-900, West-Berlin 
Pre-coated TLC sheets Alugram Xtra SIC G/UV254, Layer 0.2 mm with 
fluorescent indicator UV254, Macherey-Nagel GmbH & Co. KG, Düren 
Pre-coated TLC sheets Alugram RP-18W/UV254, Layer 0.15 mm with 
fluorescent indicator UV254, Macherey-Nagel GmbH & Co. KG, Düren 
Reaction control was carried out with by TLC on silica gel precoated plates either on 
normal phase or reversed phase. Visualization of the spots was carried out by fluorescence 
detection at 254 nm UV light or by staining TLC plates.  
Transmission Electron Microscopy (TEM) 
Equipment: Tecnai T12 (FEI, acceleration voltage: 120 kV, electron source: LaB6 
BIO-TWIN cathode, TVIPS-F416 camera), Hillsboro, Oregon, USA 
300-mesh copper carbon grids (Plano GmbH) were used for sample preparation. 
Water 
Equipment:  Direct-Q® 5 UV Remote Water Purification System, Merck Millipore, 
Germany 
Water (dd-H2O) for buffers and washing steps was purified by a Direct-Q® 5 UV Remote 
Water Purification System.  
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5.2 Synthesis of an Artificial ATPase 
5.2.1 Synthesis of Macrocyclic Amine (MCA) 
Synthesis of Protected Polyamine 
(1,4,7,10,13,16-Hexakis(p-tolylsulfonyl)-1,4,7,10,13,16-hexaaza-hexadecane 5) 
 
The protected polyamine was synthesized after slightly modified published procedures.[236-
237] Briefly, p-tolylsulfonyl-chloride 4 (74.41 g, 391.89 mmol, 6 equiv) was dissolved in 
200 mL pyridine in a 500 mL round-bottom flask and warmed to 50–60 °C. 
3,6,9,12-tetraaza-tetradecane-1,14-amine 3 (15.20 g, 65.41 mmol, 1 equiv) was added during 
75 min while the temperature was kept between 50–60 °C. After complete addition of the 
amine the reaction was stirred for another 30 min at 50–60 °C and then 105 mL of distilled 
water were added. The mixture was stirred for further 2 h and then cooled down with a 
mixture of ice and sodium chloride. The precipitate was filtered off and washed two times 
with 150 mL hot ethanol. The product 5 was obtained as a beige solid (30.61 g, 40%). 
1H-NMR (300 MHz, DMSO): δ = 7.73-7.59 (m, 12H, 2,6-TsArH), 7.45-7.32 (m, 12H, 
3,5-TsArH), 3.23-3.05 (m, 16H, 2,3,5,6,11,12,13,14-CH2), 2.84 (q, 4H, 8,9-CH2), 2.43 2.32 (m, 
18H, TsAr-CH3) 
13C-NMR (75 MHz, DMSO): δ =144.18, 144.01, 143.22 (6x -CSO2), 137.72, 135.66, 135.43 
(6x -CCH3), 130.45, 130.38, 130.12 (6x arom. 3,5-CH), 127.54, 127.38, 127.01 (6x arom. 
2,6-CH), 49.10, 48.54, 48.29 (5x -TsN-(CH2)2-NTs-), 42.03 (2x TsArCH2), 21.45 (6x -CH3) 
LC-MS (m/z): calculated for [M+H+]: 1158.47, found: 1158.6 
   calculated for [M+Na+]: 1180.46, found: 1180.5 
  
3 
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Synthesis of Tosylated Macrocyclic Amine MCA(Ts)6 
 (2,5,8,11,14,17-Hexakis(p-tolylsulfonyl)-2,5,8,11,14,17-hexaaza[18]metacyclophane 7)
 
The cyclisation of 5 with 1,3-bis(bromomethyl)-benzene 6 was carried out in the same 
manner as published.[144, 236] Briefly, 5 (2 g, 1.73 mmol) and K2CO3 (4.78 g, 34.59 mmol, 
20 equiv) were suspended in refluxing 100 mL acetonitrile. The suspension was refluxed 
for 30 min. 1,3-bis(bromomethyl)-benzene 6 (0.68 g, 3.39 mmol, 1.5 equiv) was dissolved in 
80 mL acetonitrile and added dropwise to the refluxing solution. The suspension was 
refluxed for further 36 h. The white precipitated was filtered off and the solvent was 
removed under reduced pressure. The dark brown, oily residue was purified by column 
chromatography on silica (toluene:ethyl acetate, 9:1). The product 7 was obtained as a 
white solid (1.41 g, 1.12 mmol, 65%). 
1H-NMR (300 MHz, CDCl3): δ =7.66-7.55 (m, 12H, TsArH), 7.27-7.16 (m, 12H, TsArH), 
6.98-6.91 (m, 3H, ArH), 4.19 (s, 4H, ArCH2), 3.22-3.04 (m, 20H, 5x -TsN-(CH2)2-NTs-), 2.37-
2.36 (m, 6H, -CH3), 2.30 (s, 6H, -CH3), 2.25 (s, 6H, -CH3) 
13C-NMR (75 MHz, CDCl3): δ = 144.02, 143.81, 143.74 (-CSO2), 137.22 (arom. 19,23-C-
CH2), 135.99, 134.93, 134.74 (12x arom. 2,6-CH), 130.03 (arom. 24-CH), 129.15, 128.90, 128.34 
(12x arom. 3,5-CH), 127.50, 127.09 (12x arom. 2,6-CH), 125.41 (arom. 20,22-CH), 53.25 (2x 
ArCH2), 50.50, 50.36, 49.90, 48.78, 48.39 (5x -TsN-(CH2)2-NTs), 21.68-21.58 (6x -CH3) 
LC-MS (m/z): calculated for [M+H+]: 1298.57, found: 1298.6 
   calculated for [M+Na+]: 1282.59, found: 1282.6 
  
5 
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Synthesis of MCA 
(2,5,8,11,14,17-Hexaaza[18]metacyclophane 2) 
 
The deprotection of 7 was carried out after a published procedure.[236] Briefly, 
2,5,8,11,14,17-hexakis(p-tolylsulfonyl)-2,5,8,11,14,17-hexaaza[18]metacyclophane 7 
(1.07 g, 0.85 mmol) was mixed with phenol (2 g, 21.25 mmol, 25 equiv) and dissolved in 
30 mL 48% HBr. The mixture was refluxed at 130 °C for 50 h. The mixture was washed with 
chloroform (3x) and the aqueous phase was cooled to 0°C. The strong acidic pH was 
adjusted to 12 with NaOH pellets. The product 2 was extracted with chloroform (3x) and 
received after removing of the solvent under reduced pressure as a yellow oil (0.11 g, 
3.14 mmol, 37%). 
1H-NMR (300 MHz, CDCl3): δ = 7.46 (s, 1H, ArH), 7.14-7.12 (m, 2H, ArH), 3.79 (s, 4H, 
ArCH2), 2.76-2.71 (m, 20H, 5x -NH-(CH2)2-NH-), 1.88 (m, NH) 
1H-NMR (300 MHz, D2O): δ = 7.45-7.31 (m, 3H, ArH), 3.81 (s, 4H, ArCH2), 2.75 (m, 20H, 
5x -NH-(CH2)2-NH-) 
13C-NMR (75 MHz, D2O): δ = 138.54, 129.09, 128.93, 128.16 (ArC), 52.19 (2x ArCH2), 47.31, 
47.00, 46.88, 46.78, 46.02 (10x -NH-(CH2)2-NH-) 
LC-MS (m/z): calculated for [M+H+]: 335.52, found: 335.6 
   calculated for [M+Na+]: 357.49, found: 357.5 
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5.2.2 Synthesis of Modified Macrocyclic Amines 
Synthesis of 1,3-Bis(bromomethyl)-5-nitrobenzene 
 
The compound was synthesized in a slightly modified procedure as published.[246] 
5-nitro-m-xylene 8 (11.21 g, 74.16 mmol, 1 equiv) and N-bromosuccinimide 9 (29.09 g, 
163.42 mmol, 2.2 equiv) were dissolved in 200 mL CCl4 in a 500 mL round-bottom flask. 
5 spatulas of the radical initiator benzoyl peroxide were added to start the radical aromatic 
substitution reaction. The mixture was refluxed for 5 h. After cooling to room temperature, 
the precipitated succinimide was filtered off and the solvent was removed. The solid, 
slightly yellow product 10 (6.20 g, 27%) was purified by column chromatography (CC) on 
silica using petrol ether and ethyl acetate in a solvent gradient (50:15:1). 
1H-NMR (300 MHz, CDCl3): δ = 8.19 (s, 2H, ArH), 7.75 (s, 1H, ArH), 4.52 (s, 4H, -CH2) 
13C-NMR (75 MHz, CDCl3): δ = 148.69 (-CNO2), 140.53 (2x -CCH2), 135.42 (-CH), 123.85 
(2x -CH), 30.78 (2x -CH2Br) 
LC-MS (m/z): calculated for [M+Na+]: 331.94, found: 331.9 
   calculated for [M+2ACN+H+]: 392.02, found: 392.4 
 
Synthesis of NO2-MCA(Ts)6 
(2,5,8,11,14,17-Hexakis(p-tolylsulfonyl)-21-nitro-2,5,8,11,14,17-hexaaza[18]metacyclo-
phane 11) 
 
For the cyclisation a modified procedure of Aguilar et al. has been used.[144] 1,4,7,10,13,16-
hexakis(p-tolylsulfonyl)-1,4,7,10,13,16-hexaaza-hexadecane (11.82 g, 10.21 mmol, 
0.8 equiv) 5 and an excess of K2CO3 (9.21 g, 66.69 mmol, 5.2 equiv) were suspended in 
refluxing acetonitrile (200 mL). 1,3-bis(bromomethyl)-5-nitrobenzol 10 (3.94 g, 
12.75 mmol, 1 equiv) was dissolved in 200 mL acetonitrile and transferred to a dropping 
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funnel and added to the suspension during 6 h. The suspension was refluxed for further 
48 h. The precipitate was filtered off and the solution was evaporated to dryness. The solid 
product 11 was chromatographed on silica using dichloromethane. 4.71 g (35.4%) of a 
colorless solid were obtained. 
1H-NMR (300 MHz, CD2Cl2): δ = 7.93-7.20 (m, 27H, ArH), 4.43-4.31 (m, 4H, ArCH2), 
3.37-3.05 (m, 20H, 5x -TsN-(CH2)2-NTs-), 2.49-2.33 (m, 18H, -CH3) 
13C-NMR (75 MHz, CD2Cl2): δ= 149.37 (-CNO2), 144.85, 144.77, 144.58 (-CSO2), 140.38 
(arom. 19,23-C-CH2), 136.20, 135.65, 135.35 (12x arom. 2,6-CH), 133.14 (arom. 24-CH), 
130.59, 130.50, 130.40 (12x arom. 3,5-CH), 127.87, 127.74 (12x arom. 2,6-CH), 122.02 (arom. 
20,22-CH), 53.28 (2x ArCH2), 50.43, 50.33, 49.94, 49.50 (5x -TsN-(CH2)2-NTs), 21.95-21.69 
(6x -CH3) 
LC-MS (m/z): calculated for [M+CH3OH+H+]: 1337.64, found: 1337.6 
   calculated for [M+K+]: 1343.57, found: 1343.6 
   calculated for [M+Isoprop+H+]: 1365.68, found: 1365.7 
   calculated for [M+ACN+Na+]: 1368.63, found: 1368.6 
   calculated for [M+2K++H+]: 1381.53, found: 1381.6 
 
Synthesis of NH2-MCA(Ts)6 
(2,5,8,11,14,17-Hexakis(p-tolylsulfonyl)-21-amino-2,5,8,11,14,17-hexaaza[18]metacyclo-
phane 12) 
 
2,5,8,11,14,17-Hexakis(p-tolylsulfonyl)-21-nitro-2,5,8,11,14,17-hexaaza[18]metacyclo-
phane 11 (2.13 g, 1.64 mmol, 1 equiv) was dissolved in dioxane with HCl (4 M) and tin 
(2.14 g, 18.04 mmol, 11 equiv) and refluxed for 5 h. The precipitate was filtered off and the 
organic solution was washed 3x with 5 M NaOH solution. The organic phase was dried 
with Na2SO4 and evaporated to dryness. A slightly yellow solid 12 (2.05 g, 98%) was 
obtained. 
11 12 
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1H-NMR (300 MHz, CD2Cl2): δ = 7.72-7.59 (m, 12H, ArH), 7.38-7.29 (m, 12H, ArH), 6.38 (s, 
2H, 20,22-ArH), 6.26 (s, 1H, 24-ArH), 4.12 (m, 4H, Ar-CH2), 3.27-3.08 (m, 20H, 5x -TsN-
(CH2)2-NTs), 2.44-2.39 (m, 18H, -CH3) 
13C-NMR (75 MHz, CD2Cl2): δ= 147.50 (-CNH2), 144.12, 143.91, 143.78 (6x –CSO2), 138.13 
(arom. 19,23-C-CH2), 135.93, 135.01, 134.77 (-CCH3), 129.89, 129.82 (12x arom. 3,5-CH), 
127.50, 127.38, 127.29 (12x arom. 2,6-CH) 116.86 (arom. 24-CH), 113.28 (arom. 20,22-CH), 
54.56-53.83 (2x ArCH2), 51.50, 50.22, 49.75, 49.60, 48.14 (5x -TsN-(CH2)2-NTs-), 21.24 
(6x -CH3) 
LC-MS (m/z): calculated for [M+H+]: 1275.64, found: 1275.6 
   calculated for [M+Na+]: 1297.62, found: 1297.6 
   calculated for [M+K+]: 1313.59, found: 1313.5 
 
Synthesis of NH2-MCA 
(21-Amino-2,5,8,11,14,17-hexaaza[18]metacyclophane 13) 
 
The deprotection of 12 (2.00 g, 1.57 mmol, 1 equiv) was carried out with phenol (3.92 g, 
41.60 mmol, 26.5 equiv) and 45 mL HBr (48%). The mixture was refluxed for 15 h at 130 °C. 
The solution was 3x washed with 50 mL chloroform and purified by ion exchange 
chromatography on Dowex Marathon (hydroxide form). The solvent was removed under 
pressure and by lyophilization. The product 13 was obtained as a brown oil (0.47 g, 86%). 
1H-NMR (300 MHz, D2O): δ = 6.75 (s, 1H, ArH), 6.69 (s, 2H, ArH), 3.62 (s, 4H, Ar-CH2), 
2.64 (m, 20H, 5x -NH-(CH2)2-NH-) 
13C-NMR (75 MHz, D2O): δ = 146.66 (1x -CNO2), 140.60 (2x 19,23-CCH2), 119.69 (1x arom. 
24-CH), 115.35 (2x arom. 20,22-CH), 52.36 (2x Ar-CH2), 47.73, 47.49, 47.39, 47.26, 46.63 (10x 
-NH-(CH2)2-NH-) 
LC-MS (m/z): calculated for [M+H+]: 350.3, found: 350.5 
   calculated for [M+Na+]: 372.49, found: 372.4 
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Synthesis of BCN-MCA 
((1R, 8S, 9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl-21-amino-2,5,8,11,14,17-hexaaza[18]meta-
cyclophane 15) 
 
21-Amino-2,5,8,11,14,17-hexaaza[18]metacyclophane 13 (30 mg, 0.0858 mmol, 1 equiv) 
was dissolved in 10 mL dry DCM. The solution was cooled to 0 °C and 33 µL (26.04 mg, 
0.26 mmol, 3 equiv) of triethylamine (Et3N) were added. The mixture was stirred for 
10 min. (1R, 8S, 9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl carbonate, short 
BCN-NHS 14 (27.5 mg, 0.0944 mmol, 1.1 equiv) was dissolved in DCM and added to the 
mixture. The reaction was stirred overnight and slowly warmed up to room temperature. 
The solvent was evaporated under reduced pressure and the reaction mixture was tried to 
purify under several conditions with column chromatography and the solvents DCM, 
EtOH and NH4OH (15:4:1) used as the best conditions. The product 15 was obtained as a 
brown oil (4.23 mg, 9%). 
1H-NMR (300 MHz, D2O): δ = 6.83 (s, 3H, ArH), 4.35-4.32 (d, 2H, -CH-CH2-O-CO-), 4.17 
(s, 4H, Ar-CH2-), 3.15-2.92 (m, 20H, 5x -NH-(CH2)2-NH-), 2.23 (s, 6H, 2x alkyne-CH2-, 2x 
alkyne-CH2-CH2- only one of them ), 1.70 (m, 2H, 2x alkyne-CH2-CH2- only one of them ), 
cyclopropyl protons: 1.48 (t, 1H, -CH-CH-CH2-O-), 1.00 (m, 1H, -CH2-CH-CH-CH2-), 0.88 
(m, 1H, -CH2-CH-CH-CH2-) 
13C-NMR (75 MHz, D2O): not enough substance 
LC-MS (m/z): calculated for [M+H+]: 526.38, found: 526.7 
   calculated for [M+Na+]: 549.37, found: 549.5 
   calculated for [M+ACN+Na+]: 567.41, found: 567.8 
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Synthesis of Mal-MCA 
(Maleimide-poly(ethylene glycol)-21-amino-2,5,8,11,14,17-hexaaza[18]meta-cyclophane 
17)  
 
21-amino-2,5,8,11,14,17-hexaaza[18]metacyclophane 13 (28.8 mg, 0.0824 mmol, 1 equiv) 
was dissolved in 1 mL phosphate buffer (40 mM, 5 mM EDTA, pH 7.4). SM(PEG)4 (NHS-
PEG(4)-Mal) 16 (63.5 mg, 0.124 mmol, 1.5 equiv) was also dissolved in 1 mL buffer. The 
mixture was stirred for 30 min and further used without purification. LC-MS 
measurements of the reaction product mixture demonstrated the clear formation of the 
desired product. 
1H-NMR (300 MHz, D2O): not available 
13C-NMR (75 MHz, D2O): not available 
LC-MS (m/z): calculated for [M+H+]: 748.46, found: 748.47 
 calculated for [M+Na+]: 770.46, found: 770.45 
 calculated for [M+CH3OH+H+]: 780.49, found: 780.49  
13 
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5.2.3 Synthesis of Dextran-based Carrier 
Synthesis of Dex-(N3)9 
 
The synthesis was done analogously to a published procedure.[256] Dextran 18 (100 mg) 
was dissolved in 5 mL dry DMSO in a 10 mL round-bottomed flask protected from light. 
4-azidobenzoic acid (AZBA) 19 (50 mg, 0.306 mmol) and DMAP (3.75 mg, 0.0306 mmol) 
were added to the solution while stirring. The solution was cooled to 0 °C. DCC (62.5 mg, 
0.303 mmol) was added and stirring was continued for 5 h. After filtering off the 
precipitated dicyclohexyl urea, the azidated dextran 20 was precipitated into an excess 
methanol. The precipitate was centrifuged, washed several times with methanol, 
centrifuged again in order to remove any free 4-azidobenzoic acid and finally lyophilized. 
The white, fluffy powder (0.085 g) of Dex-(N3)9 20 was stored protected from light in the 
freezer. 
DS (1H-NMR): 9 per chain (61.68 AGU) 
1H-NMR (300 MHz, d6-DMSO): δ = 8.02 (d, m-C6H5), 7.24 (d, o-C6H5), 4.85-4.91 (m, OH3 
+ OH4), 4.67 (s, anomeric H), 4.49 (s, OH2), 3.19-3.76 (m, AGU-H) 
13C-NMR (90 MHz, d6-DMSO): δ = 98.73 (anomeric C), 73.79 (CH-OH-3), 72.29 (CH-OH-
2), 70.87 (CH-CH2-5), 70.59 (CH-OH-4), 66.59 (CH2-6), C atoms of AZBA not determinable 
FT-IR [cm-1]: 3330 (vs, br, OH), 2921 (m, CH2), 2124 (m, N3), 1707 (w, ester C=O), 1597 
(w), 1503 (vw), 1421 (w), 1339 (w), 1278 (m), 1147 (m), 1098 (m), 1005 (vs, sec. OHs), 947 
(m), 910 (m), 845 (w), 763 (w) 
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Synthesis of OxDex-(N3)9 
 
The oxidation was carried out similarly to a published procedure for the oxidation of 
dextran.[259] Briefly, Dex-(N3)9 20 (200 mg) were dissolved in 4 mL water. Sodium periodate 
(NaIO4) (44 mg, 0.206 mmol) were added in one portion and the solution was stirred for 
5 h. Afterward, the reaction mixture was dialyzed (MWCO 3.5 kDa) against distilled water 
for 2 d and lyophilized. The OxDex-(N3)9 21 was obtained as a fluffy, white powder 
(143 mg) which was not further characterized. 
 
Synthesis of Aminooxy-PEG (PEG-O-NH2) 
 
The end group modification of PEG 2000 22 was carried out after a published 
procedure.[264] Briefly, PEG monomethyl ether 22 (5 g, 2.5 mmol), triphenylphosphine 
(PPh3) (1.92 g, 7.313 mmol, 3 equiv) and N-hydroxyphthalimide (NHP) 23 (1.2 g, 
7.313 mmol, 3 equiv) were dissolved in 20 mL dry dichloromethane under an argon 
atmosphere. Diisopropyl azodicarboxylate (DIAD) (1.380 mL, 1.378 g, 6.813 mmol, 
2.7 equiv) was added dropwise during 15 min. After complete addition, the reaction was 
stirred for further 18 h. The mixture was precipitated in 400 mL diethyl ether and stirred 
vigorously for 20 min. The precipitate was filtered off, washed with ether and dried under 
reduced pressure. A rose solid of PEG-NHP 24 was obtained (3.849 g, 77% based on 
unsubstituted PEG). 
DS (1H-NMR): complete conversion 
1H-NMR (300 MHz, CDCl3): δ = 7.84-7.80 (m, 2H, ArH), 7.77-7.72 (m, 2H, ArH), 4.36 (t, 
2H, CH2-O-N), 3.63-3.52 (m, PEG backbone), 3.38 (s, 3H, -CH3) 
20 21 
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The phthalimide moiety was cleaved using hydrazine hydrate. 3 g (1.5 mmol) of PEG-NHP 
24 were dissolved in 10 mL dichloromethane and hydrazine monohydrate 25 (187.7 mg, 
182 µL, 3.75 mmol, 2.5 equiv) was added in one portion. The mixture was stirred for 30 min 
and a white precipitate was observed. The mixture was filtered over glass wool and 
concentrated carefully under reduced pressure. The product PEG-O-NH2 26 was obtained 
as a white powder (2.62 g, 87%). 
DS (1H-NMR): complete conversion 
1H-NMR (300 MHz, CDCl3): δ = 4.30 (t, 2H, CH2-O-NH2), 3.88-3.52 (m, PEG backbone), 
3.37 (s, 3H, -CH3) 
 
Synthesis of Dextran-PEG Polymer Brush (OxDex-(N3)9 (PEG)16) 
 
OxDex-(N3)9 21 (100 mg, 1.616 mmol) were dissolved in 2 mL phosphate buffer (40 mM, 
pH 6.5) until complete dissolution was achieved. Aniline (12.2 mg, 16.86 µL, 0.185 mmol, 
2 equiv) was added in one portion and the mixture was stirred for 45 min. 
Aminooxy-modified PEG 26 2 kDa (370 mg, 0.185 mmol, 2 equiv) was dissolved in 1 mL 
buffer and added to the stirring solution. The mixture was stirred for 7 h, before 
transferring the solution first to a dialysis bag (MWCO 12-14 kDa), then to a dialysis bag 
with larger cut-off (50 kDa). The polymer brush 27 was obtained as a colorless powder 
(364 mg). 
DS (1H-NMR): 16.5 per chain (61.68 AGU), calculated MW 43000 g mol-1 
1H-NMR (300 MHz, D2O): δ = 8.10 (d, m-C6H5), 7.25 (d, o-C6H5), 4.96 (s, anomeric H), 
4.25-3.43 (m, dextran glucosidic protons and PEG signal), 3.37 (s, 3H, -CH3) 
GPC (DMF, PEG-Standard): distribution from 40000 to 50000 g mol-1 
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Transmission Electron Microscopy (TEM) 
The dextran suspension (1 mg mL-1) was applied in 5 µL drops on a 300-mesh copper 
carbon grid from Plano GmbH for TEM measurements. The pictures were taken with a 
transmission electron microscope as described in 5.1.5. 
 
Synthesis of Dex-(SH)7 via Dex-(4-NC)7.5 
 
Dextran 18 was modified after a published procedure.[270-271] Briefly, the hydroxyl groups 
of dextran were first activated with 4-nitrophenyl-chloroformate (4-NC) 29 and then 
reacted with cysteamine. Dextran 18 (250 mg, 1.54 mmol AGU) was dissolved in 4 mL, hot 
dry DMF containing 80 mg (2% of solvent) LiCl. After cooling to 0 °C 42.7 µL (41.41 mg, 
0.52 mmol, 0.34 equiv referred to AGU) pyridine and 105.53 mg (0.52 mmol, 0.34 equiv) 
4-nitrophenyl chloroformate 29 were added and stirred for 2 h at 0 °C. The mixture was 
precipitated in ice-cold ethanol, washed with diethyl ether and filtered off. The colorless 
powder 30 (265 mg) was dried in vacuo. 
DS (1H-NMR): 7.5 per chain (61.68 AGU) 
1H-NMR (300 MHz, DMSO): δ = 8.35-8.32 (dd, aromatic protons), 7.58-7.55 (dd, aromatic 
protons), 5.11 (s, dextran glucosidic protons at positions which have nitrophenyl 
substituents), 4.68 (s, anomeric protons), 3.21-4.18 (m, dextran glucosidic protons) 
FT-IR [cm-1]: 3330 (vs, br, OH), 2914 (m, CH2), 1765 (w, acyclic carbonate), 1525 (w), 1348 
(w), 1261 (m), 1217 (m), 1149 (m), 1012 (vs, sec. OHs), 916 (m), 860 (w), 760 (w) 
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In a second reaction, the carbonates were replaced by cysteamine. Dextran-4-NC 30 
(100 mg, 0.62 mmol) was dissolved in 3 mL hot DMF containing 30 mg (1% of solvent) LiCl. 
After cooling to room temperature cysteamine 28 (45.6 mg, 0.59 mmol, 8 equiv referred to 
activated OH groups) was added in DMF. The solution turned instantly yellow 
demonstrating the cleavage of the p-nitrophenolate. After stirring overnight, the mixture 
was precipitated in ice-cold ethanol, washed several times and finally dissolved in water. 
A spatula of tris(2-carboxyethyl)-phosphine (TCEP) was added to reduce any disulfide 
bonds. The solution was again precipitated in ice-cold ethanol, washed and rapidly 
dissolved in water and lyophilized. 87.12 mg of a colorless powder of Dex-(SH)7 31 was 
obtained. 
DS (1H-NMR): 7 
DS (Ellman’s assay): 6-7 
1H-NMR (300 MHz, D2O): δ = 5.36, 5.20 (s, dextran glucosidic protons at positions which 
have cysteamine substituents), 5.01 (s, anomeric protons), 4.03-3.96 (m, dextran glucosidic 
protons), 3.80-3.72 (m, dextran glucosidic protons), 3.62-3.52 (m, dextran glucosidic 
protons), 3.37 (m, cysteamine protons), 2.70 (m, cysteamine protons) 
FT-IR [cm-1]: 3330 (vs, br, OH), 2914 (m, CH2), 1695 (w, carbamate), 1408 (w), 1338 (w), 
1147 (m), 1149 (m), 1005 (vs, sec. OHs), 912 (m), 843 (w), 762 (w) 
 
Ellman’s Assay for the Quantification of Thiol Groups 
For the Ellman’s assay[273], thiol-modified dextran 31 (3 mg mL-1) was dissolved in sodium 
phosphate buffer (0.1 M, pH 8) containing 1 mM EDTA. Ellman’s reagent was dissolved in 
the reaction buffer (4 mg mL-1) and 8 µL of this solution were added to 400 µL reaction 
buffer in black 1.5 mL Eppendorf tubes. 40 µL of sample or N-acetylcysteine were added. 
The mixtures were vortexed and incubated for 20 min at RT in the dark. 100 µL of each 
sample were pipetted in triplicate in a clear, flat bottom 96-well microplate (Sarstedt). The 
30 
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absorbance was measured with an Infinite® M200 Pro Plate Reader Tecan microplate 
reader at 412 nm. N-acetylcysteine at concentrations of 9.77 µM to 2.5 mM was used to 
prepare the standard curve. As control, unmodified dextran was measured. 
 
Synthesis of Dex-(S-Mal-MCA)6 
 
The conjugation was carried out by a thiol-maleimide reaction of Dex-(SH)7 31 and 
Mal-MCA 17. The Mal-MCA 17 was generated in situ right before the reaction by mixing 
SM(PEG)4 (NHS-PEG(4)-Mal) 16 (63.5 mg, 0.124 mmol, 7.5 equiv) with NH2-MCA 13 
(28.8 mg, 0.0824 mmol, 5 equiv) for 30 min in 1 mL phosphate buffer (40 mM, 5 mM EDTA, 
pH 7.4). Dex-(SH)7 31 (30 mg, 0.185 mmol, 0.0165 mmol thiol groups, 1 equiv) was reduced 
with TCEP (1 spatula tip) for 30 min and precipitated in ethanol. The reduced Dex-(SH)7 
31 was dissolved in buffer and mixed with the Mal-MCA 17 and stirred for 48 h at room 
temperature. The solution was purified with centrifugal filters (MWCO 3.5 kDa), washed 
7 times and lyophilized. The product 33 was obtained as a slightly brown, fluffy powder 
41.69 mg. 
1H-NMR (300 MHz, D2O): δ = 7.77 (s, 1H, aromatic protons), 7.52 (s, 4H, aromatic 
protons), 6.71 (m, 22 H, aromatic protons), 5.35, 5.20 (s, dextran glucosidic protons at 
positions which have cysteamine substituents), 5.01 (s, anomeric protons), 4.03-3.37 (m, 
dextran glucosidic protons), 3.37 (m, cysteamine protons), 2.72-2.49 (m, cysteamine protons 
and polyamine protons) 
13C-NMR (75 MHz, D2O): not available 
Ninhydrin coloration: deep purple 
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FT-IR [cm-1]: 3330 (vs, br, OH), 2914 (m, CH2), 1699 (w, carbamate), 1633 (w, prim. and 
sec. amines), 1548 (w, sec. acid amides), 1402 (w), 1349 (w), 1257 (m), 1149 (m), 1010 (vs, sec. 
OHs), 914 (m), 843 (w), 762 (w) 
Ellman’s Assay: 0 thiols detectable  
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5.2.4 Cell Culture 
HeLa cells were grown in Dulbecco’s Modified Eagle Medium (DMEM GlutaMAX™) 
supplemented with 10% (V/V) fetal calf serum (FCS), 1% pyruvate, and 1% penicillin-
streptomycin. Cell incubations were performed in a humidified incubator at 37 °C with 5% 
CO2 atmosphere. All used buffers were either autoclaved, sterile filtered or already sterile 
when supplied and were preheated to 37 °C before usage. Cells were grown in 25 cm2, 
75 cm2 or 225 cm2 standard cell culture flasks. 
Determination of Cell Viability by MTT Assay 
The cytotoxic effects of dextrans and dextran-modified samples were evaluated by MTT 
assay[277] using human HeLa cells. Cells were precultured in DMEM containing 10% FCS 
and 1% P/S and then seeded in sterile clear, flat bottom 96-well cell culture microplates at 
a concentration of 15,000 cells per well and a volume of 100 µL. Cells were allowed to 
attach and grow overnight. Dextran samples and corresponding samples of small 
molecules were prepared by dissolving the sample solutions in DMEM in a concentration 
range from 62.5 µg to 1 mg mL-1. The next day, DMEM was removed from HeLa cells and 
replaced by 100 µL of the sample solutions as well as DMEM as blank solutions. All 
measurements were carried out in triplicate. The cells were incubated for 48 h at 37 °C in 
5% CO2. After 48 h, 40 µL MTT solution (3 mg mL-1 in DMEM) was added to each well and 
incubated at 37 °C for 30 min. After total removal of the medium, a mixture of 200 µL 
DMSO and 25 µL glycine buffer (0.1 M glycine, 0.1 M NaCl, pH 10.5) was added to each well 
and softly shaken for 15 min to dissolve the purple formazan salt. 50 µL of this 
concentrated, purple DMSO solution was added to a second clear, flat bottom 96-well 
microplate containing a mixture of 17 µL glycine buffer and 133 µL DMSO per well. Finally, 
the absorbance of the formazan was read using an Infinite 200 PRO (Tecan) plate reader at 
595 nm. Furthermore, the background was measured at 670 nm and subtracted from the 
data obtained from the first read out.[326] Cell viability was calculated with Microsoft Excel. 
Cell viability was normalized to the absorbance of the blank samples. 
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5.2.5 Evaluation of ATPase-like Functionality 
31P-NMR measurements 
The ATP cleavage was investigated with 31P-NMR measurements. All measurements were 
carried out at 313 K (40 °C) in D2O solutions. Small amounts of NaOD (40% in D2O) and 
DCl (38% in D2O) were used to adjust the solutions pD. The pH was calculated from the 
measured pD value by using pH = pD-0.4.[327] The reaction progress was monitored by 
following the time dependent changes of the integrals of ATP, ADP and inorganic 
phosphate in the 31P-NMR spectrum. The NMR acquisition time was set to d1=5 s and 
8 scans were carried out per measured time point. The quantity of cleaved ATP was 
calculated by 
[ATP]=
 
 ) 	
 and [
 =
⌡
⌠ 
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+⌡
⌠ 
 
Time-course kinetics were obtained for the cleavage of 30 mM ATP in the presence of the 
respective catalytically active compounds. The MCAs were used in a 10 mM concentration 
if administered alone. The amount of dextran conjugate was adjusted that the same 
number of catalytic moieties is present in the measurements. All experiments were 
repeated twice. The catalytic rates were calculated by using Mestrenova Reaction 
Monitoring®. 
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5.3 Modification of Proteins for Artificial Enzymatic 
Cascade Reactions 
5.3.1 Protein Surface Modification 
Synthesis of Hexapeptide Ac-His-His-His-Gly-Gly-Cys-NH2 (short HHHGGC) 
 
For the solid phase peptide synthesis, Fmoc-Rink-amide-aminomethyl-polystyrene resin 
was used. The step-wise chain elongation of the peptide was performed using the CS Bio 
CS136XT peptide synthesizer which is an automated batch peptide synthesizer. The 
detailed procedure is described elsewhere.[328] Briefly, the dried resin beads were swollen 
in DCM for 10 min in a shaking reaction vessel. Afterward, the solution was removed, and 
the vessel was shaken for 20 min with a mixture of piperidine (20% in DMF). The resin 
beads were washed four times with DMF, then twice with DCM and the corresponding 
protected amino acid (6.0 mmol, 4 equiv), the coupling reagent HBTU (4 equiv) and the 
base DIPEA (6 equiv) were added in DMF. This mixture was shaken with the resin for 1 h. 
Then the resin was washed five times with DMF. This protocol was repeated for every 
corresponding amino acid in the coupling process. The first step was always the Fmoc 
deprotection on the resin. After the last amino acid was coupled, the resin was washed 
with DCM. 
Then the resin was treated manually and was washed three times with DCM, three times 
with MeOH and three times with DCM. A mixture of 10 mL Ac2O and 10 mL DMF was 
shaken with the resin for 1 h to ensure the complete acyl capping of the terminal amino 
group. The cleavage of the protected peptide from the resin was carried out with a mixture 
of 1 mL TIPS (5%) in 19 mL TFA (95%) incubated for 1.5 h. During that time a color change 
of the resin from yellow to deep red occurred. The solution was removed from the resin 
and the resin was washed with pure TFA and pure DCM. All filtrates were collected, and 
the solvents were removed under pressure. The resulting white residue was dissolved in 
little DCM and precipitated in ice-cold diethyl ether. The precipitate was centrifuged down, 
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redissolved and reprecipitated for four times. Afterward, the sample was dissolved in H2O, 
a few drops HCl were added to ensure the exchange of anions and the sample was 
lyophilized (95%). 
1H NMR (300 MHz, DMSO, Me4Si, 298 K): δ(ppm) = 9.01 (s, 3H, ε-CHHis), 8.54-8.33 (m, 
5H, α-NH), 8.14 (m, 1H, α-NH), 7.46-7.09 (m, 6H, δ-CHHis, NHHis), 4.60 (m, 3H, α-CHHis), 4.29 
(m, 1H, α-CHCys), 3.80 (s, 4H, α-CHGly), 3.14-2.74 (m, 8H, β-CH2His, β-CH2Cys), 1.84 (s, 
3H, -CH3) 
LC-MS (m/z): calculated for [M+H]+: 688.74, found: 688.8 
Synthesis of Cyt(Mal) 
Cyt c (3.00 mg, 0.242 µmol) was dissolved in 1.5 mL phosphate buffer (40 mM, 5 mM EDTA, 
pH 7.4). NHS-PEG(4)-Maleimide linker (7.08 mg, 0.014 mmol) was also dissolved in 
0.75 mL phosphate buffer. Both solutions were combined and shaken at room temperature 
for 2 h. The solution was purified with a centrifugal filter unit (3 kDa, 7500 rpm, 12 min, 
6 °C) and washed twice with phosphate buffer. For the reaction with the peptide, the 
modified protein was used directly. In case of the isolation of maleimide-functionalized 
cytochrome Cyt(Mal), the solution was purified 3 more times with the centrifugal filter 
unit using distilled water. Red crystals were obtained after lyophilization (4.6 mg). 
Synthesis of Cyt(CGGHHH)14 
The peptide (13.47 mg, 19.6 µmol) was dissolved in 250 µL phosphate buffer (40 mM, 5 mM 
EDTA, pH 7.4) and pretreated with TCEP (49.01 mg, 196 µmol, in 250 µL phosphate buffer). 
Both solutions were combined, and the pH value was adjusted to 2 with 1 M NaOH. The 
mixture was shaken for 2 h. Excess of TCEP was removed by adding AZBA (63.95 mg, 
392 µmol, in 2 mL buffer). 120 µL 1 M NaOH were added to ensure the complete dissolution 
of AZBA (pH >5.5). The AZBA solution was added to the peptide TCEP solution and 
shaken for 1 h. The pH value of the peptide mixture was adjusted to the buffered protein 
solution (7.4) of Cyt(Mal) and the mixtures were combined and stirred overnight. The next 
day the solution was mixed with 1 mM H2O2 solution to ensure the complete oxidation of 
Fe2+ to Fe3+ (checked with absorption spectra). The Cyt(CGGHHH)14 conjugate was 
purified with a centrifugal filter unit (3 kDa, 7500 rpm, 10 min, 6 °C) and five times washed 
with distilled water. After lyophilization red crystals were obtained (7.93 mg). 
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Synthesis of Lyz(Mal) and Lyz(CGGHHH)5 
Lysozyme (Lyz) (3.00 mg, 0.210 µmol) was modified in an analog procedure as described 
for Cyt c. The NHS-PEG(4)-Maleimide linker (2.26 mg, 0.0044 mmol) and the peptide 
(5.05 mg, 0.0073 mmol) were adjusted to the amount of seven amines present on the surface 
of lysozyme. White crystals of Lyz(CGGHHH)5 were obtained after lyophilization 
(3.94 mg). 
Synthesis of BLG(SMCC-Mal) and BLG(CGGHHH)7 
β-Lactoglobulin (BLG) (3.00 mg, 0.164 µmol) was modified in an analog procedure as 
described for Cyt c. Here the sulfo-SMCC (sulfosuccinimidyl 4-(N-maleimidomethyl) 
cyclohexane-1-carboxylate) linker was used for the surface modification of the amines. 
s-SMCC (2.58 mg, 0.0059 mmol) and the peptide (13.47 mg, 0.0196 mmol) were adjusted to 
the amount of twelve amines present on the surface of BLG. Light brown crystals of 
BLG(CGGHHH)7 were obtained after lyophilization (6.21 mg). 
5.3.2 Protein Characterization Techniques 
SDS-Gel 
The SDS-PAGE was performed as described elsewhere[297] using a polyacrylamide gel 
(Rotiphorese® 30 gel mix) with a thickness of 0.75 mm (C.B.S. Scientific) and stained with 
Coomassie Brilliant Blue G. 5 µL of PageRuler pre-stained protein ladder (10-170 kDa) were 
used as marker. Samples of the proteins were dissolved of a concentration of 4 mg mL-1 in 
water. The proteins were denaturized by adding 5 µL of Roti®-Load 1 (Carl Roth) to 15 µL 
protein solution and heating in a boiling water bath for 10 min. 20 µL were loaded on each 
bag. Images of SDS-PAGE gels were taken with the GelDocTM XR+ (Bio-Rad Laboratories 
Inc.) and processed with the Image LabTM Software (camera filter 1). 
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MALDI-ToF (Matrix-assisted Laser Desorption/Ionization Time of Flight) 
The measurements were carried out on a Shimadzu Axima CFR MALDI-ToF mass 
spectrometer, equipped with a nitrogen laser delivering 3 ns laser pulses at 337 nm. 
Samples were prepared by dissolving the sample in CH3CN/TFA 0.1% at a concentration 
of ~1 mg mL-1. 1 µL of this mixture was applied to a multistage target to evaporate and 
create a thin analyte film. Sinapic acid was used as matrix and applied to the target before 
adding the sample. The samples were measured in positive ion and in a linear mode of the 
spectrometer. 
TNBS Assay for the Quantification of Amino Groups 
The number of modified amino groups of the respective protein was determined by a TNBS 
(2,4,6-trinitrobenzene sulfonic acid) assay (Figure 83).[299-300] The detailed protocol is 
described elsewhere.[329] Briefly, to 500 µL of protein solution with various concentrations 
(ranging from 2.5 to 20 µM in 0.1 M borate buffer, pH 9) were added 3 µL 2.5% TNBS 
solution in an opaque container. The mixtures were incubated at 37 °C for 2 h. Afterward, 
100 µL of each solution were pipetted in a clear 96-well plate and the absorbance was 
measured in triplets at 335 nm at a Tecan plate reader (as described above) (Figure 84). 
For all protein concentrations, blank measurements (without TNBS) were carried out at 
335 nm and subtracted from the original values. 
 
Figure 83: Reaction scheme of primary amines on the surface of Cyt c with 2,4,6-trinitrobenzene sulfonic 
acid resulting in a colored reaction product. 
5 Experimental Part 147 
 
Figure 84: TNBS assay of modified amino groups with Cyt c (orange) as a standard curve and a 20 µM 
concentration of Cyt(CGGHHH)14 (blue). The assay shows that Cyt(CGGHHH)14 has 4.92 ± 0.31 amino 
groups left corresponding to 14 introduced peptides on the surface of the enzyme. 
Dynamic Light Scattering (DLS) Measurements 
Dynamic light scattering experiments were performed on a Malvern Zetasizer Nano ZS in 
disposable polystyrene micro cuvettes (VWR) using 120 µL of freshly prepared protein and 
modified protein solutions in PBS (pH 7.4). Generally, after equilibration to 25 °C, three 
measurements were performed, with the instrument optimizing the number of runs for 
each measurement. The refractive index (RI) of the dispersant (preset: water) was set to 
1.330 and the viscosity to 0.8872 cP, respectively. The RI of the particle was set to 1.45. The 
absorption of the protein was set to 0.00, both attenuator and measurement position were 
controlled by the instrument and all measurements were performed at a scattering angle 
of 173°. The measurements are normalized to each other. 
Circular Dichroism (CD) Spectroscopy 
CD spectra were recorded on a J 815 (JASCO) using the software Spectra Manager 2.12.00. 
All spectra for the Cyt(CGGHHH)14 were recorded at 20 °C with a total concentration of 
0.1 mg mL-1 protein in 10 mM K3PO4/50 mM Na2SO4 buffer pH 7 using quartz cells with a 
path length of 1 mm. All spectra were corrected by subtraction from the background 
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(buffer). Data points were collected at a resolution of 1 nm. Secondary structure contents 
were predicted with DICHROWEB using the CONTIN-LL method (reference set 7). 
5.3.3 Evaluation of Enzymatic Activity 
Peroxidase Functionality (ABTS Assay) 
A published protocol of the assay has been slightly modified.[311] Briefly, ABTS was 
dissolved at a concentration of 2 mM in 10 mM phosphate buffer pH 7.4. The protein 
samples were dissolved at a concentration of 40 µM and their concentration was adjusted 
to the same values by absorption measurements at 409 nm. The H2O2 concentration ranged 
between 0.4 mM and 30 mM. In a 96-clear well plate, 50 µL ABTS solution were pipetted 
and 25 µL protein sample were added. 25 µL of the respective H2O2 concentrations were 
added to the ABTS/protein sample mixture and the absorption was measured at 410 nm 
for 3 min every 10 s in a kinetic cycle. As a blank, measurement buffer was added to the 
samples instead of H2O2. All measurements were carried out in triplicate and were 
corrected by subtraction of the blank sample. The data analysis (determination of 
Michaelis-Menten values) was carried out with GraFit 7.0.3 (Figure 85). 
 
Figure 85: Michaelis-Menten kinetics of peroxidase activity of peptide-modified Cyt(CGGHHH)14, Cyt c* (in 
parallel to the synthesis treated cytochrome) and native Cyt c. Data represent averages with error bars from 
three independent experiments performed in triplicate. 
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Esterase-like Activity (MUF Assay) 
The induced esterase activity was determined using 4-methylumbelliferyl butyrate 
(MUF).[313] The ester is a non-fluorescent compound, which is hydrolyzed by esterases and 
lipases into the highly fluorescent 4-methylumbelliferone (4-MU). 
Two different procedures for the MUF assay were carried out. In the case of Cyt c, the 
Michaelis-Menten parameters of the esterase-like functionality were determined. For 
lysozyme and β-lactoglobulin a simpler form was used which is only comparing the 
esterase-like activities of the modified proteins with the native ones. 
Determination of Michaelis-Menten Kinetics 
All cytochrome c samples were dissolved at a concentration of 3.5 mg mL-1 in 20 mM 
phosphate buffer (pH 6.0). MUF was dissolved in acetonitrile at a concentration of 40 mM. 
In a black 96-well plate, 25 µL phosphate buffer (for blank/autohydrolysis) or protein 
solution were pipetted. 25 µL of the MUF solution in concentration ranges from 1.875 mM 
to 40 mM were added right before the measurement started. The fluorescence (Ex: 342 nm, 
Em: 445 nm) was measured for 3 min every 10 s in a kinetic cycle. All measurements were 
carried out in triplicate and were corrected by subtraction of the blank sample. The data 
analysis was carried out with GraFit 7.0.3 (Figure 86). 
 
Figure 86: Michaelis-Menten kinetics of esterase-like activity of peptide-modified Cyt(CGGHHH)14. Native 
Cyt c did not show any activity concerning the cleavage of MUF. Data represent averages with error bars 
from three independent experiments performed in triplicate. 
Simple Form of Assay 
The protein samples were dissolved at a concentration of 0.5 µmol mL-1 in 20 mM 
phosphate buffer (pH 6.0). MUF was dissolved in an acetonitrile/water mixture (50:50) at a 
concentration of 0.738 mg mL-1. In a black 96-well plate, 25 µL phosphate buffer (for 
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blank/autohydrolysis) or protein solution were pipetted. 25 µL of the MUF solution were 
added right before the measurement started. The fluorescence (Ex: 342 nm, Em: 445 nm) 
was measured for 3 min every 15 s in a kinetic cycle. All measurements were carried out 
in triplets. The autohydrolysis of MUF was observed with buffer instead of protein sample. 
Coupled Esterase and Peroxidase Activity (HVA Assay) 
The coupled catalytic activity of Cyt(CGGHHH)14 was assayed with the ethyl ester of 
homovanillic acid (HVA). The HVA ester was dissolved at a concentration of 13.7 mM in 
100 mM phosphate buffer (pH 8). 30% H2O2 solution was diluted to 1% for the experiments. 
The protein samples were dissolved at a concentration of 16 µM in phosphate buffer. The 
concentration of Cyt(CGGHHH)14 was adjusted by absorption measurements at 409 nm. 
In a black 96-well plate 100 µL buffer were pipetted and in each case 9 µL protein sample, 
9 µL HVA ester and 9 µL H2O2 were added. The developing fluorescence was observed 
(Ex: 315 nm, Em: 425 nm) in triplicate over 60 min in kinetic cycles of 10 s. After the 
reaction, the triplicates were collected and purified with a centrifugal filter unit (3 kDa, 
7500 rpm, 10 min, 6 °C). The filtrates were analyzed by HPLC-MS.  
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6.1 List of Abbreviations 
Abbreviation Meaning 
Ø diameter 
abs. absorbance 
ADP adenosinediphosphate 
AGU anhydrous glucose unit 
AMP adenosinemonophosphate 
anhyd. anhydrous 
approx. approximately 
aq. aqueous 
ATP adenosinetriphosphate 
Boc tert-butoxycarbonyl 
Br bromine 
br broad 
BSA Bovine Serum Albumine 
Bz benzoyl 
c centi- 
C carbon 
°C degrees Celsius 
CD Circular dichroism, Cyclodextrin 
CDCl3 deuterated chloroform 
conc. concentration 
COOH carboxyl group 
COSY homonuclear correlation spectroscopy 
cP centipoise 
CPP cell penetrating peptide 
CTF cell titer fluor 
δ chemical shift (ppm), downfiled from TMS 
dd- double distilled 
D2O deuterium oxide 
d6 deuterated (6-times) 
Da Dalton 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
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Abbreviation Meaning 
DCC N,N’-dicyclohexylcarbodiimide 
DC dendritic cell 
DCl deuterium chloride 
DCM dichloromethane 
DEAD diethyl azodicarboxylate 
DEPT distortionless enhancement by polarization transfer 
Dex dextran 
DIAD diisopropyl azodicarboxylate 
DIPEA N,N-diisopropylethylamine 
DLS Dynamic Light Scattering 
DMAP 4-(N,N-dimethylamino)pyridine 
DMEM Dulbecco’s modified Eagle’s medium 
DMF dimethylformamide 
DMSO dimethyl sulfoxide 
DS Degree of Substitution 
DTNB 5,5’-dithio-bis-(2-nitrobenzoic acid) 
EDC N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
EDTA ethylenediaminetetraacetic acid 
e.g. exempli gratia, means: for example 
em. emission 
equiv equivalent 
et al. et alii, means: and others 
etc. and so forth 
Et2O diethyl ether 
EtOH ethanol 
ex. excitation 
FCS fetal calf serum 
Fmoc fluorenylmethyloxycarbonyl 
FTIR Fourier transform infrared spectroscopy 
g gram 
g gravity of Earth 
GPC Gel Permeation Chromatography 
h hour 
H hydrogen 
H2O water 
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Abbreviation Meaning 
HeLa tumor cells from the patient Henrietta Lacks 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HMBC heteronuclear multiple bond correlation 
HPLC high performance liquid chromatography 
HSQC heteronuclear single quantum coherence 
IR infrared spectroscopy 
k kilo- 
KBr potassium bromide 
λ wavelength 
L liter 
LC-MS liquid chromatography-mass spectrometry 
Lys lysine 
µ micro- 
m mass 
m meter 
m milli- 
M molar 
max. maximum 
MeOH methanol 
MHz megahertz 
min minute 
mL milliliter 
mm millimeter 
mol mole(s) 
MS mass spectrometry 
MTT 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide 
MW molecular weight 
MWCO molecular weight cut-off 
m/z mass to charge ratio (in MS) 
N nitrogen 
N3 azide 
n.a. not available 
NaBH4 sodium borohydride 
NBS N-bromosuccinimide 
NHS N-hydroxysuccinimide 
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Abbreviation Meaning 
NMR nuclear magnetic resonance 
OVA ovalbumin 
ox oxidized 
p pico- 
P phosphorous 
PBS phosphate buffered saline 
PEG poly(ethylene glycol) 
pH proton log units 
ppm part per million 
P/S penicillin-streptomycin 
RI refractive index 
RT room temperature 
SD standard deviation 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SMCC 
succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-
carboxylate 
Sp spermine 
TEA triethylamine 
TLC thin layer chromatography 
TMS tetramethylsilane 
ToF Time of Flight (in MS) 
tosyl p-toluenesulfonyl 
UV ultraviolet 
V Volt 
V volume 
vs. versus 
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6.2 Supplemental Data 
6.2.1  1H-NMR and 31P-NMR Spectra 
Amino-modified Macrocyclic Polyamine NH2-MCA 
 
Figure 87: 1H-NMR spectra of NH2-MCA 13. 
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BCN-modified Macrocyclic Polyamine BCN-MCA 
 
Figure 88: 1H-NMR of BCN-MCA 15. 
Azidated Dextran Dex-(N3)9 
 
Figure 89: 1H-NMR of Dex-(N3)9 20. 
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End group functionalized PEG 
 
Figure 90: 1H-NMR of PEG-NHP 24. 
 
Figure 91: 1H-NMR of PEG-O-NH2 26. All aromatic protons have disappeared. 
158 6.2 Supplemental Data 
Dextran-PEG polymer brush 
 
Figure 92: 1H-NMR of Dextran-PEG polymer brush 27. 
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Activated Dextran Dex-(4-NC)7.5 
 
Figure 93: 1H-NMR of Dex-(4-NC)7.5 30. 
Thiol-modified Dextran Dex-(SH)7 
 
Figure 94: 1H-NMR of Dex-(SH)7 31. 
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Carrier-Catalyst Conjugate Dex-(S-Mal-MCA)6 
 
Figure 95: 1H-NMR of Dex-(S-Mal-MCA)6 33. 
Hexapeptide Ac-HHHGGC-NH2 
 
Figure 96: 1H-NMR of hexapeptide Ac-HHHGGC-NH2. 
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31P-NMR Kinetics 
Time-Course Kinetics of NH2-MCA 
 
Figure 97: 31P-NMR time-course kinetics of NH2-MCA 13. Plotted and fitted to first order kinetics (green 
line) and Y’ equation with Mestrenova. 
Time-Course Kinetics of Dex-(S-Mal-MCA)6 
 
Figure 98: 31P-NMR time-course kinetics of Dex-(S-Mal-MCA)6 33. Plotted and fitted to first order kinetics 
(green line) and Y’ equation with Mestrenova. 
162 6.2 Supplemental Data 
Time-Course Kinetics of Dex-(SH)7 
 
Figure 99: 31P-NMR time-course kinetics of Dex-(SH)7 31. No ATP cleavage is observed. 
  
6 Appendix 163 
6.2.2 Electrospray Ionization Mass Spectra (ESI-MS) 
Amino-modified Macrocyclic Polyamine NH2-MCA 
 
Figure 100: Mass spectrum of NH2-MCA 13. 
BCN-modified Macrocyclic Polyamine BCN-MCA 
 
Figure 101: Mass spectrum of BCN-MCA 15. 
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Mal-modified Macrocyclic Polyamine Mal-MCA 
 
Figure 102: Mass spectrum of Mal-MCA 17. 
Hexapeptide Ac-HHHGGC-NH2 
 
Figure 103: Mass spectrum of hexapeptide. 
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6.2.3 Graphs of Standard Curves 
Aromatic Azide Content 
 
Figure 104: Standard curve (green line) of azidobenzoic acid 19 (green dots) and measured Dex-(N3)9 20 
sample at 280 nm to determine the amount of conjugated AZBA to the dextran backbone. 
Ellman’s Assay 
 
Figure 105: Standard curve (purple line) of acetyl cysteine (purple dots) and Dex-(SH)7 31 (pink dot) sample 
at 412 nm to determine the number of thiols per dextran backbone. 
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6.2.4 Esterase-like Activity of Pure Peptide 
As described, the esterase-like activity of modified Cyt c compared to unmodified Cyt c 
was measured and it was possible to measure Michaelis-Menten kinetics for the system 
(Figure 85). For one substrate concentration (1.5 mM), the esterase-like activity of the pure 
peptide was measured in the same concentration as attached to the enzyme’s surface 
(Figure 106). A higher esterase-like activity for the unconjugated peptide was observed 
which can be explained by a much higher diffusion of the small molecules in solution. 
 
 
Figure 106: Comparison of esterase-like activity at one substrate concentration (1.5 mM) for unmodified 
Cyt c (dark red line), Cyt(CGGHHH)14 (orange line) and pure peptide HHHGGC (grey line). 
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